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VALENCIAN SUMMARY 




La depressió és un dels trastorns mentals més comuns a tot el món. Està associada 
amb costos significants de tipus personal (p.e. en termes de qualitat de vida i benestar) i 
social (p.e. en termes de despeses econòmiques i ús de serveis) (Gustavsson et al., 2011; 
Kessler, 2012; Mrazek, Hornberger, Altar, i Degtiar, 2014; Parés-Badell et al., 2014). En 
especial, la prevalença de depressió en l'Atenció Mèdica Primària espanyola es troba entre 
el 13.9% i el 29% (Alonso et al., 2004; Roca et al., 2.009) i menys del 50% de la gent rep 
el tractament adequat (p.e. Aragonès, Piñol, Labad, Folch, i Mèlich, 2004). 
Tot i que actualment existeixen tractaments efectius per a la depressió (medicació, 
psicoteràpia o ambdós) (Cuijpers, van Straten, van Oppen, i Andersson, 2008; Cuijpers 
et al., 2013; Huhn et al., 2014) no arriben al nombre creixent de gent que els necessita 
(Kazdin i Blase, 2011). Les causes poden ser els llargs períodes de llistes d'espera en 
l’Atenció Primària, el temps limitat d'atenció al pacient, l'estigma social associat a les 
malalties mentals i la falta de professionals ben qualificats, entre altres (Gaston, Abbott, 
Rapee, i Neary, 2006; Harvey i Gumport, 2015; Sartorius, 2002; Wittchen et al., 2011). 
Així doncs, cal incorporar ferramentes noves que proporcionen tractaments basats en 
l'evidència per a tractar la depressió amb l'objectiu de respondre de manera efectiva a 
aquesta necessitat. 
Les intervencions de baixa intensitat podrien ser una bona alternativa per a superar 
aquestes limitacions (Bockting, Williams, Carswell, i Grech, 2016). En particular, les 
intervencions basades en Internet són un exemple d'aquest tipus d'intervencions que han 
rebut evidència empírica com opcions adequades dins del model d'atenció escalonada 
(Bennett-Levy, Richards, i Farrand, 2010). De fet, alguns meta-anàlisis  suggereixen que 
la depressió pot ser tractada de manera efectiva amb psicoteràpia breu (de 6 a 8 sessions), 
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en concret amb teràpia cognitiva conductual (TCC), teràpia de resolució de problemes 
(Nieuwsma et al., 2012) i orientació (Cape, Whittington, Buszewicz, Wallace, i 
Underwood, 2010). Però, es necessiten més estudis sobre l'eficàcia i assajos controlats 
aleatoris per analitzar els efectes d'aquestes intervencions emprant una condició de 
control actiu com a comparació. 
S'han proposat les intervencions basades en Internet com una opció assequible que 
pot ajudar a reduir la diferència entre la demanda i l'oferta de tractaments (Andersson & 
Titov, 2014; Cuijpers, Kleiboer, Karyotaki, i Riper, 2017; Holst et al., 2018). Un 
considerable nombre d'estudis han demostrat la seua eficàcia i acceptabilitat en el 
tractament de la depressió (Andersson i Cuijpers, 2009; Andersson, 2016; Andrews, 
Cuijpers, Craske, McEvoy, i Titov, 2010; Karyotaki et al., 2018). A més a més, alguns 
estudis han demostrat que les intervencions basades en Internet son més eficaces quan 
són guiades (des de recordatoris automàtics fins feedback per correu electrònic, missatges 
de text o breus trucades), cosa que emfatitza la relació positiva entre l'assistència 
terapèutica i els índexs de millora (Baumeister, Reichler, Munzinger, i Lin, 2014; Berger, 
Hämmerli, Gubser, Andersson, i Caspar, 2011; Johansson i Andersson, 2012; Richards i 
Richardson, 2012). Finalment, s'han trobat magnituds d'efecte similars entre 
intervencions basades en Internet i teràpies cara a cara (Andersson, Cuijpers, Carlbring, 
Riper, i Hedman, 2014; Andersson, Topooco, Havik, i Nordgreen, 2016). 
Fins el moment, moltes intervencions basades en Internet per a la depressió estan 
basades principalment en TCC (Andersson, 2009; Hedman, Ljótsson, i Lindefors, 2012) 
i en altres aproximacions terapèutiques com la teràpia de resolució de problemes (van 
Straten et al., 2008), teràpia interpersonal (Donker et al., 2013), teràpia d'acceptació i 
compromís (Glendenning, Hoon, i John, 2016), teràpia psicodinàmica (Johansson et al., 
2012) o activació conductual (Nyström et al., 2017). Tot i que aquestes aproximacions 
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són eficaces per al tractament de la depressió, no tots els pacients es beneficien d'elles. 
La causa podria ser que molts tractaments estàndard paren més atenció a trastorns mentals 
específics sense tindre en compte la presència de comorbiditats (p.e. trastorns d'ansietat) 
o trastorns no especificats (Fairburn, Cooper, i Shafran, 2003; Kring i Sloan, 2009). Una
aproximació alternativa que podria contribuir a resoldre aquesta limitació és la 
perspectiva transdiagnòstica (Sauer-Zavala et al., 2017). 
La perspectiva transdiagnòstica es centra principalment en allò que tenen en comú 
els trastorns emocionals (TEs) (p.e. depressió i ansietat) en compte d’allò que és específic 
i diferencial (Sandín, 2012). En aquesta línia, Brown i Barlow (2009) han suggerit que 
els TEs tenen en comú una estructura latent amb dues dimensions (afecte negatiu o 
inhibició conductual i afecte positiu o activació conductual) que, associades amb diferents 
factors d’estrès, poden resultar en símptomes d'ansietat o depressió. Aquesta 
conceptualització dels TEs ha permès el disseny i la implementació dels protocols 
transdiagnòstics amb components de tractaments comuns a través d'un marc més 
parsimoniós com és el Protocol Unificat (Barlow et al., 2011) i la teràpia grupal 
transdiagnóstica TCC (Norton, 2012). Estudis recents i meta-anàlisis han demostrat que 
els tractaments transdiagnòstics són efectius en TEs respecte als grups en llista d'espera o 
al tractament habitual (Reinholt i Krogh, 2014) i fins i tot en comparació amb les 
intervencions destinades a trastorns específics (Pearl i Norton, 2017). Així mateix, 
l'eficàcia d'aquests resultats pot ser transferida al camp de les intervencions basades en 
Internet (Newby, McKinnon, Kuyken, Gilbody, i Dalgleish, 2015; Newby, Twomey, 
Yuan Li, i Andrews, 2016; Păsărelu, Andersson, Bergman Nordgren, i Dobrean, 2017). 
Fins el moment, la majoria dels tractaments psicològics per als TEs (p.e. TCC o 
transdiagnòstic) s'han centrat, principalment, en intervencions dissenyades per a la 
dimensió d'afecte negatiu i han parat menys atenció a construir recursos positius. Alguns 
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estudis proposen que el sistema d'afecte positiu podria ser la clau per a facilitar la 
recuperació dels trastorns d'ansietat i depressió (Dunn, 2012; Fredrickson, 2013; Garland 
et al., 2010; Layous, Chancellor, i Lyubomirsky, 2014).  Si tenim en compte el paper de 
l’afecte positiu en TEs, és necessari incloure aquesta dimensió com una estratègia 
d'intervenció especialment als tractaments transdiagnòstics (Carl, Soskin, Kerns, i 
Barlow, 2013). 
Una perspectiva que va emergir amb força amb l'objectiu de reforçar el funcionament 
emocional positiu humà, i particularment l’afecte positiu, és la psicologia positiva 
(Seligman i Csikszentmihalyi, 2000). Aquesta pretén augmentar o generar una sèrie de 
factors protectors (p.e. benestar, resiliència, satisfacció amb la vida) que preparen la 
persona per a lidiar amb situacions d’estrès que pot trobar en el present o que poden 
aparèixer en el futur (Fredrickson, 2001; Tugade i Fredrickson, 2007; Vázquez i Hervás, 
2008). 
La psicologia positiva és especialment rellevant per a aquells que pateixen depressió. 
Per exemple, Santos et al. (2013) van concloure que les intervencions amb psicologia 
positiva redueixen tant els símptomes de depressió com la possibilitat de recaiguda durant 
els subseqüents períodes de depressió. A més a més, diversos meta-anàlisis han demostrat 
la seua efectivitat a l'hora de reduir la simptomatologia depressiva i d'incrementar el 
benestar (Bolier et al., 2013a; Chakhssi, Kraiss, Sommers-Spijkerman, i Bohlmeijer, 
2018; Sin i Lyubomirsky, 2009; Weiss, Westerhof, i Bohlmeijer, 2016) emfatitzant el seu 
paper juntament amb tractaments convencionals per a la depressió clínica (Johnson i 
Wood 2015). 
Pel que fa a les intervencions basades en Internet i les intervencions de psicologia 
positiva, la literatura ha posat de manifest resultats desiguals en relació amb la millora de 
la simptomatologia de la depressió (Bolier i Abello, 2014; Mitchell, Vella-Brodrick, i 
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Klein, 2010). Alguns estudis mostren que les intervencions de psicologia positiva online 
podrien augmentar el benestar dels participants i reduir la seua depressió en comparació 
de les condicions de control (Bolier et al., 2013b; Mitchell, Stanimirovic, Klein, i Vella-
Brodrick, 2009; Seligman et al., 2005; Shapira i Mongrain, 2010; Wellenzohn, Proyer, i 
Ruch, 2016). Tot i això, altres estudis no ho fan (Abbott, Klein, Hamilton, i Rosenthal, 
2009; Gander, Proyer, Ruch, i Wyss, 2013; Mitchell et al., 2009; Mongrain i Anselmo-
Matthews, 2012; Woodworth, O’Brien-Malone, Diamond, i Schüz, 2016). A part d'això, 
la majoria de les intervencions de psicologia positiva online han emprat exercicis curts 
d'una setmana de durada si es comparen amb els tractaments convencionals, els qual usen 
sèries de mòduls i exercicis. Fins el moment, hi ha pocs estudis que inclouen programes 
més llargs i molts d'ells incorporen exercicis de psicologia positiva i d’altres disciplines 
com la teràpia cognitiva (Abbott et al., 2009; Bolier et al., 2013b; Roepke et al., 2015). 
Així doncs, és necessari desenvolupar més estudis que investiguen l'eficàcia d' 
intervencions basades en Internet més complexes basades en la perspectiva 
transdiagnòstica i la psicologia positiva per tal de verificar la seua eficàcia (Görges, 
Oehler, von Hirschhausen, Hegerl, i Rummel-Kluge, 2018). En aquesta línia, Taylor, 
Lyubomirsky, i Stein (2017) i González-Robles, García-Palacios, Baños, Quero, i Botella 
(2017) avaluaren l'eficàcia de dos noves intervencions transdiagnòstiques basades en la 
psicologia positiva per augmentar l’afecte positiu en casos d'ansietat i depressió i 
obtingueren prometedors resultats d'eficàcia per al tractament de TEs.  A més, Díaz-
García et al. (2017) també desenvoluparen una intervenció basada en Internet i 
transdiagnòstica amb un component particular per abordar l'afecte positiu. El tractament 
de protocol va consistir en 16 mòduls que van incloure elements per reduir l'afecte 
negatiu, elements convencionals del tractaments basats en l'evidència per a TEs i elements 
per promoure l’afecte positiu. Aquesta intervenció també formà part d'un assaig controlat 
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aleatori amb dues altres condicions (un protocol a través d'Internet i transdiagnòstic sense 
un component d'afecte positiu i un grup de control en llista d'espera). Aquest projecte està 
en curs i no s'han publicat resultats per a aquest estudi. 
2. Objectius
Atès que les intervencions de baixa intensitat basades en Internet, la perspectiva 
transdiagnòstica i les intervencions de psicologia positiva han començat a acumular 
evidència empírica per al tractament de la depressió, és necessari realitzar més estudis per 
demostrar la seua eficàcia en la pràctica d’Atenció Primària. Aquest estudi pretén explorar 
l'eficàcia i la cost-efectivitat d'un tractament habitual millorat (THM) per part del metge 
amb una intervenció computeritzada de baixa intensitat a través d’Internet centrada en la 
promoció de l’afecte positiu (THM+IPAP) comparada amb només el THM (només-
THM), per al tractament de la depressió en centres espanyols d’Atenció Primària. Aquest 
assaig forma part del projecte FIS de l'Institut de Salut Carlos III del Ministeri d'Economia 
i Competitivitat espanyol (ETES n° PI13/00982; PSI2010-17563), el qual inclou un 
assaig controlat aleatori multicèntric en quatre condicions paral·leles: a) un programa 
psicoeducacional d'estil de vida saludable, b) un programa centrat en la promoció de 
l'afecte positiu, c) una breu intervenció basada en el mindfulness i d) un THM en l’Atenció 
Primària. 
Només la informació clínica relacionada amb les condicions THM+IPAP i només-
THM es tindran en compte en aquest estudi. Els objectius concrets són: 
1. Examinar l'eficàcia de ambdues intervencions (THM+IPAP i només-THM) en la
severitat de la depressió i altres variables secundàries (afecte, qualitat de vida en 
relació amb la salut, benestar i mindfulness) després del tractament i als 
seguiments (de 6 i 12 mesos). 
VALENCIAN SUMMARY
8 
2. Analitzar si ambdues intervencions (THM+IPAP i només-THM) són tractaments
psicològics cost-efectius per a la depressió en un entorn d’Atenció Primària. 
3. Observar l'opinió dels participants sobre el tractament rebut.
4. Analitzar si l'efecte de la condició (THM+IPAP vs. només-THM) media en la
severitat de la depressió a causa de l'afecte positiu. 
5. Explorar si les variables sociodemogràfiques (sexe, edat, estat civil, nivell
d'estudis, treball i nivell d'ingressos) i les variables clíniques de la línia base 
(severitat de la depressió, qualitat de vida en relació amb la salut, benestar i 
mindfulness) moderen els efectes de la severitat de la depressió després del 
tractament i els seguiments. 
En concret, les hipòtesis d'aquest estudi són: 
H1. La condició THM+IPAP serà més eficaç comparada amb la condició només-
THM en la millora de la severitat de la depressió i altres variables secundàries (afecte, 
qualitat de vida en relació amb la salut, benestar i mindfulness) després del tractament i 
dels seguiments (de 6 a 12 mesos). 
H2. La condició de THM+IPAP serà mes cost-efectiva comparada amb la condició 
només-THM en termes de l’ús dels serveis sanitaris i socials (visites al metge de família, 
visites al servei d'urgències, absències al treball, deixar tasques habituals inacabades i 
reducció en la qualitat de tasques habituals per causa de problemes de salut) en el 
seguiments. 
H3. L'opinió de l'usuari sobre el tractament (lógica, satisfacció, recomanació a altres 
i utilitat) serà millor per a la condició THM+IPAP en tots els moments de l'avaluació. 
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H4. Els participants de la condició THM+IPAP (comparats amb el control) tindran 
un major canvi en l'afecte positiu (després del tractament i el seguiments) donant lloc a 
una major reducció de la severitat de la depressió (després del tractament i el seguiments). 
H5. No es generen hipòtesis específiques sobre quines variables moderadores 
(sociodemogràfiques i variables clíniques en la línia base) podrien ser significatives en 
l'efecte de la condició (THM + IPAP vs. només-THM) sobre la severitat de la depressió 
després del tractament i seguiments, a causa de l'exploratori naturalesa de les anàlisis. 
3. Metodologia
3.1.   Disseny 
S’ha portat a terme un assaig controlat aleatori accessible amb avaluacions contínues 
(pre-tractament, post-tractament, 6 mesos de seguiment, 12 mesos de seguiment) i en dues 
condicions: THM+IPAP i només-THM (grup de control) en un entorn d'Atenció Primària. 
3.2.   Mostra 
La mostra va ser estimada mitjançant G*Power 3 (Faul, Erdfelder, Lang, i Buchner, 
2007). Es va requerir una mostra de 52 participants (26 per condició) tenint en compte 
una potència de 0.80, un nivell alfa de 0.05 i una magnitud de l’efecte baixa-mitja (f = 
0.20 d’acord amb els estudis de Bolier et al., 2013b i Meyer et al., 2015).  Segons la 
literatura sobre intervencions a través d’Internet, s’espera una taxa d’abandó d’entre el 
20-30% (Spek et al., 2007; van Ballegooijen et al., 2014). Així doncs, el nombre total de 
participants que era necessari reclutar va ser 66. 
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3.3.   Població estudiada, reclutament, criteris d’eligilibitat i aleatoritat 
El reclutament va ser posat en pràctica  en centres espanyols d'Atenció Primària de 
les regions d’Aragó, Andalusia i les Illes Balears. Va començar en maig de 2015 i va 
finalitzar en maig de 2017. El metge de família va completar un informe de derivació 
psicològica on descrivia les característiques generals del pacient per què l’investigador 
local contactés amb el participant. Tots els pacients interessats van haver de signar un 
informe de consentiment per poder formar part de l’estudi.  Per confirmar els criteris 
d’inclusió (> de 18 anys, conèixer els criteris diagnòstics per al Trastorn Depressiu Major 
o el Trastorn de Depressió Persistent), l’investigador va administrar instruments
d’avaluació a través d’una entrevista telefònica: la entrevista neuropsiquiàtrica 
internacional per a diagnòstic -MINI versió 5- (Ferrando et al., 1998), el qüestionari sobre 
la salut del pacient-9 (PHQ-9) (Diez-Quevedo, Rangil, Sanchez-Planell, Kroenke, i 
Spitzer, 2001)  i un breu qüestionari sobre variables sociodemogràfiques. 
Després de la realització del diagnòstic, els pacients van ser assignats aleatòriament 
a una de les dues condicions (THM+IPAP o només-THM). L’assignació va ser duta a 
terme per un investigador independent pertanyent a la REDIAPP (Red d’Investigació 
d’Activitats Preventives i Promoció de la Salut) que no va participar en l’estudi. 
3.4.   Intervencions 
Tots els pacients que van participar en l’estudi (independentment del grup on van ser 
aleatòriament assignats) van ser tractats pels seus metges de família. 
3.4.1.   Tractament habitual millorat 
El tractament habitual va ser millorat perquè els metges de família que participaren 
van rebre un programa d’entrenament sobre com diagnosticar i tractar la depressió. El 
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programa estava basat en la guia espanyola per al tractament de la depressió en l’Atenció 
Primària (Fernández et al., 2006). En cas de risc de suïcidi, disfunció social severa o 
empitjorament dels símptomes, es va recomanar derivar el pacient al servici de salut 
mental. 
3.4.2.   Tractament habitual millorat amb una intervenció computeritzada de baixa 
intensitat a través d’Internet centrada en la promoció de l’afecte positiu 
Sessió cara a cara 
A banda de rebre tractament per part del metge de família, els participants van 
participar en una sessió cara a cara de 90 minuts de durada (3-5 pacients) dirigida per un 
psicòleg clínic. L’objectiu de la sessió era explicar l’estructura del programa i els 
components principals del tractament, deixar clares les instruccions d’ús de la plataforma 
online i motivar els participants al canvi. En últim lloc, l’objectiu últim era reforçar el 
compromís i l’adhesió al tractament. 
Programa d’intervenció online 
El programa auto-guiat online va consistir en 4 mòduls terapèutics (60 minuts per 
mòdul aproximadament). La durada del programa podia variar entre els usuaris, però 
normalment va ser completat entre 4 i 8 setmanes (com a màxim 2 setmanes per mòdul). 
Aquests mòduls contenien elements multimèdia (vídeos, imatges, textos) que 
proporcionaven informació sobre la depressió i estratègies d’afrontament. Els mòduls 
eren seqüencials per avançar pas a pas al llarg del programa. Una volta acabat, l’usuari 
podia repassar els continguts. 
En concret, aquesta intervenció seguia la perspectiva transdiagnòstica i estava basada 
en tècniques de la psicologia positiva. Va ser dissenyada principalment per disminuir la 
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severitat de la depressió i previndre recaigudes mitjançant la promoció del benestar i 
l’afecte positiu. 
Per a més informació sobre el protocol per a la promoció de l’afecte positiu consulteu 
el capítol de García-Palacios, Mira, Mayoral, Baños, i Botella (2017) i el protocol de 
l’estudi de Castro et al. (2015). 
3.5.   Mesures 
3.5.1.   Mesura principal 
Severitat de la depressió: Qüestionari sobre la Salut del Pacient-9 (PHQ-9; Kroenke, 
Spitzer, i Williams, 2001). 
3.5.2.   Mesures secundàries 
Entrevista de diagnostic: entrevista neuropsiquiàtrica internacional per a diagnòstic 
versió 5.0 (M.I.N.I. 5.0; Ferrando et al., 1998; Sheehan et al., 1998). 
Afecte: escala de l’afecte positiu i negatiu (PANAS; Sandín et al., 1999; Watson, 
Clark, i Tellegen, 1988). 
Qualitat de vida en relació a la salut: qüestionari de salut SF-12 (SF-12; Vilagut et 
al., 2008; Ware, Kosinski, i Keller, 1996). 
Benestar: L’índex de felicidat de Pemberton (PHI; Hervás i Vázquez, 2013). 
Facetes del mindfulness: qüestionari de les cinc facetes del mindfulness (FFMQ; 
Baer, Smith, Hopkins, Krietemeyer, i Toney, 2006; Cebolla et al., 2012). 
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3.5.3.   Altres indicadors 
Ús dels serveis sanitaris i socials: qüestionari ad hoc de 5 preguntes per a les despeses 
relacionats amb l’ús dels serveis sanitaris i socials, la pèrdua de productivitat al treball, i 
l’impacte de la malaltia en les tasques habituals dels usuaris. 
Informació sociodemogràfica: sexe, estat civil, nivell educatiu, ocupació i nivell 
d'ingressos. 
Opinió sobre el tractament rebut. 
3.6.   Anàlisi de dades 
Totes les anàlisis estadístiques van ser realitzades amb el software SPSS 24.0 (IBM) 
per a Windows. 
Les anàlisis per intenció de tractar de models mixtos sense imputació ad hoc van ser 
emprats per afrontar la pèrdua d’informació (Chakraborty i Gu, 2009). La hipòtesi de què 
la informació faltava de manera completament aleatòria (MCAR) va ser avaluada amb el 
Little's MCAR test. Per tal d’analitzar l’efecte de la condició en els indicadors primaris 
(severitat de la depressió) i secundaris (afecte, qualitat de vida en relació amb la salut, 
benestar recordat i experimentat i facetes del mindfulness), així com la relació cost-
efectivitat i l’opinió dels participants, s’implementaren 29 models mixtos lineals. 
L’index de canvi fiable (ICF) (Jacobson i Truax, 1991) per a la severitat de la 
depressió va ser calculat en la mostra completa. 
Per analitzar els canvis en la severitat de la depressió i l’afecte tot tenint en compte 
l’assessorament posterior al mòdul en la condició THM+IPAP, es desenvoluparen 3 
models mixtos lineals. 
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Finalment, per explorar les variables de mediació i moderació, es realitzaren les 
anàlisis de mediació i moderació mitjançant el procediment descrit per Hayes (2013)  del 
PROCESS macro (versió 2.16). Es van elegir els models 4 i 1, respectivament. 
4. Resultats
4.1.   Participants i abandons 
En principi, 113 participants van interessar-se per l’estudi, dels qual 47 van ser 
exclosos del procés. Finalment, es van incloure a l’estudi 66 participants, que foren 
aleatòriament assignats a cada condició (THM+IPAP, n = 40; només-THM, n = 26). El 
25% dels participants de la condició THM+IPAP i el 19% de la condició només-THM 
van abandonar durant el post-tractament. El 47.5% dels participants de la condició 
THM+IPAP i el 23.07% de la condició només-THM abandonaren durant els 6 mesos de 
seguiment. Finalment, el 55% dels participants de la condició THM+IPAP i el 30.76% de 
la condició només-THM abandonaren durant els 12 mesos de seguiment. 
Respecte el percentatge de participants que completaren cada mòdul en la condició 
THM+IPAP, només el 45% completaren tots els mòduls del tractament; el 65% va 
completar tres mòduls; el 72.5%, dos mòduls; i el 77.5%, un mòdul. 
4.2.   Diferències d’eficàcia entre les dues condicions del tractament 
Severitat de la depressió (PHQ-9) 
Va haver-hi un efecte principal significant amb el pas del temps en la severitat de la 
depressió, F(3, 130.68) = 20.90, p < .001, cosa que indica que ambdues condiciones van 
ser eficaces en la disminució de la severitat en el temps. Però, no es va produir cap efecte 
significatiu de la interacció condició x temps en la severitat de la depressió, F(3, 130.68) 




Va haver-hi un efecte principal significant amb el pas del temps en l’afecte positiu 
F(3, 133.48) = 12.16, p < .001, i l’afecte negatiu, F(3,130.30) = 9.14, p < .001, cosa que 
indica que els dos grups van ser eficaços en l’increment de l’afecte positiu i la disminució 
de l’afecte negatiu en el temps. Però, no es va produir cap efecte significatiu de la 
interacció condició x temps en l’ afecte positiu , F(3, 133.48) = 0.57, p = .636, i l’afecte 
negatiu , F(3, 130.30) = 0.20, p = .896. 
Qualitat de vida en relació amb la salut (SF-12) 
Va haver-hi un efecte principal significant amb el pas del temps en la salut en general 
F(3, 125.79) = 3.53, p < .05; dolor corporal, F(3, 129.39) = 6.64, p < .001; rol físic, F(3, 
133.41) = 5.54, p < .001; salut mental, F(3, 137.27) = 10.09, p < .001; rol emocional, F(3, 
135.76) = 15.18, p < .001; funcionament social, F(3, 128.25) = 12.71, p < .001; i vitalitat, 
F(3, 135.75) = 7.85, p < .001, excepte en la variable del funcionament físic, F(3, 125.25) 
= 1.84, p = .143. Aquests resultats indiquen que les dues condicions van ser eficaces a 
l’hora de millorar la qualitat de vida amb la salut física i mental en el temps. Però, no es 
va produir cap efecte significatiu de la interacció condició x temps en la salut general , 
F(3, 125.79) = 2.07, p = .108; dolor corporal, F(3, 129.39) = 1.39, p = .247; rol físic, F(3, 
133.41) = 0.62, p = .602; funcionament físic, F(3, 125.25) = 0.37, p = .777; salut mental, 
F(3, 137.27) = 0.85, p = .47; rol emocional, F(3, 135.76) = 2.30, p = .080; funcionament 




Va haver-hi un efecte principal significant amb el pas del temps en el benestar total, 
F(2, 75.75) = 17.84, p < .001; benestar recordat, F(2, 75.74) = 16.63, p < .001; i benestar 
experimentat, F(2, 95.74) = 3.29, p < .05, cosa que indica que ambdues condiciones van 
ser eficaces en l’increment del benestar en el temps. Però, no es va produir cap efecte 
significatiu de la interacció condició x temps en el benestar total, F(2, 75.75) = 1.57, p = 
.215; benestar recordat, F(2, 75.74) = 1.51, p = .228; i benestar experimentat, F(2, 95.74) 
= 0.42, p = .661. 
Facetes del mindfulness (FFMQ) 
Va haver-hi un efecte principal significant amb el pas del temps en la variable d’ 
observar, F(2, 77.14) = 9.49, p < .001; actuar de manera conscient , F(2, 78.35) = 5.05, p 
< .01; no jutjar l’experiència interior, F(2, 79.92) = 5.28, p < .01; i no reaccionar a 
l’experiència interior, F(2, 80.99) = 6.10, p < .01, excepte en descriure, F(2, 78.88) = 
1.81, p = .170. Aquests resultats indiquen que les dues condicions del tractament van ser 
eficaces a l’hora de millorar les facetes del mindfulness en el temps. Però, no es va produir 
cap efecte significatiu de la interacció condició x temps en observar, F(2, 77.14) = 0.36, 
p = .697; descriure, F(2, 78.88) = 1.25, p = .293; actuar de manera conscient, F(2, 78.35) 
= 0.55, p = .581; no jutjar l’experiència interior, F(2, 79.92) = 0.59, p = .553; i no 
reaccionar a l’experiència interior, F(2, 80.99) = 0.57, p = .568. 
4.2.1.   Canvi clínicament significant en la severitat de la depressió (PHQ-9) 
En general, ambdues condicions del tractament mostraren un alt percentatge de 
participants “sense canvis” durant el post-tractament, participants “millorats” durant el 
seguiment 1 i participants “sense canvis” durant el seguiment 2. 
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4.3.   Diferències en la relació cost-efectivitat entre les dues condicions del tractament 
No va haver-hi un efecte principal significant amb el pas del temps en el nombre de 
visites al metge de família durant els últims 3 mesos F(2, 53.19) = 2.96, p = .061; el 
nombre de visites a emergències durant els últims 3 mesos, F(2, 16.51) = 1.33, p = .292; 
el nombre de dies de treball durant l’últim any, F(2, 25.17) = 0.18, p = .839; i el nombre 
de dies en què les tasques habituals no es van finalitzar per causa de problemes de salut 
durant l’últim mes, F(2, 47) = 1.48, p = .239, excepte en el nombre de dies en què la 
qualitat de les tasques habituals es va veure reduïda per causa de problemes de salut durant 
l’últim mes. Però, no es va produir cap efecte significatiu de la interacció condició x temps 
en el nombre de visites al metge de família durant els últims tres mesos, F(2, 53.19) = 
0.11, p = .897; el nombre de visites a emergències durant els últims 3 mesos, F(2, 16.51) 
= 0.54, p = .591; el nombre de dies de treball durant l’últim any, F(2, 25.17) = 2.29,  p = 
.122; el nombre de dies en què les tasques habituals no es van finalitzar per causa de 
problemes de salut durant l’últim mes, F(2, 47) = 0.81, p = .451; i el nombre de dies en 
què la qualitat de les tasques habituals es va veure reduïda per causa de problemes de 
salut durant l’últim mes, F(2, 47.55) = 1.38, p = .262. 
4.4.   Opinió dels participants sobre el tractament rebut 
Va haver-hi un efecte principal significant en la lògica del tractament, F(1, 60.24) = 
12.67, p ≤ .001; el grau de satisfacció amb el tractament, F(1, 61.61) = 12.91, p ≤ .001; 
la recomanació del tractament a altres persones, F(1, 62.54) = 15.97, p ≤ .001; la utilitat 
del tractament en el cas propi, F(1, 60.77) = 10.97, p ≤ .001; i la utilitat del tractament 
per a altres problemes psicològics, F(1, 62.24) = 8.54, p < .01. 
Va haver-hi un important efecte principal de la condició en la lògica del tractament, 
F (1, 60.24) = 12.67, p ≤ .001; el grau de satisfacció amb el tractament, F (1, 61.61) = 
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12.91, p ≤ .001; la recomanació de tractament als altres, F (1, 62.54) = 15.97, p ≤ .001; 
utilitat del tractament en el cas propi, F (1, 60.77) = 10.97, p ≤ .001; i la utilitat del 
tractament per a altres problemes psicològics, F (1, 62.24) = 8.54, p <.01, indicant que 
els participants en la condició THM+IPAP van mostrar una millor opinió sobre el 
tractament rebut en tots els punts del temps que els participants de la condició només-
THM. 
Però, no es va produir cap efecte significatiu de la interacció condició x temps en 
relació a la lògica del tractament, F(1, 54.99) = 2.69, p = .107; el grau de satisfacció amb 
el tractament, F(1, 54.46) = 2.45, p = .123; i la utilitat del tractament per a altres 
problemes psicològics , F(1, 53.78) = 1.24, p = .27, excepte en la recomanació del 
tractament a altres persones, F(1, 56.41) = 5.66, p < .05; i la utilitat del tractament en el 
cas propi, F(1, 54.49) = 5.83, p < .05. 
4.5.   Afecte positiu com a mediador 
No hi va a ver efectes indirectes significants en cap dels models, cosa que indica que 
el canvi en l’afecte positiu, (resultats del post-tractament, seguiment 1 i seguiment 2-
PANAS) no va afectar a la relació entre la condició i la severitat de la depressió (resultats 
del post-tractament, seguiment 1 i seguiment 2-PHQ-9). Ni els efectes directes ni l’efecte 
total dels models van resultar significants. 
4.6.   Models de moderació 
Variables sociodemogràfiques 
Les anàlisis mostraren que les variables sociodemogràfiques no van moderar l’efecte 
de la condició en els resultats posteriors al qüestionari PHQ-9 (p>.05). 
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Variables clíniques de la línia base 
Severitat de la depressió (PHQ-9) 
La mesura PHQ-9 no va moderar l’efecte de la condició en els resultats posteriors 
(post-tractament i en el seguiments) al PHQ-9 (p>.05). 
Qualitat de vida en relació amb la salut (SF-12) 
La variable de funcionament físic va moderar l’efecte de la condició en els resultats 
al PHQ-9 en el post-tractament. Els participants del THM+IPAP amb altes puntuacions 
en el funcionament físic en el pre-tractament aconseguiren una menor puntuació en el 
PHQ-9 durant el post-tractament, b = 6.11, 95% CI [2.41, 9.80], t = 3.32, p = .002. 
A més, la variable rol emocional va moderar l’efecte de la condició en els resultats 
al PHQ-9 en el post-tractament. Els participants de la condició THM+IPAP que partiren 
amb baixes puntuacions en el rol emocional en el pre-tractament aconseguiren una menor 
puntuació en el PHQ-9 durant el post-tractament, b = 3.46, 95% CI [0.11, 6.81], t = 2.08, 
p = .043. 
Finalment, la variable funcionament social va moderar l’efecte de la condició en el 
resultats al PHQ-9 en el seguiment 1 (6 mesos), però de forma marginalment significativa. 
Els participants de la condició THM+IPAP que partiren amb baixes puntuacions en el 
funcionament social en el pre-tractament aconseguiren una menor puntuació en el PHQ-
9 durant el seguiment 1, b = 6.04, 95% CI [0.42, 11.66], t = 2.19, p = .036. 
La resta de variables del SF-12 no van moderar l'efecte de la condició sobre les 




Cap variable de la mesura PHI va moderar l’efecte de la condició en els resultats 
posteriors (post-tractament i en el seguiments) al PHQ-9: benestar total, benestar recordat 
i benestar experimentat (p>.05). 
Facetes del mindfulness (resultats FFMQ) 
La variable observar va moderar de manera marginal significant l’efecte de la 
condició en els resultats posteriors al PHQ-9. Els participants de la condició THM+IPAP 
que partiren amb baixes puntuacions en observar en el pre-tractament aconseguiren una 
menor puntuació en el PHQ-9 durant el post-tractament, b = 3.93, 95% CI [0.59, 7.26], t 
= 2.37, p = .022. 
A banda d’això, la variable descriure va moderar l’efecte de la condició en els resultats 
posteriors al PHQ-9. Els participants de la condició THM+IPAP que partiren amb baixes 
puntuacions en la variable descriure en el pre-tractament aconseguiren una menor 
puntuació en el PHQ-9 durant el post-tractament b = 6.87, 95% CI [2.71, 11.04], t = 3.32, 
p = .002. 
La resta de variables del FFMQ no van moderar l'efecte de la condició sobre les 
puntuacions del PHQ-9 en el post-tractament i en el seguiments. 
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5. Discussió i conclusions
5.1.   Eficàcia dels tractaments per a la depressió en atenció primària 
La primera hipòtesi proposada va ser que la condició THM+IPAP seria més eficaç 
comparada amb la condició només-THM respecte a la millora de la severitat de la 
depressió i altres variables secundàries (afecte, qualitat de vida en relació amb la salut, 
benestar i mindfulness) després del tractament i els seguiments. Aquesta hipòtesi no es va 
confirmar. 
Ambdues intervencions van resultar igualment eficaces a l'hora de reduir la severitat 
de la depressió i l'afecte negatiu, així com d'incrementar la resta de variables relatives al 
funcionament positiu (afecte positiu, qualitat de vida en relació a la salut, benestar i 
facetes del mindfulness) fins el mes 12 del seguiment. L’índex d'adherència va ser major 
en la condició només-THM. 
Tot i que no hi hagueren diferències estadísticament significatives entre els 
tractaments, ens agradaria subratllar dos aspectes: en primer lloc, sembla que la condició 
THM+IPAP va produir millores més ràpides i amb unes magnituds de l’efecte del 
tractament majors a curt termini. I en segon lloc, sembla que la condició només-THM va 
resultar més eficaç a l'hora de generar i mantenir els canvis a llarg termini (excepte per a 
les variables del mindfulness). 
En relació amb l'alt índex d'abandonament de la condició THM+IPAP, ens agradaria 
matissar que aquest tractament va ser més eficaç a curt termini, cosa que ens fa considerar 
si aquesta gran eficàcia podria ser la responsable dels abandonaments del tractament en 
un context amb una adherència tan limitada a l’ordinador. 
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Per tal d'explicar els resultats sobre l'eficàcia i els abandonaments, en agradaria 
considerar altres possibles factors (p.e. la duració i el nombre de mòduls, la teràpia de 
suport) (Sin, Della Porta, i Lyubomirsky. 2011). Aquest factors seran detallats a 
continuació. 
Duració i nombre dels mòduls dels tractaments: Algunes evidències demostren que 
les intervencions de psicologia positiva amb una major duració (més setmanes) són més 
eficaces a l'hora de reduir la simptomatologia de la depressió i d'incrementar el benestar 
que les intervencions més curtes (Sin i Lyubomirsky, 2009). En aquest sentit, les 
intervencions més llargues poden permetre que els pacients tinguin més temps de 
practicar activitats, ajudant, així, a convertir-les en hàbits. 
La majoria dels estudis sobre les intervencions de psicologia positiva online 
normalment empren exercicis curts d'una setmana de duració en comparació amb els 
tractaments estàndard, que usen una sèrie de mòduls i exercicis (Görges et al., 2018). Així 
doncs, és necessari dur a terme més investigacions per determinar la duració apropiada 
(més llarga o més curta) dels programes del tractament basats en la psicologia positiva i 
així aconseguir que segueixen eficaces a llarg termini. 
Inclusió del suport del terapeuta en la intervenció basada en Internet: S'ha observat 
que les intervencions basades en Internet són més eficaces quan s'ofereix més suport per 
part del terapeuta (Baumeister et al., 2014; Berger et al., 2011; Richards i Richardson, 
2012). En una línia similar, s'ha comprovat que les intervencions de psicologia positiva 
sense suport per part d'un terapeuta no són tan eficaces com la teràpia individual o en 
grup (Sin i Lyubomirsky, 2009). 
Auto-selecció i motivació en relació al tractament assignat: Les probes mostren que 
les intervencions en què les persones elegeixen lliurement participar tendeixen a tindre 
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més èxit que les intervencions en què les persones han sigut assignades (Sin i 
Lyubomirsky, 2009). Possiblement, aquestes persones estaven més motivades i, per tant, 
mantenien una actitud més responsable i entusiasta a l'hora de seguir les directrius de les 
intervencions. 
Implicació del metge de família en el tractament: El grup de control en aquest estudi 
va consistir en un THM, cosa que significa que el metge de família va haver d’aplicar un 
tractament mèdic (p.e. medicació) i també seguir les directrius recomanades pel 
tractament per a la depressió en l’Atenció Primària segons les guies. És possible que 
aquesta indicació, sumada al fet de saber que estaven participant en un estudi de prova 
controlat, haja afavorit el seguiment efectiu de les directrius i per això la condició només-
THM va resultar tan eficaç. 
Finalment, tenint en compte el grau d'implicació dels participants en el tractament, 
la realització del THM+IPAP va implicar que tingueren un paper més actiu en relació 
amb la seua resposta al tractament. A més de rebre un THM (medicació, sessions amb el 
seu metge de família) hagueren de dur a terme una intervenció a través d'Internet. Açò 
podria donar com a resultat un nivell d'implicació millor per part dels participants (en 
matèria de temps, activitat, ocupació) en comparació als participants de la condició 
només-THM. 
5.2.   Cost-efectivitat de les dues condicions del tractament 
La segona hipòtesi proposava que la condició THM+IPAP resultaria més cost-
efectiva que la condició només-THM en termes de l’ús dels serveis sanitaris i socials 
(visites al metge de família, visites al servei d'urgències, absències al treball, deixar 
tasques habituals inacabades i reducció en la qualitat de tasques habituals per causa de 
problemes de salut) en els seguiments. Aquesta hipòtesi no es va confirmar i els resultats 
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només mostraren que ambdós tractaments (THM+IPAP i només-THM) van resultar 
igualment eficaços a l'hora de produir canvis en la qualitat de tasques quotidianes (nombre 
de dies en què la qualitat de les tasques quotidianes s’havien reduït a  causa de problemes 
de salut durant l'últim mes) al llarg del temps. 
Aquests resultats se situen en la mateixa línia que estudis similars com el de Duarte 
et al. (2017) el qual va demostrar que no sembla que les intervencions amb suport i a 
través d’Internet siguen més cost-efectives que el tractament del metge des d'una 
perspectiva sanitària. A més a més, Kenter et al. (2015) confirmaren que l'assistència 
combinada (intervencions a través d'Internet en combinació amb sessions cara a cara) era 
més cara en comparació amb els tractaments cara a cara establerts i no s'aconseguien 
millors resultats en termes de funcionament general. 
5.3.   Anàlisis post-mòduls en la condició THM+IPAP: Canvis en la severitat de la 
depressió i l'afecte 
La IPAP va ser eficaç en la reducció de la severitat de la depressió i l'afecte negatiu 
i en l'increment de l'afecte positiu al llarg dels mòduls del tractament. Tot i això, l'efecte 
dels mòduls va ser millor entre l’1 i el 2. Així doncs, sembla que les intervencions basades 
en Internet tenen un impacte inicial important en totes les variables, cosa que reforça la 
idea d'una trajectòria més ràpida en la millora de la simptomatologia. 
Pel que fa al percentatge de participants que van completar cada mòdul, només el 
45% dels participants van completar tots els mòduls del tractament, el 65% van completar 
tres mòduls, el 72.5% dos mòduls i el 77.5% un mòdul. Com es va esmentar anteriorment, 
la disminució del nombre de participants per mòdul podria explicar-se pel grau 
d'implicació que aquest tractament els suposava, en comparació amb la condició només-
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THM. A més, la severitat de la depressió dels participants i la millora de la 
simptomatologia també poden influir en la resposta als mòduls del tractament. 
5.4.   Opinió dels participants sobre el tractament rebut 
La tercera hipòtesi proposava que l'opinió dels participants sobre el tractament seria 
millor en la condició THM+IPAP. Aquesta hipòtesi es va confirmar, ja que els 
participants de THM+IPAP van mostrar una millor opinió sobre el tractament rebut (en 
termes de lògica, satisfacció, recomanació a altres persones, utilitat per al problema en el 
cas propi, i la utilitat per a altres problemes psicològics) en tots els moments d’avaluació. 
5.5.   Afecte positiu com a mediador 
La quarta hipòtesi proposava que els participants de THM+IPAP incrementarien més 
el seu afecte positiu (després del tractament i els seguiments), donant lloc a una major 
reducció en la severitat de la depressió (després del tractament i els seguiments). Aquesta 
hipòtesi no es va confirmar perquè l'efecte de la condició en les puntuacions de la severitat 
de la depressió després del tractament i els seguiments no es va veure mediat pel canvi en 
l’afecte positiu en qualsevol moment de l'avaluació. Aquest resultat suggereix que la 
IPAP no era tan eficaç a l'hora de produir canvis en l’afecte positiu. Com es va explicar 
anteriorment, no es van trobar diferències estadísticament significatives entre els 
tractaments, i la inclusió de la IPAP no va donar com a resultat majors grandàries de 
l’efecte en comparació amb la condició de control per a reduir els símptomes de depressió 
a llarg termini. 
Encara que les intervencions de psicologia positiva s'han utilitzat sovint per 
promoure el benestar i regular l'afecte positiu en l'individu, les seues implicacions en 
l'àmbit clínic semblen qüestionables segons la literatura (p.e., Mongrain i Anselmo-
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Matthews, 2012). Per exemple, en alguns estudis no s'han trobat diferències entre les 
intervencions de psicologia positiva online i els grups placebo per augmentar la felicitat 
i reduir la depressió (Woodworth, O'Brien-Malone, Diamond, i Schütz, 2016a). És 
important seguir investigant els factors mediadors dels efectes en aquest tipus 
d'intervencions sobre la severitat de la depressió (Woodworth, O'Brien-Malone, 
Diamond, i Schütz, 2016b). 
5.6.   Models de moderació 
No es van generar hipòtesis específiques sobre quines variables moderadores 
(variables sociodemogràfiques i clíniques) podrien ser significatives en l'efecte de la 
condició (THM+IPAP vs. només-THM) sobre la severitat de la depressió (després del 
tractament i els seguiments), a causa de la naturalesa exploratòria de les anàlisis. 
Els resultats van mostrar que les variables sociodemogràfiques (sexe, estat civil, 
nivell educatiu, ocupació i nivell d'ingressos) i algunes variables clíniques de la línea base 
com la severitat de la depressió, la qualitat de vida relacionada amb la salut (salut en 
general, dolor corporal, rol físic, salut mental i vitalitat), el benestar (el benestar total, el 
benestar recordat i el benestar experimentat) i les facetes de mindfulness (actuant de 
manera conscient, no jutjar l'experiència interior i no reaccionar a l'experiència interior) 
no van moderar l'efecte de la condició sobre les puntuacions de la severitat de la depressió 
després del tractament i els seguiments. A continuació veurem algunes excepcions. 
Els participants de la condició de THM+IPAP amb una puntuació basal més alta en 
la variable de funcionament físic i més baixa en la variable de rol emocional van 
aconseguir puntuacions més baixes en la severitat de la depressió després del tractament. 
A més, els participants amb una puntuació basal més baixa en la variable de funcionament 
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social van aconseguir puntuacions més baixes en la severitat de la depressió en el 
seguiment de 6 mesos. 
El bon funcionament físic (com a factor protector de depressió) dels participants en 
el pretractament podria haver contribuït a una major adhesió a les directrius de la IPAP 
(una de les quals es va centrar en el paper de l'activitat en el benestar) (Warburton, Nicol, 
i Bredin, 2006). A més, altres estratègies terapèutiques de la IPAP (p.e. la regulació 
emocional o el suport social) podrien haver ajudat a millorar la seua funció emocional 
(intel·ligència emocional) i funcionament social (habilitats socials), cosa que va 
comportar en una millora de la severitat de la depressió al llarg del temps. Aquests 
resultats recolzen la idea que la regulació emocional (Extremera i Rey, 2015) i el suport 
social (Chou i Chi, 2001) poden moderar l'efecte de la depressió. 
Pel que fa a les facetes del mindfulness, els participants de la condició de THM+IPAP 
amb una puntuació basal més baixa en les variables observar i descriure van aconseguir 
puntuacions més baixes en la severitat de la depressió després del tractament. Per tant, la 
inclusió de la IPAP com a tractament complementari (centrat també en aspectes 
relacionats amb el mindfulness) va permetre als participants assistir a les seues 
experiències internes i externes (p.e. sensacions, pensaments o emocions), i també 
etiquetar-les amb paraules, contribuint així a la millora de la severitat de la seua depressió. 
Aquests resultats indiquen que és important considerar les habilitats del mindfulness dins 
de les intervencions de psicologia positiva per a reduir la simptomatologia depressiva 
(Cebolla, Enrique, Alvear, Soler, i García-Campayo 2017; Sin et al., 2011). 
Es necessiten més estudis per identificar els moderadors potencials de les 




5.7.   Limitacions 
Cal assenyalar algunes limitacions de l'estudi actual: 
En primer lloc, la taxa d’abandonaments en ambdues condicions i especialment en la 
condició THM+IPAP podria haver afectat la potència estadística i, per tant, en la resta de 
les anàlisis (eficàcia, cost-efectivitat, opinió, mediació i moderació) del present estudi. 
En segon lloc, no tenim informació sobre els motius d’abandonament dels 
participants. És rellevant explorar les seues raons per trobar maneres d'abordar aquest 
problema. La perspectiva qualitativa podria ajudar a analitzar aquestes experiències d'una 
manera més clara i profunda (Fernández-Álvarez et al., 2017). 
En tercer lloc, no tenim cap registre sobre les sessions amb el metge per temes de la 
depressió i tampoc sobre la dosi de la medicació. Caldria considerar aquestes variables 
en el futur i analitzar si els participants sota una intervenció basada en Internet reben 
menys atenció mèdica i, per tant, aquesta podria ser una variable d'eficàcia en aquest 
tractament. 
En quart lloc, no tenim informació sobre el diagnòstic de possibles trastorns 
comòrbids de depressió. Hauria estat interessant saber si els tractaments també eren 
eficaços en produir canvis respecte a altres simptomatologies com l'ansietat. D'aquesta 
manera, podríem haver obtingut més informació sobre el paper que jugava la IPAP, que 
es basava en la perspectiva transdiagnòstica. 
En cinquè lloc, la informació sobre la història anterior de depressió dels participants 
no s'ha tingut en compte en aquest estudi. Aquestes dades són importants perquè la 
possible cronicitat o familiaritat amb els tractaments (mèdics o psicològics) podria haver 
influït en els resultats (p.e. Görges et al., 2018). 
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Finalment, aquest estudi no va utilitzar un instrument de mesura validat per analitzar 
la relació cost-efectivitat dels tractaments avaluats. És important que tots els assajos 
controlats incloguen els mateixos instruments o similars per analitzar la seua evidència 
d'una manera més sistemàtica. 
5.8.   Línies futures 
En aquest estudi, incloem alguns elements relacionats amb el suport terapèutic per 
augmentar l'adhesió a la intervenció basada en Internet. En concret, hi va haver una sessió 
grupal cara a cara amb un terapeuta per explicar la intervenció. A més, incloem missatges 
setmanals de text i correus electrònics per animar els participants a continuar amb el 
programa i realitzar tasques. La investigació futura podria explorar altres tipus de suport 
terapèutic (per exemple, assistència telefònica setmanal, ús de terapeutes en línia) per 
analitzar si hi ha una major participació i una major adherència al tractament 
informatitzat. Fins ara, s'ha demostrat que el suport terapèutic s'associa positivament amb 
una major eficàcia i una menor taxa d'abandonament de les intervencions basades en 
Internet (p.e. Johansson i Andersson, 2012; Richards i Richardson, 2012). 
Un altre aspecte que seria interessant analitzar en el futur és la inclusió d'altres 
components psicoterapèutics destinats a la regulació del afecte negatiu (p.e. TCC) 
juntament amb la IPAP, com en altres estudis (p.e. Díaz et al., 2017). Això ens permetria 
saber si la IPAP seria més eficaç pel que fa a la simptomatologia depressiva i altres 
variables relacionades amb el funcionament positiu. 
Altres estudis podrien incloure intervencions adaptades a les característiques, 
necessitats i preferències dels pacients amb depressió i possibles trastorns comòrbids 
(Batterham, Calear, Farrer, McCallum, i Cheng, 2018). D'aquesta manera, els 
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professionals de la salut (metges de capçalera i psicòlegs) tractarien de manera més eficaç 
la depressió (Johansson et al., 2012). 
A més, es necessiten dissenys híbrids per avançar en l'eficàcia clínica (per 
proporcionar tractaments basats en l'evidència) i  en la implementació (tenint en compte 
processos com planificar, educar, finançar, reestructurar, gestionar la qualitat i context de 
política) per millorar la seua traducció a la rutina d'assistència sanitària per al tractament 
de la depressió (Powell et al., 2012). 
Fins ara, la majoria dels tractaments basats en l'evidència (online) per a la depressió 
s'han dispensat a través d'ordinadors. Els estudis futurs també haurien de tenir en compte 
altres tecnologies innovadores (per exemple, telèfons intel·ligents, avatars i realitat 
virtual) per millorar l'accés a aquests tractaments i, fins i tot, els seus efectes (Cuijpers et 
al., 2017). Una metaanàlisi recent mostra que els dispositius intel·ligents són una eina 
prometedora d'autogestió per a la depressió (Firth et al., 2017). Es necessiten més estudis 
sobre l'aplicació d'aquestes tecnologies en un entorn d’Atenció Primària. 
5.9.   Conclusions 
Aquest és el primer estudi a Espanya que analitza l'eficàcia i la relació cost-efectivitat 
d'una intervenció basada en Internet de baixa intensitat centrada en la perspectiva 
transdiagnòstica i la psicologia positiva combinada amb el THM per part del metge i en 
comparació amb el només-THM, per al tractament de la depressió en un context 
d’Atenció Primària. A més, aquest treball proporciona dades sobre l'eficàcia d'ambdues 
intervencions al llarg del temps en relació amb els canvis aconseguits després del 
tractament (seguiment de 6 i 12 mesos). 
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Les principals conclusions sobre els objectius d'aquesta tesi es presenten en els 
següents punts: 
 La inclusió d'una intervenció basada en Internet no va millorar substancialment
els resultats de la severitat de la depressió en comparació amb el només-THM. 
Tanmateix, els nostres resultats recolzen l'ús d'intervencions basades en Internet 
de baixa intensitat per promoure millores més ràpides en la depressió, juntament 
amb el THM. La seua implementació en centres d’Atenció Primària ajudaria tant 
al pacient (que sovint no rep un tractament adequat o es troba a la llista d'espera) 
i el metge de capçalera (que no té prou temps de consulta per oferir un tractament 
adequat) per reduir la bretxa entre la demanda i l’oferta del tractament. 
 El nostre estudi no va recolzar la idea que la intervenció basada en Internet de
baixa intensitat, juntament amb el THM, era més cost-efectiva en comparació amb 
el només-THM. Ambdós tractaments van ser igualment cost-efectius només pel 
que fa a la qualitat del rendiment de les tasques habituals. 
 Pel que fa a l'opinió dels participants sobre el tractament rebut, el THM+IPAP es
va valorar millor que el només-THM des del tractament previ al tractament 
posterior. Això suggereix que les tecnologies podrien ser una eina atractiva per al 
tractament de la depressió en l'Atenció Primària. 
 El afecte positiu no era una variable mediadora per a la relació entre la condició i
la severitat de la depressió. 
 Algunes variables de la qualitat de vida relacionada amb la salut (funcionament
físic, rol emocional, funcionament social) i les facetes de mindfulness (observar i 
descriure) van ser variables moderadores associades a un millor pronòstic en la 
depressió després del THM+IPAP. 
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 És important continuar investigant el paper de les intervencions basades en Internet 
de baixa intensitat guiades per a la depressió i en un context d’ Atenció Primària, tenint 
en compte la perspectiva transdiagnòstica, la psicología positiva, els programes 
personalitzats, les estratègies d'implementació i altres dispositius tecnològics, com els 
telèfons intel·ligents. 
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Depression is the most common mental disorder in the health care services. 
Specifically, 60% of patients with depression are attended to in primary care centers 
(Fernández et al., 2006). 
This psychological problem presents a high rate of comorbidity with other disorders, 
and if not treated correctly, its course tends to become chronic, interfering significantly 
in different areas of the individual's functioning (Wittchen et al., 2011). Therefore, 
effective treatments that can be easily applied and disseminated are needed (Collins et al., 
2011). 
So far, there are numerous evidence-based psychological treatments (e.g., cognitive-
behavioral therapy) for depression (Cuijpers, van Straten, van Oppen, Andersson, 2008; 
Cuijpers et al., 2013; Huhn et al., 2014). However, despite the existence of these 
treatments, the provision of mental health services is considerably low in terms of access 
and quality (Kazdin & Blase, 2011). In fact, less than 50% of people receive appropriate 
treatment, due to the cost, time required or lack of well-trained professionals (Gaston, 
Abbot, Rapee, & Neary, 2006).  A fundamental challenge in research is the dissemination 
of these treatments, that is, making them available to all those who need them. Numerous 
studies have already shown that it is possible to apply these treatments via the Internet 
without losing their effectiveness (Andersson & Cuijpers, 2009; Andersson, 2016; 
Andrews, Cuijpers, Craske, McEvoy, & Titov, 2010). In addition, several meta-analyses 
show that these treatments have effects comparable to those of face-to-face treatments 
(Andersson, Cuijpers, Carlbring, Riper, & Hedman, 2014; Andersson, Topooco, Havik, 
& Nordgreen, 2016). Moreover, low-intensity psychological interventions, applied by 
Information and Communication Technologies could be an efficacious and cost-effective 
therapeutic option for the treatment of depression in primary care, given their 
potentialities (Donker et al., 2015). 
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Finally, although good efficacy data are available, further efforts are needed to find 
ways to treat depression in its different manifestations (e.g., degree of severity) and in 
different healthcare settings (e.g., primary care, specialized care). 
In recent years, the transdiagnostic perspective (Sauer-Zavala et al., 2017) has 
received considerable importance as one of the approaches to improve the understanding 
and treatment of emotional disorders, including depression and anxiety. This perspective 
emphasizes the role of emotional regulation as a key concept in understanding and 
treating emotional disorders (Brown & Barlow, 2009). 
It is worth to consider, in addition, a relevant aspect proposed to improve the 
currently available treatments: the promotion of positive affect. Thus far, psychological 
treatments for emotional disorders have focused primarily on the dimension of negative 
affect. Taking into account the central factors defended from the transdiagnostic 
perspective to explain the vulnerability of the emotional disorders, it is necessary to 
improve the intervention strategies for the positive affect dimension (Carl, Soskin, Kerns, 
& Barlow, 2013). Another perspective that emerged precisely with the aim of enhancing 
the positive aspects of the human being is the Positive Psychology movement (Seligman 
& Csikszentmihalyi, 2000). This perspective is especially relevant to people suffering 
from depression (e.g., Santos et al., 2013). 
Therefore, the general objective of this dissertation is to investigate the efficacy and 
cost-effectiveness of an improved treatment as usual (ITAU) with a low-intensity 
Internet-based computerized intervention focused on the promotion of positive affect 
(ITAU+IPPA) for the treatment of depression, compared to only the ITAU (only-ITAU) 




In chapter 1 “Depression and new psychotherapeutic approaches”, a review of the 
scientific literature will be carried out to frame the topic of study, a key process in this 
research. 
In chapter 2 “Efficacy and cost-effectiveness of a low-intensity Internet-based 
intervention focused on the promotion of positive affect for the treatment of depression 
in primary care: a randomized control trial”, the experimental study of this dissertation 
will be presented. 
Finally, in chapter 3 “General discussion”, the main findings, limitations and future 
lines of research will be discussed. 
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1.1. Concept and diagnosis 
Depression is a term that refers both to a transient mood state and a clinical syndrome 
or disorder characterized by the presence of a variety of behavioral (e.g., psychomotor 
agitation or retardation, avoidance behaviors in daily tasks and social interactions), 
cognitive (e.g., inability to concentrate, ruminations, dysfunctional beliefs), emotional 
(e.g., sadness, frustration, irritability, feeling of failure or emptiness), motivational (e.g., 
anhedonia, apathy or indifference), and somatic (e.g., sleeping problems, appetite and 
weight changes, fatigue) manifestations (Carrobles, 2011; Vázquez & Sanz, 2008). The 
range and severity of symptoms varies from individual to individual and over time. 
Depression is also associated with an increased risk of mortality (Cuijpers & Smit, 2002), 
and it can lead to suicide (Li et al., 2017). 
To diagnose depression, the criteria most commonly used in both clinical and research 
settings are those contained in the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) of the American Psychiatric Association (APA), and in the International 
Classification of Diseases (ICD) of the World Health Organization (WHO) (Evans et al., 
2013). 
According to the DSM-5 (APA, 2013), the diagnosis of a Major Depressive Episode 
(MDE) is established by the presence of at least five of the nine symptoms listed, with at 
least one of them being depressed mood or loss of interest or pleasure in activities. 
Moreover, the symptoms must be maintained for at least two weeks and cause clinically 
significant distress or impairment in social, occupational, or other important areas of the 
person's activity. Table 1 shows the diagnostic criteria for Major Depressive Disorder 
(MDD) according to the DSM-5 (APA, 2013).
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Table 1. Diagnostic criteria for MDD according to DSM-5 (APA, 2013, p. 160). 
Major Depressive Disorder 
A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a 
change from previous functioning: at least one of the symptoms is either (1) depressed mood or (2) loss of interest 
or pleasure. 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective reports (e.g., feels sad,
empty, hopeless) or observations made by others (e.g., appears tearful).
(Note: In children and adolescents, it can be irritable mood).
2. Markedly diminished interest or pleasure in all or almost all activities most of the day, nearly every day (as
indicated by either subjective accounts or observations).
3. Significant weight loss when not dieting, or weight gain (e.g., a change of more than 5% of body weight in
a month), or a decrease or increase in appetite nearly every day.
(Note: In children, consider failure to make expected weight gain).
4. Insomnia or hypersomnia nearly every day.
5. Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings
of restlessness or being slowed down).
6. Fatigue or loss of energy nearly every day.
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day
(not merely self-reproach or guilt about being sick).
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective accounts
or as observed by others).
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a
suicide attempt or a specific plan for committing suicide.
B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important 
areas of functioning. 
C. The episode is not attributable to the physiological effects of a substance or to another medical condition. 
Note: Criteria A-C represent a major depressive episode. 
Note: Responses to a significant loss (e.g., bereavement, financial ruin, losses from a natural disaster, a serious 
medical illness or disability) may include the feelings of intense sadness, rumination about the loss, insomnia, 
poor appetite, and weight loss noted in Criterion A, which may resemble a depressive episode. Although such 
symptoms may be understandable or considered appropriate to the loss, the presence of a major depressive 
episode in addition to the normal response to a significant loss should also be carefully considered. This decision 
inevitably requires the exercise of clinical judgment based on the individual’s history and the cultural norms for 
the expression of distress in the context of loss. 
D. The occurrence of the major depressive episode is not better explained by schizoaffective disorder, 
schizophrenia, schizophreniform disorder, delusional disorder, or other specified and unspecified schizophrenia 
spectrum or other psychotic disorders. 
E. There has never been a manic episode or a hypomanic episode. 
Note: This exclusion does not apply if all of the manic-like or hypomanic-like episodes are substance-induced or 
are attributable to the physiological effects of another medical condition. 
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Table 1. Continued 







 With psychotic features.
 In partial remission.
 In full remission.
 Unspecified.
Specifiers for the current episode: 
 With anxious distress.
 With mixed features.
 With melancholic features.
 With atypical features.
 With mood-congruent psychotic features.
 With mood-incongruent psychotic features.
 With catatonia.
 With peripartum onset.
 With seasonal pattern (recurrent episode only).
The diagnosis of Persistent Depressive Disorder (Dysthymia) represents a 
consolidation of DSM-IV-defined chronic MDD and dysthymic disorder (APA, 2013). 
The symptoms of dysthymia are similar to those of an MDE, but they tend to be less 
intense and last longer. Table 2 shows the diagnostic criteria for Persistent Depressive 
Disorder (Dysthymia) according to the DSM-5 (APA, 2013). 
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Table 2. Diagnostic criteria for Persistent Depressive Disorder (Dysthymia) according to the 
DSM-5 (APA, 2013, p. 168). 
Persistent Depressive Disorder (Dysthymia) 
A. Depressed mood for most of the day, for more days than not, as indicated by either subjective 
accounts or observations by others, for at least 2 years. 
Note: In children and adolescents, mood can be irritable and duration must be at least 1 year. 
B. Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating.
2. Insomnia or hypersomnia.
3. Low energy or fatigue.
4. Low self-esteem.
5. Poor concentration or difficulty making decisions.
6. Feelings of hopelessness.
C. During the 2-year period (1 year for children or adolescents) of the disturbance, the individual has 
never been without the symptoms in Criteria A and B for more than 2 months at a time. 
D. Criteria for a major depressive disorder may be continuously present for 2 years. 
E. There has never been a manic episode or a hypomanic episode, and criteria have never been met 
for cyclothymic disorder. 
F. The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, 
delusional disorder, or other specified or unspecified schizophrenia spectrum or other psychotic 
disorder. 
G. The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, 
a medication) or another medical condition (e.g. hypothyroidism). 
H. The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. 
Note: Because the criteria for a major depressive episode include four symptoms that are absent from 
the symptom list for persistent depressive disorder (dysthymia), a very limited number of individuals 
will have depressive symptoms that have persisted longer than 2 years but will not meet| the criteria 
for persistent depressive disorder. If all the criteria for a major depressive episode have been met at 
some point during the current illness episode, they should be given a diagnosis of major depressive 
disorder. Otherwise, a diagnosis of other specified depressive disorder or unspecified depressive 
disorder is warranted. 
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Table 2. Continued 
Specify if: 
 With anxious distress.
 With mixed features.
 With melancholic features.
 With atypical features.
 With mood-congruent psychotic features.
 With mood-incongruent psychotic features.
 With peripartum onset.
Specify if: 
 In partial remission.
 In full remission.
Specify if: 
 Early onset: If onset is before 21 years old.
 Late onset: If onset is at 21 years or older.
Specify if (for most recent 2 years of persistent depressive disorder): 
 With pure dysthymic syndrome: Full criteria for a major depressive episode have not been met
in at least the preceding 2 years.
 With persistent major depressive episode: All the criteria for a major depressive episode have
been met throughout the preceding 2-year period.
 With intermittent major depressive episodes, with current episode: All the criteria for a major
depressive episode are currently met, but there have been periods of at least 8 weeks in at least
the preceding 2 years with symptoms below the threshold for a full major depressive episode.
 With intermittent major depressive episodes, without current episode: All the criteria for a major
depressive episode are not currently met, but there has been one or more major depressive
episode in at least the preceding 2 years.






Other diagnostic categories of depressive disorders, according to the DSM-5 (APA, 
2013), are: Disruptive Mood Dysregulation Disorder; Premenstrual Dysphoric Disorder; 
Substance/Medication-Induced Depressive Disorder; Depressive Disorder Due to another 
Medical Condition; Other Specified Depressive Disorder, and Unspecified Depressive 
Disorder. 
The common characteristics of the spectrum of depressive disorders are the presence 
of sadness, empty or irritable mood, accompanied by somatic and cognitive changes that 
significantly affect the individual's ability to function. The difference between them lies 
in their duration, chronology, or etiology (APA, 2013). 
Regarding ICD-11 (WHO, 2018), the following diagnostic categories are included in 
the epigraph of Mood Disorders: Single Episode Depressive Disorder, Recurrent 
Depressive Disorder, Dysthymic Disorder, and Mixed Depressive and Anxiety Disorder. 






Table 3. Description of principal diagnostic categories of Mood Disorders according to ICD-11 
(WHO, 2018). 
Single Episode Depressive Disorder 
Single episode depressive disorder is characterized by the presence or history of one depressive episode 
when there is no history of prior depressive episodes. A depressive episode is characterized by a period 
of almost daily depressed mood or diminished interest in activities, lasting at least two weeks and 
accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive 
or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, 
psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior 
manic, hypomanic, or mixed episodes that would indicate the presence of a bipolar disorder. 
Recurrent Depressive Disorder 
Recurrent depressive disorder is characterized by a history of or at least two depressive episodes 
separated by at least several months without significant mood disturbance. A depressive episode is 
characterized by a period of almost daily depressed mood or diminished interest in activities, lasting at 
least two weeks and accompanied by other symptoms such as difficulty concentrating, feelings of 
worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, 
changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There 
have never been any prior manic, hypomanic, or mixed episodes that would indicate the presence of a 
Bipolar disorder. 
Dysthymic Disorder  
Dysthymic disorder is characterized by a persistent depressive mood (i.e., lasting 2 years or more) for 
most of the day, on more days than not. In children and adolescents, depressed mood can manifest as 
pervasive irritability. The depressed mood is accompanied by additional symptoms, such as markedly 
diminished interest or pleasure in activities, reduced concentration and attention or indecisiveness, low 
self-worth or excessive or inappropriate guilt, hopelessness about the future, disturbed sleep or increased 
sleep, diminished or increased appetite, or low energy or fatigue. During the first two years of the 
disorder, there has never been a 2-week period during which the number and duration of symptoms were 
sufficient to meet the diagnostic requirements for a Depressive Episode. There is no history of Manic, 
Mixed, or Hypomanic Episodes. 
Mixed Depressive and Anxiety Disorder 
Mixed depressive and anxiety disorder is characterized by symptoms of both anxiety and depression 
more days than not for a period of two weeks or more. Neither set of symptoms, considered separately, 
is sufficiently severe, numerous, or persistent to justify a diagnosis of a depressive episode, dysthymia, 
or an anxiety and fear-related disorder. Depressed mood or diminished interest in activities must be 
present, accompanied by additional depressive symptoms, as well as multiple symptoms of anxiety. The 
symptoms result in significant distress or significant impairment in personal, family, social, educational, 
occupational or other important areas of functioning. There have never been any prior manic, 




As can be observed, there are some differences between the two principal 
classification systems, for example: ICD-11 continues to maintain the diagnosis of mixed 
anxiety-depressive disorder (in the DSM-5, anxiety is a specifier of MDD), and 
bereavement is maintained as an exclusion criterion for MDD (in the DSM-5, it is 
withdrawn as an exclusion criterion for MDD). The bereavement exclusion in the DSM-
5 was removed and replaced with much more descriptive guidance about the distinction 
between symptoms characteristic of normal grief and symptoms indicative of a clinical 
disorder (Zisook et al., 2012). 
In general, although the current main classification systems are eminently 
categorical, it seems that an important effort is being made to include the advantages of 
the dimensional approach in the new versions of the diagnostic classification. 
1.2. Depression as a public health problem 
1.2.1. Prevalence 
The WHO highlights that depression will be the third cause of disability in 2030, and 
it estimates that 4.4% were depressed in 2015, with this being more common in females 
(5.1%) than males (3.6%) (WHO, 2017). Prevalence rates vary by age and more prevalent 
in older adulthood (over 7.5% in females aged 55-74 years and over 5.5% in males). 
Depression also emerges in children and adolescents (<15 years), but at a lower level than 
older age groups (WHO, 2017). The regions of South-East Asia and the Western Pacific 
present a higher prevalence rate than the African region. Table 4 shows the percentages 
of cases with depressive disorder in different regions. 
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Table 4. Percentage of cases of depressive disorders by WHO Region (WHO, 2017). 
In Spain, it has been estimated that 10.6% of the population has suffered from MDD 
at some point in their lives (Alonso et al., 2002). Another Spanish community-based study 
estimated a 12-month prevalence of 6% (Navarro-Mateu et al., 2015) and a point 
prevalence ranging from 1.5% (Calvó-Perxas, Garre-Olmo, & Vilalta-Franch, 2015) to 
1.8% (Ayuso-Mateos, 2001). 
1.2.2. Course and development 
The course of a depressive episode is quite variable. In general, it begins during the 
second and third decades of life (Kessler et al., 2003), although it can also begin earlier, 
during childhood. The average duration of an MDE in the general population is three 
months (Eaton et al., 2008; Spijker et al., 2002). Approximately 53% of the cases of 
untreated depression remit within 12 months (Whiteford et al., 2013), and in less than 
10% of the cases, depression persists or becomes chronic (Kessler et al., 2003). The risk 
of recurrence of major depression is high. It has been estimated that at least 60% of people 
who have had one episode of depression will suffer another (APA, 2002). In addition, the 
risk of recurrence in the long term is high, with a percentage of recurrence after 20 years 
of around 42% (Hardeveld, Spijker, De Graaf, Nolen, & Beekman, 2013). Finally, one 
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variable that can affect the course of depression is the presence of comorbid psychiatric 
or medical illnesses (Richards, 2011). 
1.2.3. Comorbidity 
Important North American studies such as the National Comorbidity Study (Kessler 
et al., 1996) and the Epidemiologic Catchment Area (Andrade, Eaton, & Chilcoat, 1994) 
reveal that depression has a high rate of comorbidity with anxiety disorders. Specifically, 
between 40% and 80% of patients with panic disorder (PD) and 49% of patients with 
generalized anxiety disorder (GAD) suffer from depression. Along the same lines, the 
Spanish study by Aragonès, Piñol, and Labad (2009) observed that 45.7% of patients with 
MDD also had another mental disorder, such as GAD (55.2%), PD (33.8%), dysthymia 
(15.7%), or somatization disorder (6.6%). Moreover, depression presents comorbidities 
with other mental disorders, such as eating disorders (Campos & Martínez-Larrea, 2002), 
obsessive-compulsive disorder, (Vallejo, 2002), alcohol dependence (Santodomingo & 
Rubio, 2000), and substance abuse (Andrade et al., 1994). 
Depressive disorders are also characterized by a high rate of comorbidity with other 
medical conditions. Specifically in patients with cancer, stroke, and acute coronary 
syndrome (Kang et al., 2015), depression can affect the course of these diseases, which 
are accompanied by poor quality of life, worse medical outcomes, and a higher mortality 
rate (Moussavi et al., 2007). 
Finally, it is important to highlight that the psychiatric comorbidity of depression 
implies a worse prognosis, that is, a greater probability of resistance to treatment and 
recurrence. It also entails a greater risk of suicide, difficulties in clinical management, 
and costs of health resources (Aragonès et al., 2009). 
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1.2.4. Sociodemographic correlates 
In the majority of the countries and the international data collected, a number of 
sociodemographic patterns are associated with depression, for example: problems in role 
transitions (e.g., poor academic performance, marital separation, unemployment), 
reduced role functioning (e.g., lower marital quality, lower work performance), high risk 
of a wide range of secondary disorders, and high risk of early mortality due to physical 
disorders and suicide (Kessler & Bromet, 2013). 
1.2.5. Societal costs 
As mentioned above, if depression is not treated correctly, its course will tend to 
become chronic, influencing people’s health, well-being, quality of life and functioning 
in different areas (e.g., personal, academic, professional) (Judd et al., 2000; Plaisier et al., 
2010; Saarnin et al., 2007). In Spain, it is the main specific cause of adjusted years of life 
due to disability (Génova-Maleras, Álvarez-Martín, Morant-Ginestar, de Larrea-Baz, & 
Catalá-López, 2012). 
This psychological problem also causes serious economic costs. In the United States, 
only in the year 2000, the total economic cost of depression was estimated at around 
83.000 $ million (Greenberg et al., 2003). Of that amount, 26.100 $ million were direct 
medical costs, 5.400 $ million were costs related to mortality due to suicides, and 51.500 
$ million were indirect costs related to lost productivity. In Europe it is estimated that the 
treatment of depression represents an annual cost of 118.000 € million, of which 61% is 
due to indirect costs related to workers’ lost productivity and sick leave, and the remaining 
39% to direct costs (Sobocki, Jönsson, Angst, & Rehnberg, 2006). In Spain in 2010, the 
societal cost was estimated at 10.763 € million (4.546 € million as direct healthcare costs, 
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1.410 € million as non-medical costs, and 4.807 € million as indirect costs) and 3584 € 
per patient/year (Parés-Badell et al., 2014). 
1.3. Prevalence and diagnosis of depression in primary care 
Between 10% and 16% of primary care (PC) patients meet the criteria for MDD 
(King et al., 2008; Serrano-Blanco et al., 2010), and over 60% of patients with depression 
are treated in PC settings (Fernández et al., 2006). The Diagnostic and Assessment Study 
of Mental Disorders in Primary Care (DASMAP), based on 3.815 patients from PC 
centers in Spain, showed that almost 30% reported a lifetime history of MDD, with 9.6% 
experiencing MDD in the past 12 months (Serrano-Blanco et al., 2010). 
Patients with depression who are treated at PC settings do not usually demand 
attention for their psychological symptoms, and they usually report more somatic or 
physical complaints without referring directly to their emotional problems. Some studies 
have shown that the probability of presenting symptoms of muscle, head, or stomach pain 
is between 4 and 7 times higher in patients diagnosed with depression (Means-
Christensen, Roy-Byrne, Sherbourne, Craske, & Stein, 2008). Therefore, it is not always 
easy to make a correct diagnosis (Cano-Vindel, Salguero, Mae-Wood, Dongil, & Latorre, 
2012). 
The scientific literature points out two difficulties in the diagnosis of depression: 
underdiagnosis (not diagnosing depression in people who really suffer from depression, 
thus leading to false negatives), and overdiagnosis (diagnosing depression in people who 
do not really suffer from depression, thus leading to false positives). In fact, the Spanish 
study by Fernández et al. (2010) showed that nearly 78% of patients with depression are 
misdiagnosed, indicating that only about 1/4 of the cases diagnosed as depressed by 
general practitioners (GPs) are correctly diagnosed. Some obstacles that prevent a correct 
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diagnosis are: the time available for the patient, keeping the patient from expressing 
him/herself in a more comprehensive and detailed manner (Mitchell, Vaze, & Rao, 2009); 
whether the type of diagnosis is made for research or clinical purposes (Fernández et al., 
2010); and the attitude of GPs towards the recognition of depression. The attitudes related 
to the possibility of successfully treating depression or to the effectiveness of 
psychotherapy have been shown to be associated with greater accuracy in the diagnosis 
(Gask, Dixon, May, & Dowrick, 2005). Therefore, a correct diagnosis is necessary for 
adequate treatment. 
2. Evidence-based treatments for depression
2.1. Effectiveness of evidence-based treatments 
Currently, there are evidence-based treatments (EBTs) for depression, both 
pharmacological and psychological, that have been accumulating empirical support for 
their effectiveness. Numerous randomized controlled trials (RCTs) and meta-analyses 
have shown that psychotherapies such as cognitive behavioral therapy (CBT), 
interpersonal therapy (IPT), problem solving therapy (PST), behavioral activation (BA), 
and Psychodynamic psychotherapy are effective treatment strategies for depression on 
average, with effect sizes between 0.56-0.82 compared to control conditions (Churchill 
et al., 2002; Cuijpers et al., 2013; Cuijpers et al., 2011; Cuijpers, van Straten, & 
Warmerdam, 2007; Driessen et al., 2010; Ekers, Richards, & Gilbody, 2008). In addition, 
these psychotherapies have been shown to be as effective as pharmacological treatments 
such as selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake 
inhibitors (SNRIs), tricyclic antidepressants (TCIs), and monoamine oxidase inhibitors 
(MAOIs) (Amick et al., 2015; Cuijpers, van Straten, van Oppen, & Andersson, 2008; 
Dobson, 1989; Kirsch et al., 2008). 
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Given the effectiveness and success of EBTs, the National Institute for Health and 
Care Excellence (NICE) included them as the main guidelines for the treatment of 
depression (NICE, 2017). Table 5 shows the type of first-line treatments depending on 
the severity of the depression. 
Table 5. First-line treatments according to the severity of the depression (NICE, 2017). 
Note. BA, Behavioral Activation; CBT, Cognitive Behavioral Therapy; IPT, Interpersonal Therapy; SSRIs, 






Lower half of moderate
depression
Lower intensity psychological interventions
 Group-based CBT specific to depression as the initial treatment.
 Individual self-help with support for people who do not want group CBT.
 Physical activity program specifically designed for people with depression who do
not want group CBT or self-help with support.
Pharmacological interventions
 SSRIs or mirtazapine for people who choose not to have psychological
interventions, or based on previous treatment history confirming depression had a








Higher intensity psychological interventions
 Individual CBT or BA.
 IPT if the person would like help for interpersonal difficulties that focus on role
transitions or disputes or grief.
 Counselling if the person would like help for significant psychosocial,
relationship, or employment problems.
 Short-term psychodynamic therapy if the person would like help for emotional and
developmental difficulties in relationships.
 Individual CBT in combination with an SSRI or mirtazapine as the initial
treatment.
 If the person does not want to take medication, offer: group CBT, or individual
CBT or BA if the person does not want group therapy.
 If the person does not want psychological therapy, offer an SSRI or mirtazapine.
 Short-term psychodynamic psychotherapy, alone or in combination with an SSRI
or mirtazapine, for the person who would like help for emotional and
developmental difficulties in relationships.
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2.2. Treatment of depression in primary care 
In Spain, approximately 1/3 of patients with MDD do not receive minimally adequate 
treatment (Fernández et al., 2006). This can have significant health consequences, 
affecting the course of treatment (Kravitz, Bloom, & Fawcett, 2000), increasing suicidal 
acts (Oquendo et al., 2002), decreasing quality of life (Mendlowicz & Stein, 2000), and 
increasing societal costs (Lépine, 2002). Thus far, pharmacological treatment is the 
standard recommendation in a PC, including for mild depression. The most commonly 
used drugs by GPs are SSRIs (98.3%) and anxiolytics (73.4%) (Martin-Agueda et al., 
2007). A meta-analysis showed that the effect of antidepressants is non-existent or 
negligible in patients with mild or moderate symptoms (Fournier et al., 2010). Clinical 
guidelines for depression recommend active monitoring of symptoms or collaborative 
strategies with specialized services, along with a stepped model of care in which 
psychological treatments play a very important role (NICE, 2009). In fact, several studies 
suggest that patients prefer psychological treatments to medication (McHugh, Whitton, 
Peckham, Welge, & Otto, 2013; Raue, Schulberg, Heo, Klimstra, & Bruce, 2009). 
Psychological treatment in PC has been shown to be more effective than conventional 
treatment (Bortolotti, Menchetti, Bellini, Montaguti, & Berardi, 2008), even when in the 
case of brief interventions (Cape, Whittington, Buszewicz, Wallace, & Underwood, 
2010). A meta-analysis by Cuijpers, van Straten, van Schaik, and Andersson (2009) found 
that psychological treatment was more effective when GPs referred patients with 
depression for treatment. 
All these data suggest that psychological intervention is a very important variable in 
the treatment of depression in the context of PC. The use of psychological (e.g., CBT, 
physical activity) or pharmacological treatments is recommended in moderate cases, as 
well as the application of combined treatments or access to specialized services when the 
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symptomatology does not improve or the symptoms are very severe (e.g., suicidal 
ideation, psychotic symptoms, or serious personal neglect) (NICE, 2017). 
2.3. Limitations of evidence-based psychological treatments 
Although there are evidence-based psychological treatments (EBPTs) for 
depression, these treatments present a series of limitations. 
The provision of mental health services is generally less than adequate in terms of 
accessibility and quality (Kazdin & Blase, 2011), and especially in PC (Bower & Gilbody 
2005). Findings have shown that less than 50% of people with depression receive the 
correct treatment due to the economic cost, the time required for its application, and or 
the lack of well-trained professionals (Andrade et al., 2003; Gaston, Abbott, Rapee, & 
Neary, 2006; Harvey & Gumport, 2015). Specifically, difficulty in accessing facilities or 
professionals, ethnic and cultural barriers, geographical barriers (e.g., living in rural areas 
or small towns), and other obstacles (e.g., transport, babysitting, elderly people) are some 
of the factors that make it difficult for people to receive EBPTs (Harvey & Gumport, 
2015; Hinrichsen, 2010; Institute of Medicine, 2008; Kazdin & Blase, 2011). 
Social stigma about mental health problems or about being treated by mental health 
professionals may also be another factor that complicates access to treatment (Sartorius, 
2002; Weissman et al., 1996). This can lead many people to decide not to seek help or to 
have difficulties in seeking help (Bebbington et al., 2000; Gaston et al., 2006), or they 
may only receive it after the problem has produced adverse effects in their lives (Kessler 
& Greenberg, 2002). 
The therapist's beliefs about EBPTs may have an adverse impact on the therapeutic 
relationship. EBPTs may be too structured and technique-focused, and they may not 
necessarily yield a better outcome (Harvey & Gumport, 2015). 
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The existence of an excessive range of EBPTs may hinder their dissemination and 
implementation (Weisz, Ng, & Bearman, 2014). It is very difficult for a therapist to be 
able to master all the EBPTs. The need for training in a variety of single-disorder 
treatments may be unrealistic (McHugh & Barlow, 2012). In addition, most EBPTs focus 
on specific mental disorders, regardless of the presence of comorbidities (Fairburn, 
Cooper, & Shafran, 2003; Kring & Sloan, 2009). 
Another limitation of EBPTs is the high dropout rate from all forms of 
psychotherapy. Swift and Greenberg (2012) found that 1 in every 5 patients drops out of 
therapy prematurely. 
In the following sections, we will focus on the need to continue to work towards 
innovating EBPTs, while also solving these limitations in order to contribute to their 
dissemination. We review new therapeutic approaches for depression and Internet as an 
innovative tool to deliver treatments. 
3. Other therapeutic approaches for depression
3.1. Transdiagnostic perspective 
Recently, a strong emergence of alternative approaches has been observed, some of 
which are crystallizing into a different way to understand mental disorders (Mansell, 
Harvey, Watkins, & Shafran, 2009). The problems with subclinical forms point to the 
difficulty of establishing diagnostic thresholds, the high rates of comorbidity between 
disorders, the increase in "not specified" diagnoses, the overlapping of symptoms, and the 
greater intra-subject variability in the longitudinal evolution of clinical manifestations. 
These issues raise an important question: perhaps there is a more parsimonious structure, 
and the different diagnostic entities are in fact small variations of a broader syndrome 
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(Barlow, Sauer-Zavala, Carl, Bullis, & Ellard, 2013). Therefore, instead of highlighting 
the differences between the wide variety of mental disorders, the emphasis is on studying 
what they have in common (Barlow, Allen, & Choate, 2004; Harvey, Watkins, Mansell, 
& Shafran, 2004). 
This perspective, called the “transdiagnostic perspective” (TP), has received 
considerable interest from clinicians and researchers in recent years (Sauer-Zavala et al., 
2017). From the point of view of psychopathology, the "TP consists in understanding 
mental disorders based on a range of cognitive and behavioral etiopathogenic processes 
that cause and/or maintain most mental disorders or consistent groups of mental 
disorders” (Sandín, Chorot, & Valiente, 2012, p. 187). Thus, this approach focuses 
primarily on what these disorders have in common, rather than on what is specific and 
differential (Sandín, 2012). 
Regarding emotional disorders (EDs), empirical evidence shows the existence of an 
overlap between the latent structures and the clinical characteristics of anxiety disorders 
and mood disorders, both forming EDs (Brown, 2007; Brown & Barlow, 2009; 
Wilamowska et al., 2010). The nature of EDs shows that the common aspects in terms of 
their etiology are greater than their differences, and they present a high rate of 
comorbidity (Allen et al., 2010; Brown, Campbell, Lehman, Grisham, & Mancill, 2001; 
Kessler, Berglund, & Demler, 2003; Kessler et al., 2008). Psychological treatments for 
anxiety disorders often produce additional improvements in other anxiety disorders or in 
co-morbid mood disorders to which the treatment is not specifically directed (Allen et al., 
2010; Borkovec, Abel, & Newman, 1995; Brown, Antony, & Barlow, 1995; Tsao, Lewin, 
& Craske, 1998; Tsao, Mystkowski, & Zucker, 2002). Moreover, there is evidence of the 
existence of shared neurobiological mechanisms between them (Etkin & Wager, 2007; 
Porto et al., 2009; Shin & Liberzon, 2010). 
CHAPTER 1 
68 
Barlow (2000, 2002) proposed three vulnerabilities that contribute to the etiology of 
EDs: 1) general biological vulnerability (e.g., dimensions of temperament such as 
neuroticism and extraversion); 2) general psychological vulnerability (e.g., perceived 
control over life stress and emotional states); and 3) disorder-specific psychological 
vulnerability (e.g., anhedonia in MDD). It is argued that the two generalized 
vulnerabilities work as direct risk factors for the development of an ED, which, associated 
with the third specific vulnerability, allow it to crystallize into one or disorder or another 
(Brown, 2007). 
Later, Brown and Barlow (2009) suggest that EDs have a common latent structure 
with two dimensions: a) "anxiety / neuroticism / behavioral inhibition or negative affect 
(NA)" (associated with generalized chronic discomfort, perception of uncontrollability 
about threatening and challenging future events, attentional hypervigilance, and low self-
confidence and self-efficacy in coping with future threatening events), which is present 
in most EDs; and b) "positive affect (PA) / BA" (associated with low enthusiasm and 
interest and a predominant pessimism), which seems to be more specific to some 
disorders (e.g., depression). In addition, these authors also highlight various fundamental 
transdiagnostic processes that underlie the ED (e.g., emotional problems, avoidance 
behaviors, rumination, etc.). 
Moreover, these ED dimensions are related to the neuropsychological constructs 
pointed out by Gray and McNaughton (2000): the behavioral inhibition system (BIS) and 
the behavioral activation system (BAS). It is proposed that the individual will experience 
several levels of severity of neuroticism-BIS and extroversion-BAS. Neuroticism is 
related to chronic stress that includes the hypothalamic-pituitary-adrenal axis. Low PA is 
related to reduced BAS activity. This vulnerability, associated with stressors, can lead to 
anxious or depressive symptoms. 
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People with EDs have higher levels of NA and experience negative emotions more 
intensely and more frequently (Brown & Barlow, 2009; Campbell-Sills, Barlow, Brown, 
& Hofman, 2006; Mennin, Heimberg, Turk, & Fresco, 2005). In fact, this population 
shows greater intolerance to uncertainty and ambiguity, or situations that are perceived 
as uncontrollable, which leads to an increase in NA (Boelen, Vrinssen, & van Tulder, 
2010; Boswell et al., 2013; Lee, Orsillo, Roemer, & Allen, 2010). All these ways of 
interpreting and responding to negative emotions, paradoxically, serve to increase and 
maintain them. Therefore, this pathological reaction to emotional experience is 
considered the phenotypic core of EDs (Barlow et al., 2013). 
Several constructs have been identified as problematic reactions to emotions that may 
be involved in the development and maintenance of different ED: sensitivity to anxiety 
(Reiss, 1991), avoidance of internal experience (Hayes, Wilson, Gifford, Follette, & 
Strosahl, 1996), deficits in mindfulness (Rasmussen & Pidgeon, 2011), the suppression 
of emotion (Abramowitz, Tolin, & Street, 2001), rumination (Aldao, Nolen-Hoeksema, 
& Schweizer, 2010), and behavioral avoidance (Manos, Kanter, & Busch, 2010). 
In summary, the TP seem to propose the role of emotional regulation as a key factor 
in understanding the development of EDs. 
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3.1.1. Main transdiagnostic treatments for emotional disorders 
Taking into account the considerable overlap among anxiety and mood disorders, the 
etiology of ED, the shared neurobiological mechanisms, the high rates of diagnostic 
comorbidity, and some generalization of the treatment response, the TP could be a 
powerful option in the field of psychological treatments. 
From the point of view of psychopathology, there are different ways of understanding 
what makes a transdiagnostic treatment. For example, McEvoy, Nathan, and Norton 
(2009) have defined them as “those that apply the same underlying treatment principles 
across mental disorders without tailoring the protocol to specific diagnoses” (p. 21), 
whereas Mansell, Harvey, Watkins, and Shafran (2008) defined them as “a therapy that 
is made available to individuals with a wide range of diagnoses, and that does not rely on 
knowledge of these diagnoses to operate effectively” (p. 14). Some authors propose 
different treatment approaches within the TP. 
For example, Sauer-Zavala et al. (2017) propose three categories to classify 
transdiagnostic treatments: a) universally applied therapeutic principles (top-down 
approach): these include all interventions that start from a theoretical model or therapy 
orientation (e.g., humanistic, psychodynamic, cognitive therapy) whose therapeutic 
strategies (e.g., unconditional acceptance, transfer process, cognitive restructuring) are 
applied to all the problems, without explicitly considering if all the disorders treated with 
this technique are maintained by similar processes. Clear examples would be client-
centered therapy (Rogers, 1951), psychodynamic psychotherapy focused on resolving 
psychic conflicts (Gabbard, 2000; Shedler, 2010), or cognitive therapy (Beck, 1976); b) 
modular treatments: these allow the clinician to choose from an organized bank of 
empirically validated therapeutic strategies, assembling a treatment that maps the 





intervention represents an empirical approach, instead of a theoretical one, because it uses 
strategies that show a reduction in the symptoms, but without necessarily addressing the 
basic psychopathological mechanisms. The use of this type of intervention has been tested 
in the therapeutic approach to anxiety problems in children (Chorpita, Taylor, Francis, 
Moffitt, & Austin, 2004) and in mental health problems in adults from countries with a 
low-medium socioeconomic level (Murray et al., 2014); and c) treatments of shared 
mechanisms (bottom-up approach): these are based on theoretical models of 
psychopathology, and not on universally applied therapeutic principles, with the aim of 
treating psychological processes that are involved in the development and maintenance 
of disorders. Two examples of this type of treatment are: the Unified Protocol (UP) for 
EDs by Barlow et al. (2004, 2011) and transdiagnostic group CBT for anxiety (T-GCBT) 
by Norton (2012). 
3.1.1.1. The Unified protocol 
The UP is a transdiagnostic, emotion-focused CBT designed to be applicable to all 
anxiety and unipolar mood disorders, and possibly other disorders with strong emotional 
components, such as many somatoform and dissociative disorders (Allen, McHugh, & 
Barlow, 2008; Barlow et al., 2004, 2011). It addresses core temperamental factors that 
maintain EDs, specifically frequent and acute NA and the perception of negative emotion 
as intolerable. Therefore, its final objective is to extinguish distress in response to the 
experience of strong emotion. 
This protocol includes aspects from traditional empirically supported CBT (Barlow 
& Cerny, 1988; Barlow & Craske, 2006; Beck, 1976), but incorporating advances in 
research on modern learning theory, cognitive neuroscience, and ER literatures (Barlow 





cognitive appraisals; 2) reducing and preventing avoidance of dysregulated emotions; 
and 3) encouraging actions that are inconsistent with disordered emotional states 
(Barlow et al., 2004). Moreover, UP consists of eight modules, with five of these modules 
forming the core treatment components in a maximum of 18 1-hr individual sessions 
(Farchione et al., 2012; Wilamowska et al., 2010). Table 6 shows the UP modules. 
Table 6. Modules of the UP for transdiagnostic treatment of EDs. 
Module Title 
1 Motivation Enhancement 
2 Psychoeducation and Treatment Rationale 
3 Emotion Awareness Training* 
4 Cognitive Reappraisal* 
5 Emotion Driven Behaviors and Emotional Avoidance* 
6 Awareness and Tolerance of Physical Sensations* 
7 Interoceptive and Situational Exposure* 
8 Relapse Prevention 
Note. *Indicates core UP module. 
 
A unified transdiagnostic treatment approach could help in the dissemination of 
treatment and training of professionals by providing a single set of therapeutic principles 
rather than numerous specific protocols. Moreover, this type of treatment could increase 
the availability of psychological interventions for anxiety and depression disorders, thus 






3.1.1.2. Transdiagnostic group cognitive-behavioral therapy  
The T-GCBT consists of 12 weekly 2-hr sessions in groups of six to eight individuals 
with any anxiety disorder. Treatment highlights the excessive or irrational fear of a 
particular thing (e.g., somatic symptoms), as opposed to having a particular diagnosis 
(e.g., PD), so that patients are seen as sharing the same basic pathology, even though the 
specific stimuli that trigger the fear/anxiety and the associated behavioral responses may 
differ (García-Escalera, Chorot, Valiente, Reales, & Sandín, 2016; Norton, 2012). The T-
GCBT incorporates psychoeducation, cognitive restructuring, graduated in-session 
exposure and response prevention, cognitive restructuring of core beliefs, and relapse 
prevention. Table 7 shows the T-GCBT sessions. 
Table 7. T-GCBT sessions. 
Module Title 
1 Psychoeducation and group socialization 
2 Psychoeducation and introduction of cognitive 
restructuring 
3 Cognitive restructuring 
4-9 Graduated in-session exposure and response 
prevention 
10-11 Cognitive restructuring of core beliefs 







3.1.2. Effectiveness of transdiagnostic treatments 
One of the big questions that the TP must answer is about its effectiveness compared 
to waitlist groups or the usual treatment. Nevertheless, it is also very important to find out 
if it is at least as effective as the specific treatments for specific disorders. Currently, there 
is already some accumulated evidence about the effectiveness of these treatments, both 
in individual and group formats. Below, we present a series of recent reviews about this 
question. 
The review by Rector, Man, and Lerman (2014) was carried out with studies that 
applied transdiagnostic CBT (T-CBT) for anxiety and depression. They found 
preliminary empirical evidence suggesting that this treatment modality is effective in 
reducing both primary and comorbid symptoms, and it has an impact on shared 
psychological mechanisms. However, these authors concluded that the empirical 
literature remains provisional because most of the studies used a small sample, made 
direct comparisons with the disorder-specific CBT, and only compared specific disorders 
with the mechanisms of shared action in the treatment. Based on their results, these 
authors concluded that T treatments should be considered complementary to specific 
CBT. 
Reinholt and Krogh (2014) analyzed the overall efficacy of T-CBT for anxiety 
disorders compared to waitlist conditions, usual treatment, and disorder-specific CBT. 
The results of 11 controlled trials highlighted the potential of T-CBT in comparison with 
the aforementioned conditions, even obtaining positive effects in the follow-ups. 
However, the pooled estimate showed a moderate treatment effect, but with differences 
between the included studies. These authors suggested that T-CBT can be a very 
promising, affordable, and pragmatic pathway for anxiety disorders, and it may be a 





Other studies that will be explained in more detail in the next section are those by 
Newby, McKinnon, Kuyken, Gilbody, and Dalgleish (2015); Newby, Twomey, Yuan Li, 
and Andrews (2016); and Păsărelu, Andersson, Bergman Nordgren, and Dobrean (2017). 
These authors carried out a systematic review and meta-analysis about clinician-guided 
Internet/computerized and face-to-face transdiagnostic treatments. 
Norton and Paulus (2016) reviewed the empirical evidence on two of the most widely 
used transdiagnostic treatments in anxiety and mood disorders: the T-GCBT by Norton 
(2012), and the UP by Barlow et al. (2004, 2011). Some studies suggest that group T-
CBT is effective in reducing anxiety symptoms (Norton et al., 2013), and comorbid 
depression (Norton, Hayes, & Hope, 2004), compared to disorder-specific CBT. Along 
the same lines, the UP showed positive results in the reduction of primary (Farchione et 
al., 2012) and comorbid (Davis, Barlow, & Smith, 2010) symptoms, in the improvement 
of subjective quality of life (Gallagher et al., 2013), and in two personality factors, 
neuroticism and extraversion (Carl, Gallagher, Sauer-Zavala, Bentley, & Barlow, 2014). 
These authors concluded that despite the boom and empirical support for these treatments, 
more controlled trials and more information about their long-term effects (e.g., results 
after completing the intervention) are still needed to ensure their effectiveness and 
efficiency. 
Finally, Pearl and Norton (2017) carried out a meta-analysis to compare T-CBT with 
disorder-specific CBT, and investigate the differential impact of comorbidity on the effect 
size. To do this, they compared the pre- and post-scores of primary anxiety measures in 
83 treatment conditions taken from studies aimed mainly at anxiety disorders. They found 
that both types of CBT entailed large effect sizes and overlapping confidence intervals, 
and that the two were similar. In addition, they found that comorbidity rates did not appear 





In conclusion, although the reviews are still scarce and preliminary,  their results are 
very promising and encouraging, and it seems that we are in a position to encourage the 
promotion and dissemination of transdiagnostic treatments, at least for EDs, in clinical 
settings. 
3.1.3. Advantages of transdiagnostic treatment 
The advantages of a transdiagnostic treatment are threefold: 1) It is possible to focus 
the treatment on the maintenance of the symptoms across multiple disorders, rather than 
on the large number of specific disorders proposed in the DSM. This would contribute to 
more effective and efficient treatments. 2) Treating processes that are common across the 
comorbidities provides a path toward improving clinical outcomes. This would avoid the 
dilemma about which disorder to prioritize for treatment. 3) It is possible to reduce the 
time and effort of clinicians, who must otherwise learn multiple disorder-focused 
protocols, often with common theoretical underpinnings and interventions (Harvey et al., 
2004; Mansell et al., 2009). 
For more information about TP see our chapter “Transdiagnostic as an alternative” 
(Baños, Vara, Miragall, 2017). 
3.2. Interventions focused on positive affect 
In order to improve the current available treatments, the enhancement of PA has been 
considered a relevant variable (Algoe, Fredrickson, & Chow 2011; Carl, Soskin, Kerns, 
& Barlow, 2013). 
Watson and Tellegen (1985) proposed the factorial model of affection and 
established that the structure of affectivity was composed of two independent dimensions 
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(PA and NA). This means that the absence of negative feelings is not equivalent to the 
presence of positive ones. 
Thus far, psychological treatments for EDs have focused primarily on interventions 
designed for the NA dimension. Therefore, it is necessary to improve the intervention 
strategies for the PA dimension (Carl et al., 2013). 
In the next sections, some treatment alternatives are examined whose main work axis 
lies in the promotion of PA for the treatment of depression. 
3.2.1. Positive affect in the transdiagnostic treatments 
As shown in the previous section, the UP has received great interest as a treatment 
for EDs, and especially for the regulation of negative emotions (Barlow et al., 2013). 
However, the main objective of this treatment is to train patients in NA regulation, paying 
less attention to the inclusion of treatment components directly targeting PA regulation. 
Likewise, this also occurs with other types of transdiagnostic treatments for anxiety 
disorders (e.g., Norton, 2012) and mixed anxiety and depression (e.g., Berger, Boettcher, 
& Caspar, 2014). 
The literature suggests that there is a link between the maladaptive strategies used by 
depressed people to regulate PA and the rest of the depressive symptoms (Gilbert, 2012; 
Gilbert, Nolen-Noeksema, & Gruber, 2013; Werner-Seidler, Banks, Dunn, & Moulds, 
2013), and that deficits in PA regulation are associated with a worse depression prognosis 
(Shankman, Nelson, Harrow, & Faull, 2011). In addition, a theoretical review on positive 
emotional regulation concluded that there are transdiagnostic disturbances in the 
strategies used to regulate positive emotions that may provide the explanation for the low 
levels of PA in depression and several anxiety disorders (Carl et al., 2013). 
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Moreover, the research reveals that EDs (e.g., Dunn, 2012; Kashdan, Weeks, & 
Savostyanova, 2011) are associated with aberrant functioning of the positive emotional 
system, including low levels of PA (e.g., Brown, Chorpita, & Barlow, 1998), decreased 
approach motivation and behavior (e.g., Campbell et al., 2009), biased processing of 
reward-related signals (e.g., Joormann & Gotlib, 2007), and reduced behavioral and 
neural reactivity to rewards (e.g., Carl et al., 2013; Pizzagalli, Iosifescu, Hallett, Ratner, 
& Fava, 2008). 
Some studies suggest that the PA system may be the key to facilitating recovery from 
anxiety and depression (Dunn, 2012; Fredrickson, 2013; Garland et al., 2010; Layous, 
Chancellor, & Lyubomirsky, 2014). In this regard, positive emotions fulfill a number of 
functions that mitigate the adverse effects of negative emotions by promoting PA, 
resilience, and psychological well-being (e.g., Fredrickson & Levenson, 1998; 
Fredrickson, Mancuso, Branigan, & Tugade, 2000). 
Thus, several theories have suggested the adaptive value of positive emotions in 
cognition and action processes. For instance, the Broaden and Build Theory proposed by 
Fredrickson (1998, 2001, 2013) asserts that certain positive emotions, such as joy, 
interest, contentment, pride and love, share the ability to broaden people’s momentary 
thought-action repertories, inciting them to accomplish a wider range of thoughts and 
actions (i.e., to play, explore, savor, and integrate current life circumstances, or envision 
future achievements) that lead to creating enduring personal resources (i.e., physical, 
intellectual, social, or psychological resources). 
Finally, the regulation of PA can have important implications in the treatment of ED 
(Carl et al., 2013) because it has been observed that high PA is associated with better 
physical and psychological health, healthier lifestyles, and better general functioning 
(Cohen & Pressman, 2006; Fredrickson, 2001; Livingstone & Srivastava, 2012; Pressman 
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& Cohen, 2005; Quoidbach, Berry, Hansenne, & Mikolajczak, 2010; Tugade & 
Fredrickson, 2007). 
Taking into account the role of PA in EDs, it is necessary to include this dimension 
as an intervention strategy, especially in the transdiagnostic treatments (Carl et al., 2013). 
3.2.2. Positive psychology and depression treatments 
A recent perspective that emerged strongly with the aim of enhancing positive 
emotional human functioning, and especially PA, is positive psychology (PP) (Seligman 
& Csikszentmihalyi, 2000). PP emerged to unite disparate theory and knowledge on 
positive human functioning and advance the work on positive mental health and well-
being (Seligman, Steen, Park, & Peterson, 2005). Psychological well-being is understood 
as “both the absence of mental illness and the presence of positive psychological 
resources, such as PA and satisfaction with one’s life (Diener, 1984), autonomy, 
competence, relatedness (Ryan & Deci, 2001), self-acceptance, purpose, and personal 
growth (Ryff, 1989)” (Sin, Della Porta, & Lyubomirsky, 2011, p. 79). 
To date, treatments for depression seem to have focused more on relieving mood, 
paying less attention to building positive resources. According to a frequently mentioned 
analogy, many therapies have only focused on increasing the mental health of people 
from -5 to 0 (neutral), without aiming to elevate these people to +5 or higher. 
Psychological interventions should strive to work on the well-being of an individual, 
instead of focusing only on improving depressive symptomatology (Lyubomirsky, 2008). 
The benefits of positive emotions are especially relevant to those suffering from 
depression. Santos et al. (2013) concluded that positive psychology interventions (PPIs) 
reduce both symptoms of depression and the potential for relapse into subsequent periods 





such as the exercise of counting your blessings (Emmons & McCullough, 2003; Seligman 
et al., 2005), practicing kindness (Otake, Shimai, Tanaka-Matsumi, Otsui, & Fredrickson, 
2006), setting personal goals (Green, Oades, & Grant, 2006; Sheldon, Kasser, Smith, & 
Share, 2002), expressing gratitude (Seligman et al., 2005; Sheldon & Lyubomirsky, 2006) 
and using personal strengths to improve well-being and improve or relieve depressive 
symptoms (Seligman et al., 2005). The meta-analysis by Sin and Lyubomirsky (2009) 
showed that PPIs can indeed be effective in enhancing well-being (Cohen’s d = 0.61) and 
helping to reduce depressive symptom levels in clinical samples (Cohen’s d = 0.65). 
Along the same lines, the meta-analysis by Bolier et al. (2013a) revealed that PPIs 
produced a small but significant treatment efficacy on variables of subjective well-being 
(Cohen’s d = 0.34), psychological well-being (Cohen’s d = 0.20), and depression 
(Cohen’s d = 0.23). A later meta-analysis conducted by Weiss, Westerhof, and 
Bohlmeijer (2016) also showed that PPIs are effective. Finally, other authors have found 
that PPIs may help individuals with other EDs and somatic disorders (Chakhssi, Kraiss, 
Sommers-Spijkerman, & Bohlmeijer, 2018).  
Another very promising way to increase well-being and PA is to engage individuals 
in valuable and enjoyable activities. The contemporary BA approach tries to make 
patients commit to their life again, increase their experiences of well-being, and get 
involved in behaviors that give them a greater sense of self-efficacy and that are consistent 
with their values (Kanter, Puspitasari, Santos, & Nagy, 2012). A meta-analysis about BA 
interventions for well-being showed that these interventions can increase the well-being 
of participants, and that they are equally effective regardless of depression severity 
(Mazzucchelli, Kane, & Rees, 2010). The moderate effect size (Hedges's g = 0.52) was 
comparable in size to the mean effect on measures of well-being achieved by PPIs (0.61; 
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Sin & Lyubomirsky, 2009). This finding suggests that BA could be added to the growing 
number of interventions in the field of PP. 
In summary, it seems that the inclusion of PPIs in existing CBT interventions (e.g., 
transdiagnostic interventions) may help to increase the effect on PA, and thus, lead to 
better and longer-lasting outcomes of positive emotional functioning and well-being 
(González-Robles, García-Palacios, Baños, Quero, & Botella, 2017). 
3.2.3. Transdiagnostic interventions based on positive psychology 
Recently, Taylor, Lyubomirsky, and Stein (2017) evaluated the efficacy of a pilot 
study about a new transdiagnostic intervention based on PP to upregulate PA in anxiety 
and depression. Participants with clinically impairing symptoms of anxiety and/or 
depression were randomly allocated to two conditions: 1) 10 1-hr sessions of an individual 
therapist-delivered protocol comprised of positive activity intervention (PAI) (13 




Table 8. Modules of the PAI protocol for EDs. 
Module Goal 
1. Psychoeducation
Present treatment rationale; self-
monitoring of emotions. 
2. Noticing and amplifying positive
events
Train attention towards and increase 
awareness of positive events; intensify 
and prolong positive emotional 
experiences. 
3. Gratitude: Counting one’s blessings Direct attention to positive events.
4. Acts of kindness Increase prosocial behaviors. 
5. Pleasurable, engaging, and
meaningful activities
Increase participation in rewarding 
activities, both hedonic and eudaimonic. 
6. Strengths Increase awareness of personal strengths 
and opportunities to use those strengths. 
7. Affirming values
Strengthen commitment to personal 
values. 
8. Optimism: Best possible future Promote future-oriented positive 
cognitions and behaviors. 
9. Make someone else happier Increase investment in relationships; 
increase prosocial behaviors and 
connection with others. 
10. Live this month like it’s your last in
this area
Promote increased engagement in positive 
activities; increase anticipation, 
appreciation, and sustained 
responsiveness to positive events. 
11. Gratitude: Gratitude letter Direct attention to another person’s role in 
positive events; strengthen social 
connections. 
12. Develop personalized positive
activity plan
Maximize person-activity fit and 
continued engagement in activities; 
translate activities into habits. 




The results show that the PAI group presents significantly greater improvements in 
PA and psychological well-being from pre- to post-treatment compared to the WL group. 
The PAI group also shows significant reductions in NA, as well as in anxiety and 
depression symptoms, compared to WL. Improvements across all outcomes (positive and 
negative emotions, psychological well-being, and symptoms) were large in magnitude 
and maintained over a 6-month follow-up period. Therefore, these findings support the 
idea of explicitly treating positive emotions in disorders classically defined and 
conceptualized according to heightened negative emotions. 
Other study carried out by members of our research group Labpsitec (González-
Robles et al., 2017), analyzed the preliminary effects of positive affectivity in the 
transdiagnostic treatment of ED. This study differs from the previous treatment because 
it also includes strategies for downregulating NA. These authors develop a 
transdiagnostic protocol (T-protocol) for EDs based on the UP (Barlow et al., 2011) and 
some strategies for ER from dialectical behavior therapy (DBT, Linehan, 1993) (12 
modules). Another version of this protocol also includes a specific component mainly 
based on PPIs to directly address PA regulation (T-protocol+PA) (11 modules + 4 specific 
modules of PP). Participants with ED were randomly allocated to 12 to 15 1-hr sessions 
of individual therapist-delivered T-protocol (N = 12) or to 16 to 19 1-hr sessions of 
individual therapist-delivered T-protocol+PA (N= 12). Table 9 shows the modules in both 
conditions: T-protocol and T-protocol+PA. 
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Table 9. Modules of the T-protocol and T-protocol+PA for EDs. 
Module Title 
1 Introduction to treatment 
2 Motivation for change and goal-setting 
3 
Understanding the role of emotions (psychoeducation 
about emotions and goal-setting) 
4 
Nonjudgmental emotional awareness and acceptance 
of emotional experiences 
5 
Practicing present-focused awareness: Physical 
sensations, thoughts, emotions, and daily activities 
6 
Learning to be flexible (identification of thinking 
traps) 
7 
Practicing cognitive flexibility (cognitive reappraisal 
and evaluation of intrusive thoughts) 
8 Emotional avoidance 
9 Emotion-driven behaviors 
10 
Accepting and facing physical sensations 
11 
Facing emotions in the contexts in which they occur 
12 Relapse prevention 
Learning to move on (e.g., BA)* 
13 Learning to enjoy (e.g., the importance of smiling, 
savoring)* 
14 Learning to live (e.g., identifying individual`s own 
psychological strengths, meaningful activities linked to 
personal values)* 
15 Living and learning (e.g., gratitude, hope, curiosity)* 
16 Relapse prevention* 





The results reveal that both interventions (T-protocol and T-protocol+PA) led to 
improvements in all measures (anxiety, depression, positive and negative affectivity, and 
quality of life) at post-treatment, and these changes were maintained at the 3-month 
follow-up, with large effect sizes. Moreover, the effect sizes for the PA were larger in the 
condition that included the component to upregulate positive affectivity. Once again, the 
potential impact of including therapeutic components directly addressing PA regulation 
in the treatment for EDs is shown. 
All of these findings suggest that transdiagnostic treatments focused on the regulation 
of PA may be a promising solution for the management of EDs. However, this field is 
quite new, and more research is needed.  
4. The use of the Internet in the application of psychological treatments  
4.1. The inclusion of Information and Communication Technologies (ICTs) in the 
application of psychological treatments 
The importance of disseminating EBPTs has been mentioned in previous sections. 
Many studies show that not all depressed PC patients are receiving adequate treatment 
for depression (Uebelacker, Smith, Lewis, Sasaki, & Miller, 2009). Therefore, it is a 
priority to change the way of delivering psychological treatments. In recent years, a need 
to radically change the way psychological treatments are applied has been detected.  
The work by Kazdin and Blase (2011) has proposed something as drastic as 
"rebooting" the research and practice of psychotherapy to reduce the burden of mental 
illness. In the opinion of these authors, a radical change in perspective is necessary, an 
approach that goes beyond individual one-to-one psychotherapy. We need to offer the 
best treatment, but without excessively increasing the costs or reducing the effectiveness 
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of the intervention. To do this, it is necessary to analyze other treatment frameworks as 
alternatives to the traditional ones that, without altering the essence of the clinician-
patient relationship, involve a different mode of interaction from those of traditional face-
to-face therapy, with changes in the specific responsibilities of each party (e.g., a more 
active role on the part of the patient) (Botella, Quero, Baños, & Garcia-Palacios, 2009). 
For this purpose, the inclusion of Information and Communication Technologies (ICTs) 
could be very useful (Kazdin & Blase, 2011). ICTs (e.g., virtual reality, augmented 
reality, Internet) are becoming very useful tools for delivering and improving the 
application of therapeutic services, making it possible to expand the axis of the 
effectiveness or clinical utility of EBPTs, and promoting the power to reach everyone 
who needs them (Botella et al., 2009; Kazdin & Rabbit, 2013). ICTS contribute to the 
five dimensions postulated by the RE-AIM model (reach, efficacy/effectiveness, 
adoption, implementation, and maintenance), which has received considerable empirical 
support from a large body of science (Glasgow, McKay, Piette, & Reynolds, 2001). 
Specifically, some literature suggests that the Internet can be used for the assessment 
and treatment of clinical conditions (Andersson, 2016). 
4.2. Internet-based interventions for mental disorders 
In the past 20 years, Internet-based interventions (IBIs) have emerged as a useful 
alternative for coping with the challenge of disseminating psychological treatments 
(Andersson & Titov, 2014). The IBIs, also referred to as e-therapy, online interventions, 
or computerized psychotherapy, are defined as therapeutic programs with specific health 
objectives delivered mainly using the Internet (Barak, Klein, & Proudfoot, 2009). 
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Prior to the development of IBIs, the first computer-based interventions were not 
online, such as the programs Overcoming Depression (Williams, Taylor, Aubin, Harkin, 
& Cottrell, 2002) and Blues Begone (Purves, Bennett, & Wellman, 2009). 
IBIs can be classified into six categories (Barak et al., 2009): a) web-based education 
interventions; b) self-guided web-based therapeutic interventions; c) human-supported 
web-based therapeutic interventions; d) online counseling (e.g., chat, video-based); e) 
Internet-operated therapeutic software (e.g., robotic simulation, gaming); and f) other 
online activities (e.g., blogs, podcasts). Moreover, each category of IBI is described 
taking into account four major types of components: 1) content (e.g., educational or 
directed to behavior change); 2) multimedia (e.g., text, images, videos); 3) interactive 
online activities (e.g., online quizzes, homework); and 4) guidance and supportive 
feedback (e.g., automatic reminders, professional feedback). 
In some IBIs, psycho-educational information through text is presented in a 
sequential order, whereas in others, simulated dialogues with content tailored to a user’s 
response are included (e.g., Deprexis; Meyer et al., 2009, 2015). Some IBIs may be used 
without registration (e.g., MoodGym; Christensen, Griffiths, & Jorm, 2004), whereas 
others require registration or involve careful prior evaluation (e.g., Smiling is fun; Botella 
et al., 2012). Some of them are often offered without therapist guidance (unguided 
interventions), but can be combined with minimal but regular contact with the therapist 
(guided interventions) (Andersson, 2009). Contact with the therapist is limited to 
providing support and, if necessary, clarifying questions about standardized treatment, 
and it can be provided in person, by telephone, or by e-mail (Cuijpers & Schuurmans, 
2007). The involvement of the therapist may take different forms and vary in terms of the 
time spent with the patient (Andersson, Carlbring, Berger, Almlöv, & Cuijpers, 2009). 
Finally, there are blended treatments, which are a combination of guided IBI and regular 
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contact with a therapist at different points in time during the therapeutic process (Wentzel, 
van der Vaart, Bohlmeijer, & van Gemert-Pijnen, 2016). 
In the following section, the types of IBIs for depression will be discussed in more 
detail. 
4.2.1. Internet-based Interventions for depression 
Through IBIs, patients work from a self-help guide adapted for the Internet and based 
on EBPT protocols. The patient systematically completes several online lessons, which 
usually present the same information and therapeutic strategies used in traditional face-
to-face therapy, often with the support of a therapist who is trained to do so (Titov, 2011). 
As discussed in previous sections, there are several forms of effective psychotherapy 
for the treatment of depression (e.g., CBT, IPT, PST) (e.g., Cuijpers et al., 2013). These 
structured psychological treatments seem to work better than unstructured or non-
directive therapeutic approaches (Cuijpers et al., 2012). In addition, it has become clear 
that EBPTs can be transferable to the Internet format, especially CBT (ICBT), without 
losing their effectiveness (Andersson, 2009). One of the most important aspects of IBIs 
is the possibility of improving cost-effectiveness compared to face-to-face traditional 
therapy (Andersson, 2016). 
4.2.1.1. Unguided Internet-based computerized interventions 
Unguided ICBT programs represent an attractive way to optimize the benefits of 
traditional CBT because they are eminently scalable and can be disseminated quickly 
(Leykin, Muñoz, Contreras, & Latham, 2014). Table 10 shows the main unguided ICBT 
programs for depression that have accumulated empirical evidence during these years 
(Andersson, 2014, p. 45). 
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Table 10. List of the main unguided ICBT programs for depression. 
Program, country of 





depression on the Internet) 
United States 
(Clarke et al., 2002) 
7 - Program based on training and the 




(Christensen, Griffiths, & 
Jorm 2004) 
5 - Program based on CBT, IPT and 
relaxation therapy. 
- It is also designed to prevent 
depression. 
- It has also been tested as guided 
treatment (Farrer et al., 2011). 
Deprexis 
Germany 
(Meyer et al., 2009) 
10 - Program based on CBT but also 
includes other approaches such as 
PP and mindfulness. 
- It has also been tested as guided 
treatment (Berger et al., 2011). 
Living life to the Full 
United Kingdom 
(William & Chellingsworth, 
2010) 
8 - Program based on CBT through the 
five areas approach (people and 
events, thinking, feelings, physical 
symptoms, and behavior or activity 
levels). 
Note. CBT, Cognitive Behavioral Therapy; IPT, Interpersonal Therapy; PP, Positive Psychology. 
4.2.1.2. Guided Internet-based computerized interventions 
So far, many guided IBIs for the treatment of depression have been proposed, and 
their number has steadily increased. As can be seen, all these programs differ in content 
but share common CBT components. Table 11 shows the main guided ICBT programs 
for depression (Andersson, 2014, p. 81). 
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Table 11. List of the main guided ICBT programs for depression. 
Program, country of origin, 
and authors 
Number of modules Therapeutic components 
Beating the Blues  
United Kingdom 
(Proudfoot et al., 2003) 
8 Cognitive and behavioral techniques. 
Out of Depression (DAVID) 
Sweden 
(Andersson et al., 2005) 
5 
Later: 7 adapted modules 
(Vernmark et al., 2010) 
Psychoeducation, BA, cognitive 




(Perini et al., 2009) 




(Ruwaard et al., 2009) 
8 
Inducing awareness, structuring 
activities, cognitive restructuring, 
positive self-verbalization, social skills, 
and relapse prevention. 
Relapse prevention program 
(ISIDOR) 
Sweden 
(Holländare et al., 2011) 
9  
7 optional 
 advanced  modules 
Psychoeducation, positively reinforced 
activities, cognitive restructuring, 
improving sleep, mindfulness, reducing 




(Titov et al., 2011) 
8 Transdiagnostic with a focus on 
depression. 
Psychoeducation, cognitive therapy, 
control of physical symptoms, BA, 
graded exposure, beliefs, PST, and 
relapse prevention. 
Tailored Internet 
intervention for depression 
(Taylor) 
Sweden 
(Johansson et al., 2012) 
25 that are prescribed 
according to symptom 
profile 
4 modules are fixed: 
psychoeducation, cognitive 
restructuring, and relapse 
prevention 
Psychoeducation, cognitive 
restructuring, and relapse prevention 
(fixed contents). Also: PST, 
mindfulness, and relaxation. 
Depressionshjälpen 
Sweden  
(Carlbring et al., 2013) 
7 Psychoeducation, activity and well-
being, understanding other activities 
and the role of reinforcement. 
Note. BA, Behavioral Activation; PST, Problem Solving Therapy. 
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4.2.2. Effectiveness of Internet-based interventions for depression 
The empirical evidence show that IBIs are effective for the treatment of depression 
(Richards & Richardson, 2012). Several meta-analyses indicate that IBIs (e.g., CBT, IPT) 
produce larger effect sizes than control groups, ranging from 0.5 to 0.8 (Andrews, 
Cuijpers, Craske, McEvoy, & Titov, 2010, Richards & Richardson, 2012). Moreover, 
there are no major differences between the types of psychological therapy or the types of 
intervention format (Barth et al., 2013). The meta-analysis by Cuijpers, Donker, van 
Straten, Li, & Andersson (2010) examined whether guided IBIs and other conventional 
methods (e.g., self-help books with telephone support) for depressive and anxiety 
disorders were as effective as face-to-face treatments. The results revealed that there were 
no significant differences between them (differential effect size d = 0.02), even in the 
follow-ups at 3, 6 and 12 months (Cuijpers & Riper, 2014). Nor has it been found that the 
risk of dropping out from treatment is greater or lesser in guided IBIs than in face-to-face 
treatments (Cuijpers & Riper, 2014). In another meta-analysis focused only on guided 
IBIs and face-to-face therapies for EDs and other problems (e.g., body dissatisfaction), 
no significant differences were found (Cohen’s d = 0.01) (Andersson, Cuijpers, Carlbring, 
Riper, & Hedman, 2014). Finally, all these results are also confirmed in some meta-
analyses of individual patient data (e.g., Karyotaki et al., 2017). 
Regarding unguided IBIs (interventions without any kind of human support), the 
effect sizes are significantly smaller than those for the guided IBIs (Andersson & 
Cuijpers, 2009; Richards & Richardson, 2012). A meta-analysis about unguided IBIs for 
depression reported a small effect size (Cohen’s d = 0.28) (Cuijpers, Donker, Johansson, 
Mohr, van Straten, & Andersson, 2011). This finding suggests that guidance has a 
facilitating effect on adherence, keeping users engaged in the IBI (Baumeister, Reichler, 
Munzinger & Lin, 2014). However, these types of interventions are currently being 
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examined because they could be more cost-effective (Gerhards et al., 2010), especially in 
low and middle income countries without an infrastructure for mental health care 
(Cuijpers, Riper, & Andersson, 2015). The use of interactive tools such as automatic 
messages, videos, audios, mobile features, and feedback systems could help improve 
adherence of this type of treatment (Ritterband, Thorndike, Cox, Kovatchev, & Gonder-
Frederick, 2009). 
In summary, guided IBIs can be considered an evidence-based first step option in the 
treatment of depression. 
4.2.3. Effectiveness of Internet-based interventions for depression in primary care 
Although there is empirical evidence supporting IBIs for the treatment of depression, 
it has yet to be shown that results can be transferred to routine clinical practice (Schröder, 
Berger, Westermann, Klein, & Moritz, 2016). Most of the randomized trials on IBIs have 
been carried out with self-referred depressed people recruited through advertisements, 
leaflets, and the Internet (Cuijpers et al., 2015). However, several groups in Europe, the 
US, and Australia are working on examining IBIs in PC settings (Riper et al., 2010, 
Andrews et al., 2018). For example, Watts, Newby, Mewton, & Andrews (2012) found 
that the ICBT program prescribed by GPs in PC reduced suicidal ideation. Another 
uncontrolled trial on a guided IBI implemented in routine care showed that depressive 
symptomatology decreased after treatment, remaining at the 1-year follow-up (Ruwaard, 
Lange, Schrieken, Dolan, & Emmelkamp, 2012). Along the same lines, another 
Australian study showed positive results in individuals with severe depression (Williams 
& Andrews, 2013). Finally, the recent systematic review and meta-analysis by Wells et 
al. (2018) reported that therapist-supported computer-assisted CBT in PC settings could 
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increase treatment efficiency, reduce costs, and provide access to effective interventions 
for depression. 
It is important for the research to prioritize how to implement IBIs in PC settings in 
order to reach a greater number of people, beyond the efficacy and effectiveness studies 
(Drozd et al., 2016). 
4.3. Internet-based interventions focused on positive affect for depression 
As explained above, it is important for psychological treatments to not only focus on 
reducing NA and also consider the promotion of PA as another essential aspect that can 
contribute to the therapeutic approach to depression. 
The Internet seems to be promising tool for delivering interventions to enhance PA 
in clinical population. Several IBIS will be described below, focusing on TP and PP. 
4.3.1. Internet-based transdiagnostic interventions 
Internet-delivered transdiagnostic-CBT (T-CBT) can be an alternative to standard 
treatments for EDs (Titov et al., 2011). Newby et al. (2015), through a systematic review 
and meta-analysis, showed that transdiagnostic treatments were effective in reducing 
symptoms of anxiety and depression. In addition, the modality of treatment delivery was 
found to be an important moderator, with transdiagnostic face-to-face and online-
delivered treatments being better than group-delivered treatments. Another meta-analysis 
showed that T-CBT computerized interventions for anxiety and depression are just as 
effective as disorder-specific interventions (Newby et al., 2016). A recent meta-analysis 
by Păsărelu et al. (2017) synthesized the effects of the Internet-delivered transdiagnostic 
and tailored CBT, taking into account the comorbidity of anxiety and depression. The 
results showed that these treatments produce large effects on measures of anxiety and 
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depression, and a moderate effect on comorbidities. Moreover, when compared to 
disorder-specific interventions, there were no differences in anxiety outcomes, but there 
were differences in depression outcomes, with the results favoring the Internet-delivered 
T-CBT. 
Table 12 shows some of the main studies of Internet-based transdiagnostic 
interventions for EDs. 
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Table 12. Summary of some principal studies of Internet-based transdiagnostic interventions for 
anxiety and depression. 
Note. T-CBT, Transdiagnostic-Cognitive Behavioral Therapy; WL, Waitlist; DS, disorder-specific; SG, 
self-guided. 
Study and program Treatment target Sample Therapeutic
approach
Control Number of 
modules and 
duration
Day, McGrath and Wojtowicz
(2013)







(18 years of age or 
older)
T-CBT WL 5 (6 weeks)






(18 years of age or 
older)
T-CBT WL 5 (6 weeks)






Patients in PC setting
(18 years of age or 
older)
T-CBT WL 6 (10 weeks)







Patients in PC setting
(18 years of age or 
older)
T-CBT DS 6 (90 days)





(18 years of age or 
older)
T-CBT WL 8 (10 weeks)












WL 5 (8 weeks)
Titov et al. (2015)











DS 5 (8 weeks)







(at least 60 years of 
age)
T-CBT SG 5 (8 weeks)
















4.3.2. Internet-based positive technologies 
There are several ways to capture the relationship between PPIs and ICTs, and some 
possible definitions. For example, Riva, Baños, Botella, Wiederhold, and Gaggioli (2012) 
and Botella, Riva, Gaggioli, Wiederhold, Alcañiz, and Baños (2012) proposed the term 
of Positive Technologies to refer to the “scientific and applied approach that uses 
technology to improve the quality of our personal experience with the goal of increasing 
wellness and generating strengths and resilience in individuals, organizations, and 
society”. The positive technologies could be a great tool in the evaluation and treatment 
of EDs. 
Online PPIs have shown mixed results regarding the improvement of depressive 
symptomatology (Bolier & Abello, 2014; Mitchell, Vella-Brodrick, & Klein, 2010). 
Some studies showed that online PPIs could increase participants’ happiness and decrease 
their depression compared to the control condition (e.g., waiting list, placebo) (Bolier et 
al., 2013b; Seligman et al., 2005; Shapira & Mongrain, 2010; Wellenzohn, Proyer, & 
Ruch, 2016). However, other studies did not (Abbott, Klein, Hamilton, & Rosenthal, 
2009; Gander, Proyer, Ruch, & Wyss, 2013; Mitchell, Stanimirovic, Klein, & Vella-
Brodrick, 2009; Mongrain & Anselmo-Matthews, 2012; Woodworth, O’Brien-Malone, 
Diamond, & Schüz, 2016). It seems that all the interventions (including placebo) were a 
consequence of the activation of positive and self-relevant information in participants, 
rather than the possibilities of the exercises themselves (Mongrain & Anselmo-Matthews, 
2012).  
Studies about online PPIs usually use short one-week exercises, compared to 
standard treatments, which use a series of modules and exercises. Thus far, there are very 
few studies that include longer programs, and most of them incorporate PP exercises and 
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other disciplines such as cognitive therapy (Abbott et al. 2009; Bolier et al., 2013b; 
Roepke et al., 2015), with mixed results (see table 13). One exception is the pilot study 
by Görges, Oehler, von Hirschhausen, Hegerl, and Rummel-Kluge (2018) that developed 
a more complex online program (Get.happy) consisting solely of PP exercises to analyze 
its efficacy and acceptability in a sample of patients with depression. The preliminary 
results showed that participants were satisfied with the program but less satisfied with its 
impact on the problems they were trying to solve. In addition, symptom severity 
decreased over time with mild to moderate effect sizes. 
Overall, online PPIs have been shown to be effective in reducing depressive 
symptoms in non-clinical samples (e.g., Carpenter et al., 2016). However, empirical 
evidence about their efficacy in clinical samples does not allow clear and firm conclusions 
to be drawn about their use (Görges et al., 2018). It seems that the clinical features of 
depression (e.g., apathy, concentration problems) may be an important factor that could 
explain this result showing that participants lean toward more complex programs that 
require more active involvement and response (Linden & Schermuly-Haupt, 2014). 
Taking all of the above into account, it is necessary to develop more studies that 




Table 13. Summary of some principal studies of online PPIs for depression. 
Note. PPI, Positive Psychology Intervention; CBT, Cognitive Behavioral Therapy; PST, Problem 
Solving Therapy; BA, Behavioral Activation. 
4.3.3. Internet-based transdiagnostic interventions based on positive psychology 
To date, there are very few studies on IBIs that integrate TP and PP for the treatment 







Internet-based program of seven
resilience core skills (“learning
your ABCs”, “avoiding thinking
traps”, “detecting icebergs”,
“challenging beliefs”, “putting in
perspective”, “calming and
focusing”, and “real-time
resilience”) to improve ability to
cope with challenges and setbacks
in a sample of sales managers.
There was no significant reduction in
anxiety or depression due to small




Online self-intervention based on
principles of PP and elements of
mindfulness, CBT, and PST in six
modules (“personal mission




“mastering your life”) to enhance
well-being or mental fitness for
mildly depressed adults.
A small reduction in depression
symptoms was found after treatment,
remaining at the 6-month follow-up,
compared to the waitlist control
group. However, the majority of






self-help program consisting of
two modules, one of which
incorporated CBT exercises
(“cognitive restructuring” and
“BA”), whereas the second one
included PP exercises (“the 3
good things”, “identification of
personal strengths”, and “guidance
on using strengths in new ways”),
to reduce depressive symptoms.
There was a significant reduction in
depression symptoms when
participants completed the entire
treatment program. However,
exploratory analyses showed no




EDs with a specific component to address PA. It is an adapted intervention based on UP 
(Barlow et al., 2004; Ellard, Fairholme, Boisseau, Farchione, & Barlow, 2010) and some 
strategies from Marsha Linehan’s protocol (Linehan, 1993). The treatment protocol 
consists of 16 modules (with a maximum period of 18 weeks) that includes the following 
components: a) elements addressed to down-regulate NA: present-focused emotional 
awareness and acceptance, cognitive flexibility, behavioral and emotional avoidance 
patterns, and interoceptive and situational exposure; b) traditional elements of evidence-
based treatment for EDs: psychoeducation, motivation for change, and relapse 
prevention; and c) elements to promote PA: BA strategies (e.g., pleasant and significant 
activities linked to values and life goals) and some aspects of Fredickson’s Broaden and 
Build Theory (Fredickson, 2001). This intervention is designed and carried out by our 
research group Labpsitec (http://www.labpsitec.uji.es/esp/index.php). It is also part of a 
RCT with other two conditions (transdiagnostic Internet-based protocol without a PA 
component and a waitlist control group). This work is in progress, and no efficacy results 
have been published for this study. 
Another related study that we have also developed in our research team, and that is 
part of the European ECOMPARED project (European 7FP, N° Agreement; 603,098), is 
the one by Vara et al. (2018). This project includes several randomized controlled non-
inferiority trials in both PC and specialized care in eight European countries, in an effort 
to obtain clinically significant data. Specifically, we designed a blended CBT online 
intervention for depression. The aim of this study is to explore the clinical- and cost-
effectiveness of this intervention compared to treatment as usual. Online treatment 
follows a TP and is based on CBT techniques, including PP strategies. As in the previous 





So far, little research has focused on alternative methods of treatment to CBT for 
depression. Therefore, further research is needed into other therapeutic approaches, such 
as transdiagnostic and PP. whose main objective is to treat symptomatology through the 
promotion of PA. 
4.4. Low-intensity Internet-delivered psychological interventions  
In recent years, work has been carried out to integrate psychotherapy in the PC 
setting. In particular, efforts are being made to ensure that patients with depression receive 
EBPTs (DeLeon, Rossomando, & Smedley, 2004). 
One of the most important barriers to providing EBPTs is that many of them consist 
of at least 12 to 20 weekly 1-hour sessions (Beck, 1995; Weissman, Markowitz, & 
Klerman, 2000). Although this treatment length is considered quite abbreviated compared 
to older approaches, it has been argued that it is still too intense for implementation in PC 
settings. As explained in previous sections, the lack of time and resources are important 
difficulties in the application of these types of treatments. Therefore, brief or low-
intensity psychological treatments for depression are a good alternative to overcome these 
limitations (Castro et al., 2015). In fact, some meta-analyses suggest that depression can 
be effectively treated with brief psychotherapy (6 to 8 sessions), specifically with CBT, 
PST (Nieuwsma et al., 2012), and counselling approaches (Cape et al., 2010). 
Therefore, it is necessary to have a stepped-care model that recommends low-
intensity interventions as the first option before referral to high-intensity interventions 
(Clark et al., 2009). In fact, Bockting, Williams, Carswell, and Grech (2016) propose low-
intensity interventions, the use of transdiagnostic-based treatment protocols, and the use 
of technologies as accessibility and implementation strategies that would contribute to 





Both guided and unguided IBIs are examples of low-intensity interventions that have 
received evidence as appropriate options within the stepped-care model (Bennett-Levy, 
Richards, & Farrand, 2010). More efficacy studies and RCTs are needed to analyze the 
effects of these interventions, using an active control condition as a comparison, in order 
to ensure their dissemination. 
Low-intensity. Internet-delivered interventions could be a simple, cost-effective 
method for treating depression in PC settings (Donker et al., 2015). 
5. Outline of this dissertation 
As shown in previous sections, depression is one of the most common mental 
disorders in PC and Psychiatric health care settings. It has a high rate of comorbidity with 
other disorders (e.g., anxiety). If not treated correctly, it will tend to become chronic, 
reducing people’s functioning in different areas (personal, academic, professional, etc.) 
and leading to high economic and social costs worldwide. Therefore, it is necessary to 
have effective and efficient treatments that can be spread easily, in order to address this 
major public health problem. 
Depression can be treated effectively with psychotherapy (especially CBT), 
pharmacological interventions, or a combination of the two. Until now, most of the 
scientific literature has focused more attention on more traditional therapeutic currents 
such as CBT, the gold standard psychological treatment for depression. However, 
standard treatments are not always the best option because they tend to be very specific 
to the disorder, focus mainly on down-regulating NA, and they are often longer (e.g., in 
terms of the time spent by the patient or clinician), without taking into account other 
important aspects such as the high rate of comorbidity between disorders, the role of up-





problems with accessibility to treatment) and the clinician (e.g., level of training and 
experience in the different psychological treatments). 
Transdiagnostic treatments, PPIS, the use of Internet, and the low-intensity 
treatments could be good alternative approaches to treating depression. In recent years, 
these approaches have begun to accumulate empirical evidence, although more research 
is still needed, particularly in PC settings. Therefore, the general objective of this 
dissertation is to analyze in an RCT the efficacy and cost-effectiveness of an improved 
treatment-as-usual with a low-intensity Internet-based computerized intervention focused 
on the promotion of positive affect (ITAU+IPPA), compared to only improved treatment-
as-usual (only-ITAU) in Spanish PC settings. 
The specific objectives of this dissertation are:  
1. To examine the efficacy of both interventions (ITAU+IPPA and only-ITAU) in 
decreasing depression severity and increasing other secondary variables (affect, 
health-related quality of life, well-being and mindfulness) after treatment and 
follow-ups (6 and 12 months). 
2. To analyze whether both interventions (ITAU+IPPA and only-ITAU) are cost-
effective psychological treatments for depression in PC settings. 
3. To analyze the participants' opinions of the treatment received. 
4. To explore the possible mediator and moderator roles of several relevant 
variables in the effect of the condition on the depression severity. 
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Depression is one of the most prevalent mental disorders worldwide, and it is 
associated with significant personal (e.g., in terms of quality of life or well-being) and 
social (e.g., in terms of economic expenditure and use of services) costs (Gustavsson et 
al., 2011; Kessler, 2012; Mrazek, Hornberger, Altar, & Degtiar, 2014; Parés-Badell et al., 
2014). Specifically, the prevalence of depression in Spanish Primary Care (PC) is 
between 13.9 and 29% (Roca et al., 2009; Alonso et al., 2004), and less than 50% of these 
patients receive the appropriate treatment (e.g., Aragonès, Piñol, Labad, Folch, & Mèlich, 
2004). 
Although there are currently effective treatments for depression (medication, 
psychotherapy, or both) (Huhn et al., 2014; Cuijpers, van Straten, van Oppen, Andersson, 
2008; Cuijpers et al., 2013), these treatments do not reach the growing number of people 
who need them (Kazdin & Blase, 2011). This situation may be due to long waiting list 
periods in PC settings, reduced clinician time to assist to the patient, social stigma about 
mental illness, and lack of well-trained professionals, among others (Gaston, Abbott, 
Rapee, & Neary, 2006; Harvey & Gumport, 2015; Sartorius, 2002; Wittchen et al., 2011). 
Therefore, it is necessary to incorporate new tools to provide evidence-based treatments 
(EBT) for depression in order to respond effectively to this need. 
Low-intensity interventions could be a good alternative to overcome these limitations 
(Bockting, Williams, Carswell, & Grech, 2016) and bring an adequate assistance to those 
who need it. Particularly, Internet-based interventions (IBIs) received empirical evidence 
as an appropriate option to deliver interventions within the stepped-care model (Bennett-
Levy, Richards, & Farrand, 2010). In fact, some meta-analyses suggested that depression 
can be effectively treated with brief psychotherapy (from 6 to 8 sessions). Specifically, 
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this intervention are based on cognitive behavioral therapy (CBT), problem-solving 
therapy (Nieuwsma et al., 2012), and counseling approaches (Cape, Whittington, 
Buszewicz, Wallace, & Underwood, 2010). However, none of them have proven its 
efficacy in comparative to an active condition, therefore more efficacy studies and 
randomized controlled trials (RCTs) are needed to analyze the effects of these 
interventions using an active control condition as a comparison. 
The IBIs have been proposed as a useful option that can help to reduce the gap 
between treatment demands and supply (Andersson & Titov, 2014; Cuijpers, Kleiboer, 
Karyotaki, & Riper, 2017; Holst et al., 2018). Several studies have demonstrated their 
effectiveness and acceptability in treating depression (Andersson & Cuijpers, 2009; 
Andersson, 2016; Andrews, Cuijpers, Craske, McEvoy, & Titov, 2010; Karyotaki et al., 
2018). Moreover, some reviews have shown that IBIs are more effective when patients 
received a guidance (automated reminders to motivate and feedback by e-mail, text 
messages, or brief telephone calls), emphasizing the positive relationship between 
therapist support and the improvement rates (Baumeister, Reichler, Munzinger, & Lin, 
2014; Berger, Hämmerli, Gubser, Andersson, & Caspar, 2011; Johansson & Andersson, 
2012; Richards & Richardson, 2012). In addition, a systematic review about the economic 
cost of IBIs in mental health showed that IBIs were more likely to be less cost-
effectiveness compared to non-guided interventions, waiting list, routine care, group 
CBT, and telephone counseling (Donker et al., 2015). Finally, similar effect sizes have 
been found between IBIs and face-to-face therapies (Andersson, Cuijpers, Carlbring, 
Riper, & Hedman, 2014; Andersson, Topooco, Havik, & Nordgreen, 2016). 
So far, most IBIs for depression have been based primarily on CBT (Andersson, 
2009; Hedman, Ljótsson, & Lindefors, 2012), and other therapeutic approaches such as 
problem-solving therapy (van Straten et al., 2008), interpersonal therapy (Donker et al., 
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2013), acceptance and commitment therapy (Brown, Glendenning, Hoon, & John, 2016), 
psychodynamic therapy (Johansson et al., 2012), or behavioral activation (Nyström et al., 
2017). Although these approaches are effective for depression, not all patients benefit 
from these types of treatments, perhaps because most standard treatments focus on more 
specific mental disorders without taking into account the presence of comorbidities (e.g., 
anxiety disorders) or unspecified disorders (Fairburn, Cooper, & Shafran, 2003; Kring & 
Sloan, 2009). An alternative approach that could contribute to resolving these limitations 
is the transdiagnostic perspective (TP) (Sauer-Zavala et al., 2017). 
The TP focuses primarily on what the emotional disorders (such as depression and 
anxiety) have in common, rather than on what is specific and differential (Sandín, 2012). 
Along these line, Brown and Barlow (2009) suggested that emotional disorders share a 
common latent structure with two dimensions (negative affect (NA) or behavioral 
inhibition and positive affect (PA) or behavioral activation), which, associated with 
different stressors, can lead to anxious or depressive symptoms. This conceptualization 
of emotional disorders led to the design and implementation of transdiagnostic protocols 
with common treatment components within a more parsimonious framework, such as the 
Unified Protocol (Barlow et al., 2011) and transdiagnostic group CBT (Norton, 2012). 
Recent reviews and meta-analyses have shown that transdiagnostic treatments are 
effective for emotional disorders compared to waiting list groups or treatment as usual 
(Reinholt & Krogh, 2014), and even compared to disorder-specific interventions (Pearl 
& Norton, 2017). Furthermore, these effectiveness results can be transferred to the field 
of IBIs (Newby, McKinnon, Kuyken, Gilbody, & Dalgleish, 2015; Newby, Twomey, 
Yuan Li, & Andrews, 2016; Păsărelu, Andersson, Bergman Nordgren, & Dobrean, 2017). 
Thus far, the majority of psychological treatments (e.g., CBT or transdiagnostic) for 
emotional disorders have focused primarily on interventions designed for the NA 
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dimension, paying less attention to building positive resources. Some studies suggest that 
the PA system may be the key to facilitating recovery from anxiety and depression 
disorders (Dunn, 2012; Fredrickson, 2013; Garland et al., 2010; Layous, Chancellor, & 
Lyubomirsky, 2014).  Taking into account the role of PA in the emotional disorders, it is 
necessary to include this dimension as an intervention strategy, especially in the 
transdiagnostic treatments (Carl, Soskin, Kerns, & Barlow, 2013). 
A perspective that emerged strongly with the aim of enhancing positive emotional 
human functioning, and especially PA, is positive psychology (PP) (Seligman & 
Csikszentmihalyi, 2000). PP aims to enhance or generate a series of protective factors 
(e.g., well-being, resilience, satisfaction with life) that prepare the person to deal with 
stressful situations that s/he may find in the present or that may appear in the future 
(Fredrickson, 2001; Tugade & Fredrickson, 2007; Vázquez & Hervás, 2008). 
PP is especially relevant to people suffering from depression. For example, Santos et 
al. (2013) concluded that positive psychology interventions (PPIs) reduce both symptoms 
of depression and the potential for relapse into subsequent periods of depression. 
Furthermore, several meta-analyses have demonstrated their effectiveness in reducing 
depressive symptomatology and increasing well-being (Bolier et al., 2013; Chakhssi, 
Kraiss, Sommers-Spijkerman, & Bohlmeijer, 2018; Sin & Lyubomirsky, 2009; Weiss, 
Westerhof, & Bohlmeijer, 2016), emphasizing their role alongside standard treatments 
for clinical depression (Johnson & Wood, 2015). 
Regarding IBIs and PPIs, the literature has shown mixed results regarding the 
improvement of depressive symptoms (Bolier & Abello, 2014; Mitchell, Vella-Brodrick, 
& Klein, 2010). Some studies showed that online PPIs could increase participants’ well-
being and decrease their depression, compared to the control conditions (Bolier et al., 
2013; Mitchell, Stanimirovic, Klein, & Vella-Brodrick, 2009; Seligman et al., 2005; 
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Shapira & Mongrain, 2010; Wellenzohn, Proyer, & Ruch, 2016), whereas other studies 
did not (Abbott, Klein, Hamilton, & Rosenthal, 2009; Gander, Proyer, Ruch, & Wyss, 
2013; Mitchell et al., 2009; Mongrain & Anselmo-Matthews, 2012; Woodworth, 
O’Brien-Malone, Diamond, & Schüz, 2016). In addition, most of the online PPIs have 
used short one-week exercises, compared to standard treatments, which use a series of 
modules and exercises. Thus far, there are very few studies that include longer programs, 
and most of them incorporate PP exercises and other disciplines such as cognitive therapy 
(Abbott et al. 2009; Bolier et al., 2013b; Roepke et al., 2015). 
Therefore, it is necessary to develop more studies that investigate the efficacy of 
more complex IBIs based on TP and PP in order to verify their effectiveness (Görges, 
Oehler, von Hirschhausen, Hegerl, & Rummel-Kluge, 2018). In this regard, Taylor, 
Lyubomirsky, and Stein (2017) and González-Robles, García-Palacios, Baños, Quero, 
and Botella (2017) evaluated the efficacy of two new transdiagnostic interventions based 
on PP to upregulate PA in anxiety and depression, finding promising efficacy results for 
the treatment of the emotional disorders. Furthermore, Díaz-García et al. (2017) also 
developed a transdiagnostic IBI with a specific component to address PA. The treatment 
protocol consisted of 16 modules that included elements to down-regulate NA, traditional 
elements of EBT for the emotional disorders, and elements to promote PA. This 
intervention was also part of an RCT with other two conditions (transdiagnostic IBI 
protocol without a PA component and a waitlist control group). This work is in progress, 
and no efficacy results have been published for this study. 
Given that low-intensity IBIs, TP, and PPIs have begun to accumulate empirical 
evidence for the treatment of depression, more studies are needed to demonstrate their 
efficacy and cost-effectiveness in routine clinical practice. Therefore, the present study 
aims to explore the efficacy and cost-effectiveness of an improved treatment as usual 
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(ITAU) with a low-intensity Internet-based computerized intervention focused on the 
promotion of positive affect (ITAU+IPPA) for the treatment of depression, compared to 
only the ITAU (only-ITAU) in Spanish PC centers. This trial is part of the FIS project 
from the Carlos III Health Institute of the Spanish Ministry Economy and 
Competitiveness (ETES n° PI13/00982; PSI2010-17563), which includes a multicenter 
RCT in four parallel conditions: a) a healthy lifestyle psychoeducational program, b) a 
program focused on positive affect promotion, c) a brief intervention based on 
mindfulness, and d) ITAU in PC. 
Only clinical data related to the ITAU+IPPA and only-ITAU conditions will be taken 
into account in this study. The specific objectives are: 
1. To examine the efficacy of the two interventions (ITAU+IPPA and only-ITAU)
in improving depression severity and other secondary variables (affect, health-
related quality of life, well-being, and mindfulness) after treatment and follow-
ups (6 and 12 months). 
2. To analyze whether the two interventions (ITAU+IPPA and only-ITAU) are
cost-effective psychological treatments for depression in a PC setting. 
3. To observe the participants' opinions of the treatment received.
4. To analyze whether the effect of condition (ITAU+IPPA vs. only-ITAU) on
depression severity is mediated by the change in PA. 
5. To explore whether sociodemographic (sex, age, marital status, educational
level, occupation, and income level) and baseline clinical variables (depression 
severity, health-related quality of life, well-being, and mindfulness) moderate 
the effect of the condition on depression severity. 
Specifically, the hypotheses of this study are: 
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H1. The ITAU+IPPA condition will be more efficacious than the only-ITAU 
condition in improving depression severity and other secondary variables (affect, health-
related quality of life, wellbeing, and mindfulness) after treatment and follow-ups (6 and 
12 months). 
H2. The ITAU+IPPA condition will be more cost-effective than the only-ITAU 
condition in terms of health and social services use (visits to the GP, visits to the 
emergency room, absence from work, leaving the usual tasks unfinished, and reduction 
in the quality of usual tasks due to health problems) in the follow-ups. 
H3. The user’s opinion about the treatment (rationale, satisfaction, the 
recommendation to others, and usefulness) will be better in the ITAU+IPPA condition at 
all moments of the assessment. 
H4. Participants in the ITAU+IPPA condition (compared to control) will have a 
greater change in PA (both after treatment and follow-ups), leading to a greater reduction 
in depression severity (both after treatment and follow-ups). 
H5. No specific hypotheses are generated about which moderator variables 
(sociodemographic and baseline clinical variables) could be significant in the effect of 
the condition (ITAU+IPPA vs. only-ITAU) on depression severity after the treatment and 
follow-ups, due to the exploratory nature of the analyses. 
2. Method
2.1.   Study design 
A two-arm randomized controlled and cost-effectiveness trial was carried out, with 
repeated measures (baseline, post-treatment, 6-month follow-up, 12-month follow-up) 
and two conditions: IPPA+ITAU and only-ITAU (control group) in a PC setting. The 
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study followed the CONSORT 2010 statement (Consolidated Standards of Reporting 
Trials, http://www.consort-statement.org) (Schulz et al., 2010), the CONSORT-
eHEALTH guidelines (Eysenbach et al., 2011), and the Recommendations for 
Interventional Trials (SPIRIT) (Chan et al., 2013). 
2.2.   Sample size 
The sample size was estimated using G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 
2007). A required sample size of 52 participants (26 per condition) was calculated, taking 
into account a power of 0.80, an alpha level of 0.05, and a small-medium effect size (f = 
0.20, according to the studies by Bolier et al. 2013b and Meyer et al. 2015). Based on the 
literature on Internet-based interventions, a dropout rate of between 20-30% is expected 
(Spek et al., 2007; van Ballegooijen et al., 2014). Thus, a total of 66 participants had to 
be recruited. 
2.3.   Study population, recruitment, eligibility criteria, and randomization 
Patients who reported depressive symptoms to their general practitioner (GP) were 
invited to participate in this trial. The GPs explained the characteristics of the study to the 
patients. The recruitment was implemented in Spanish PC centers in the regions of 
Aragon, Andalusia, and the Balearic Islands, and it started on May 2015 and ended on 
May 2017. The GPs completed a referral report describing general patient characteristics 
including the personal data, so the local researcher could contact the participant. All the 
interested patients signed an informed consent to take part in the study. To confirm 
inclusion/exclusion criteria (see Table 1), the researcher administered the psychological 
assessment instruments through a telephone interview: the MINI International 
Neuropsychiatric Interview for diagnosis version 5 (Ferrando et al., 1998), Patient Health 
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Questionnaire-9 (PHQ-9) (Diez-Quevedo, Rangil, Sanchez-Planell, Kroenke, & Spitzer, 
2001), and sociodemographic variables. 
Table 1. Inclusion and exclusion criteria. 
Inclusion criteria Exclusion criteria 
Minimal criteria of 18 years Presence of serious 
psychiatric comorbidities 
(substance dependence, 
bipolar affective disorder, 
obsessive compulsive 
disorder, psychotic illness) 
Meeting the DSM-5 
diagnostic criteria for 
Major Depressive Disorder 
or Persistent Depressive 
Disorder (Dysthymia) 
High risk of suicide 
Ability to understand and 
read Spanish 
Receiving psychological 
treatment for depression at 
the moment of recruitment 
Access to the Internet and 
having an email account 
An increase and/or change in 
the pharmacological 
treatment (in the case of 
receiving) during the study 
period 
Providing written informed 
consent 
Presence of severe physical 
illness 
After the confirmation of the diagnosis, patients were randomly assigned to one of 
the two conditions (ITAU+IPPA and only-ITAU). The allocation was carried out by an 
independent researcher who belonged to the REDIAPP (Research Network on 
Preventative Activities and Health Promotion) and who was not involved in the study. 
The method used to implement the random allocation sequence was a central telephone. 
The sequence was concealed until interventions were assigned. The patients agreed to 
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participate before the random assignment and without knowing what treatment would be 
assigned to them. The researchers (who conducted the psychological assessments) and 
the GPs (who applied the ITAU treatment following the recommendations of the 
guidelines for the treatment of depression) were blind to the participants’ treatment 
conditions. 
The assigned condition was communicated to the participants via phone call. In this 
call, a clinical psychologist (a professional with Master´s degree in Clinical Psychology, 
with at least two years of experience in the diagnosis, psychological evaluation, and 
treatment) explained the procedure before starting the assigned intervention. 
Before and after the interventions, the participants filled out the assessments via 
telephone or online. Online follow-up assessments were programmed at 6 and 12 months. 
2.4.   Ethics 
The study followed the guidelines of the Helsinki Declaration (World Medical 
Association, 2013). All the researchers followed the guidelines for Good Clinical Practice 
(Food Drug Administration, 1997). All the participants were volunteers, and they did not 
receive any compensation for their participation. Participants were able to withdraw from 
the study at any time, without giving any reason and with no consequences. The study 
was registered in the ISRCTN registry under the number: ISRCTN82388279 
(htpp://www.isrctn.com/ISRCTN82388279). 
2.5.   Interventions 
All the patients included in the study (regardless of the treatment group to which they 
were randomly assigned) were treated by their GPs. 
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2.5.1. Improved treatment as usual (ITAU) 
The Treatment as Usual in PC settings was improved because the participating GP 
received a training program on how to diagnose and treat depression in PC, based on the 
Spanish Guide for the Treatment of Depression in Primary Care (Fernández et al., 2006). 
In the case of suicide risk, severe social dysfunction, or worsening of symptoms, it was 
recommended to refer the patient to mental health services. 
Criteria for minimally adequate treatment were: receiving medication for at least 2 
months, plus at least 4 visits with a GP lasting an average of 30 minutes (Fernández et al., 
2006). 
2.5.2. Improved treatment as usual with a low-intensity Internet-based 
computerized intervention focused on the promotion of positive affect 
(ITAU+IPPA) 
2.5.2.1.  Face-to-face session 
In addition to the treatment provided with the GP, the participants also received a 90-
minute (3-5 patients) group face-to-face session conducted by a clinical psychologist. The 
objective of this session was to explain the program structure and main components of 
treatment, clarify the instructions for the use of the online platform, and motivate 
participants to change. Ultimately, the final goal was to reinforce commitment and 
adherence to treatment. 
2.5.2.2.  Online intervention program 
The online self-guided program consisted of 4 therapeutic modules (60 minutes per 
module). The duration of the program could vary among the users, but it was usually 
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completed in 4 to 8 weeks (maximum 2 weeks per module). These modules contained 
multimedia elements (videos, images, texts) that provided information about depression 
and coping strategies (see Figure 1). These modules were sequential in order to move step 
by step through the program. Moreover, users could review the module contents once 
they were finished. Figure 2 shows the schema of the structure of the program modules. 
Figure 1. Screenshot of module 4 “Living and learning”. 
Figure 2. Schema of the structure of the program modules. 
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Specifically, this intervention followed the TP and was based on PP techniques. It 
was mainly designed to decrease depression severity and prevent relapses using the 
promotion of well-being and PA. Each module, with its objectives, specific content, and 
empirical source, is shown in Table 2. 
Additionally, the online platform included two interactive tools that are available for 
the patients during the intervention: 1) Activity Diary, where the users had to register their 
activities performed in relation to social areas, work, and leisure, considering their 
influence on mood and enjoyment. 2) Feedback Section, where users could visualize their 
progress in their mood through different graphs (weekly and pre/post/follow-up 
moments) (see Figure 3). Moreover, the program also included an assessment protocol at 
different moments (pre-treatment, post-module, post-treatment, and follow-ups). 
Figure 3. Screenshot of the feedback section. 
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We used the web platform psicologiaytecnologia to deliver the intervention designed 
by our research team (http://www.labpsitec.uji.es/esp/index.php). 
The participants received two weekly, automated mobile phone messages, 
encouraging them to proceed with the program and reminding them of the importance of 
doing the homework tasks. In addition, the participants received automated e-mails 
encouraging them to continue with the modules if they had not accessed the program for 
a week. 
For more information on the protocol for the promotion of PA, see the chapter written 
by García-Palacios, Mira, Mayoral, Baños, and Botella (2017) and the protocol study by 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.6.   Measures 
The study measures and assessment times (online and by phone) are summarized in 
Table 3. 
2.6.1.   Primary outcome 
Depression severity: The Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, 
Williams, 2001) is a 9-item self-administered test for screening, diagnosing, monitoring 
and measuring depression severity. Participants describe their state taking into account 
the last two weeks prior to evaluation. Items are rated from 0 to 3 denoting “not at all”, 
“several days”, “more than half the days” and “nearly every day”, respectively. Cut-offs 
of 5, 10, 15 and 20 represent mild, moderate, moderately severe, and severe depression, 
based on the criteria identified by the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR; APA, 2000). The Spanish 
version has been shown to have good psychometric properties (for the diagnosis of any 
disorder, k = .74; overall accuracy, 88%; sensitivity, 87%; specificity, 88%) (Diez-
Quevedo, Rangil, Sanchez-Planell, Kroenke, & Spitzer, 2001). 
2.6.2.   Secondary outcomes 
Diagnostic interview: The MINI International Neuropsychiatric Interview version 
5.0 (M.I.N.I. 5.0; Sheehan et al., 1998) is used at the screening to assess current 
depression and comorbid disorders. This measure is a structured diagnostic interview 
based on the DSM-IV (DSM-IV, 1994) and on International Classification of Diseases-
10 (ICD-10; World Health Organization, 1993) criteria. The Spanish version (Ferrando 
et al., 1998) was used for this study. 
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Affect: The Positive and Negative Affect Scale (PANAS; Watson, Clark, Tellegen, 
1988) consists of 20 items that evaluate two independent dimensions: PA (10 items) and 
NA (10 items). The total score for each subscale ranges from 5 to 50, using a 5-point 
Likert-type scale (1=very slightly or not at all, 5 = very much). The Spanish version by 
Sandín et al. (1999) showed adequate internal consistency (Cronbach’s α between .87 and 
.91). The “state” version was used in the post-module assessment, and the “trait” version 
in the pre-treatment, post-treatment, and follow-up (6 and 12 months) assessments. 
Health-related quality of life: The Short Form 12 Health Survey (SF-12; Ware, 
Kosinski, Keller, 1996) is a 12-item questionnaire that measures aspects of health-related 
quality of life from the patient’s perspective. It contains eight domains in two dimensions: 
physical health (general health, bodily pain, role-physical, physical functioning) and 
mental health (mental health, role-emotional, social-functioning, vitality). Scores > 50 
represent better physical or mental health than the mean, and scores < 50 represent worse 
physical or mental health than the mean. The Spanish validated version (Gandek et al., 
1998) was used. This instrument has been found to be a valid and reliable measure, 
showing good internal consistency (Cronbach’s α > .70) (Vilagut et al., 2008). 
Well-being: The Pemberton Happiness Index (PHI; Hervás & Vázquez, 2013) 
consists of 11 items related to different domains of remembered well-being (general, 
hedonic, eudaimonic and social well-being), each with an 11-point Likert-type scale (0 = 
fully disagree, 10 = fully agree), and 10 items related to experienced well-being (positive 
and negative emotional events that possibly happened the day before), with dichotomous 
response options (yes/no). The remembered well-being score is calculated with the mean 
score of the 11 items and varies from 0 to 10. The items for experienced well-being are 
transformed into a single score from 0 (zero positive experiences and 5 negative 
experiences) to 10 (5 positive experiences and no negative experiences). The sum of the 
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remembered and experienced well-being scores results in a combined well-being index 
(total well-being) ranging from 0 to 10. The validated Spanish version showed adequate 
psychometric properties (Cronbach’s α > .80) (Hervás & Vázquez, 2013). 
Facets of mindfulness: The Five Facet Mindfulness Questionnaire (FFMQ; Baer, 
Smith, Hopkins, Krietemeyer, & Toney, 2006) comprises 39 items, rated on a 5-point 
Likert-type scale (1 = never or very rarely true, 5 = very often or always true), that assess 
five facets or factors of mindfulness: observing (tendency to attend to internal and 
external experiences such as sensations, emotions, sounds), describing (tendency to 
describe and label these experiences with words), acting with awareness (tendency to give 
full awareness and attention to current activities or experiences), not judging inner 
experience (tendency for a nonevaluative  stance  toward  inner  experiences), and not 
reacting to inner experience (tendency to allow thoughts and feelings to come and go, 
without getting caught up in them). The Spanish version demonstrated good internal 
consistency (Cronbach’s α > .80) (Cebolla et al., 2012). 
2.6.3.   Cost outcomes 
Health and social services use: An ad hoc 5-item questionnaire to assess costs related 
to the use of health and social services (“number of visits to the GP in the past three 
months”, “number of visits to the emergency room in the past three months”), lost 
productivity at work (“number of days off work in the past year”), and the impact of 
illness on the usual tasks (“number of days that usual tasks have been left unfinished due 
to health problems in the past month”, “number of days when the quality of usual tasks 
has been reduced due to health problems in the past month”). 
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2.6.4.   Other outcomes 
Sociodemographic data: Personal data that includes information such as age, marital 
status, educational level, occupation, and income level. 
Opinion about the treatment received: An ad hoc 5-item questionnaire rated on a 10-
point Likert-type scale (0 = fully disagree, 10 = fully agree) to measure aspects related to 
the treatment received in terms of: rationale behind the treatment, satisfaction with the 
treatment, recommendation of treatment to others, usefulness of the treatment in your 
case, and usefulness of the treatment for other psychological problems. 
Table 3. The study measures and assessment times (online and by phone). 
Note.*This instrument was also administered in the post-module assessments. PHQ-9, Patient Health 
Questionnaire-9; M.I.N.I, MINI International Neuropsychiatric Interview; PANAS, Positive and Negative 
Affect; SF-12, Short Form 12 Health Survey; PHI, Pemberton Happiness Index; FFMQ, Five Facet Mindfulness 
Questionnaire. 




Online Phone Online Phone Online Phone Online Phone
Primary outcome
Depression severity PHQ-9* x x x x
Secondary outcomes
Diagnostic interview M.I.N.I. x
Affect PANAS* x x x x
Health-related quality 
of life
SF-12 x x x
Well-being PHI x x x
Facets of mindfulness FFMQ x x x
Cost outcomes
Health and social 
services use







Ad hoc x x
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2.7.   Data analyses 
All statistical analyses were performed using the software package SPSS 24.0 (IBM) 
for Windows. Group differences in participants’ sociodemographic, clinical, and cost-
effectiveness data were examined using independent-samples t-tests (t) for continuous 
variables and chi-square tests (χ²) for categorical variables. When the contrast χ² with the 
typical asymptotic method was not reliable −because more than 20% of the cells had an 
expected frequency of less than 5−, the Monte Carlo method was used with 10.000 
samples and a 99% confidence level. 
Intent-to-treat mixed-model analyses without any ad hoc imputations were used to 
handle missing data (Chakraborty & Gu, 2009). This approach is appropriate for RCTs 
with multiple time points and pre-to-post-only designs, and it does not assume that the 
last measurement is stable (the last observation carried forward assumption). This method 
is conducted using all the available observations (Gueorguieva & Krystal, 2004; Salim, 
Mackinnon, Christensen, & Griffiths, 2008). The assumption that data were missing 
completely at random (MCAR) was evaluated using Little's MCAR test. To analyze the 
effect of condition on the primary (depression severity) and secondary outcomes (affect, 
health-related quality of life, remembered and experienced well-being, and facets of 
mindfulness), as well as on the cost-effectiveness and opinions of the participants, 29 
linear mixed models were implemented with Time (pre-treatment, post-treatment, 6-
month and 12-month follow-ups) as within-group factor and Group (ITAU+IPPA and 
only-ITAU) as between-group factor, using the MIXED procedure with 1 random 
intercept per subject, in order to analyze the effect of time and the condition x time 
interaction effect. In addition, effect sizes (Cohen’s d; 95% confidence interval, CI) were 
calculated for within-group comparisons (pre vs. post; pre vs. follow-up-1; pre vs. follow-
up-2) for each condition to analyze the size of the change from pre-treatment to post-
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treatment and follow-up scores for each condition independently, as well as between-
group comparisons at each point to analyze the size of the differences between conditions 
at post-treatment, at follow-up-1, and at follow-up-2 (Ausina & Meca, 2015; Cumming, 
2013; Cumming & Calin-Jageman, 2016). Based on Cohen's logic (1988), a standardized 
mean difference of d = 0.2 represents a “small” effect size, d = 0.5 a “medium” effect 
size, and d = 0.8 a “large” effect size. 
The Reliable Change Index (RCI) (Jacobson & Truax, 1991) for depression severity 
was calculated in the completer sample. The RCI was calculated to make sure that the 
change indicated by the PHQ-9 total score was not due to measurement error, but rather 
to a reliable and real change in the level of depression severity. Criterion C was chosen 
to determine whether the participant's score was within the functional population 
distribution (C= (M dysfunctional × SD functional + M functional × SD dysfunctional) / SD dysfunctional + 
SD functional). Participants were classified as: (a) "recovered" when the RCI was ≥ |1.96| 
and their total PHQ-9 score was within the range of the functional distribution; (b) 
"improved" when the RCI was ≥ |1.96|, but their total PHQ-9 score was not within the 
range of the functional level; (c) "unchanged" when the RCI was < |1.96|; and (d) 
“deteriorated” when the RCI was ≥ |1.96|, but their total PHQ-9 was in the direction of a 
deterioration (McGlinchey, Atkins, & Jacobson, 2002). Chi-square tests (χ²) were 
performed to evaluate group differences in RCI rates. 
In order to analyze changes in depression severity and affect taking into account post-
module assessments in the ITAU+IPPA condition, 3 linear mixed models were conducted 
for the ITAU+IPPA condition with Time (pre-treatment, post-modules, and post-
treatment) as a within-group factor, using MIXED procedure. 
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Finally, to explore the mediator and moderator variables, mediation and moderator 
analyses were performed using the procedure described by Hayes (2013) with the 
PROCESS macro (version 2.16), choosing models 4 and 1, respectively. First, three 
simple mediation analyses1 were performed to test whether the effect of condition on the 
post, follow-up-1, and follow-up-2-PHQ-9 scores was mediated by the change in positive 
affect PANAS scores (post, follow-up-1, and follow-up-2-PANAS scores). Change in PA 
was calculated using the pre-PHQ-9 score and post-follow-up-1 and follow-up-2-PHQ-9 
scores, where positive values for change in positive affect PANAS scores reflected an 
improvement. Bias-corrected bootstrap 95% CIs based on 5.000 samples were used to 
assess the indirect effects. CIs that did not include the zero-value indicated a significant 
indirect effect, meaning that the effects of the condition on the post-follow-up-1 and or 
follow-up-2-PHQ-9 scores were mediated by the changes in PA. Second, 21 moderation 
analyses were carried out to examine whether the relationship between the condition and 
the post-follow-up-1 and follow-up-2-PHQ-9 scores was moderated by 
sociodemographic (sex, age, marital status, educational level, occupation, and income 
level) and baseline clinical variables (depression severity PHQ-9, health-related quality 
of life SF-12, well-being PHI, and mindfulness FFMQ). Tests of significance (p < .05) or 
a CI (not including zero) in the interaction between independent variables (condition) and 
the moderator variables (sociodemographic variables and clinical variables) indicated 
whether these variables moderated the effect of condition on post-follow-up-1 and 
follow-up-2-PHQ-9 scores. We examined the conditional effect of condition on the post-
follow-up-1 and follow-up-2-PHQ-9 at medium (the mean), low (-1 SD), and high (+1 
SD) levels of sociodemographic variables and clinical variables using the “pick-a-point 
approach” (or analysis of the simple slopes). 




3.1.   Participants flow and attrition 
Initially, as the flow diagram shows (Figure 4), 113 participants were interested in 
the study, and 47 were excluded from the trial. Finally, 66 participants were included in 
the study, and they were randomly allocated to each condition (ITAU+IPPA, n = 40; only-
ITAU, n = 26). Thus, 25% of participants from the ITAU+IPPA condition and 19% from 
the only-ITAU condition dropped out of the post-treatment, and 47.5% of participants 
from the ITAU+IPPA condition and 23.07% from the only-ITAU condition dropped out 
during the 6-month follow-up. Finally, 55% of participants from the ITAU+IPPA 
condition and 30.76% from the only-ITAU condition dropped out during the 12-month 
follow-up. Data were missing completely at random (MCAR) (p >.05). Regarding the 
depression severity of those participants who dropped out before ITAU+IPPA post-
treatment, 2 participants showed mild depression severity, 1 participant showed moderate 
severity, and 8 participants showed moderate-severe severity. Concerning to the 
participants of the only-ITAU condition, 1 participant showed mild depression severity, 
1 participant showed moderate severity, and 3 participants showed moderate-severe 
severity. 
With respect to the percentage of participants who completed each module in the 
ITAU+IPPA condition, only 45% of participants completed all the treatment modules, 
65% completed three modules, 72.5% two modules, and 77.5% one module. Specifically, 
2 participants dropped out after post-module 1, showing a moderate and severe depression 
severity. 3 participants dropped out after post-module 2, showing a mild, moderate and 
severe depression severity; and 8 participants dropped out after post-module 3, showing 




a mild (4 participants), moderate (2 participants), and moderate-severe depression 
severity (2 participants). 





















Patients recruited by 
GPs who probably fulfill 
inclusion criteria 
(n = 113) 
Screening by researchers 
using MINI interview 
and PHQ-9 
(n = 113) 
Randomized allocation 
of participating patients 
(n = 66) 
Excluded (n = 47) 
• Did not meet inclusion and 
exclusion criteria (n = 32) 
• Refused to participate (n = 
11) 
• Unable to contact (n = 4) 
Allocated to ITAU+IPPA 
(n = 40) 
Allocated to control 
group: only-ITAU  
(n = 26) 
Post-treatment 
(n = 30) 
Post-treatment 
(n = 21) 
6-month follow-up 
(n = 21) 
6-month follow-up 
(n = 20) 
12-month follow-up 
(n = 18) 
12-month follow-up 
(n = 18) 
Dropouts = 5 
Dropouts = 9 
Dropouts = 3 
Dropouts = 10 
Dropouts = 1 
Dropouts = 2 
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3.2.   Baseline sociodemographic and clinical characteristics 
Table 4 shows participants’ sociodemographic data for each condition. There were 
no statistically significant differences between groups on sociodemographic data: age, 
t(64) = -0.39, p = .700; sex, χ²(1, N = 66) = 1.35, p = .245, Cramer’s V = 0.14; marital 
status, χ²(3, N = 54) = 5.12, p = .144, Cramer’s V = 0.29; educational level, χ²(3, N = 54) 
= 2.46, p = .514, Cramer’s V = 0.22; occupation, χ²(8, N = 60) = 6.31, p = .702, Cramer’s 
V = 0.32, and income level, χ²(3, N = 41) = 6.53, p = .083, Cramer’s V = 0.39. 
Table 4. Sociodemographic data for each condition. 
ITAU+IPPA 
n = 40 
only-ITAU 
n = 26 
Age M(SD) 45.50 (10.48) 46.62 (12.57) 
Sex (%) 
Male 25.00 38.50 
Female 75.00 61.50 
Marital status (%) 
Single 15.80 19.00 
Married/in a relationship 63.20 81.00 
Separated/divorced  18.40 0.00 
Widowed 2.60 0.00 
Educational level (%) 
No studies 2.80 0.00 
Primary studies 19.40 27.80 
Secondary studies 47.20 27.80 
University studies 30.60 44.40 
Occupation (%) 
Student 5.10 4.80 
Employed 48.70 52.30 
Subsidized unemployed 5.10 9.50 
Unemployed without benefits 18.00 0.00 
Time off work 10.30 14.30 
Permanent disability 5.10 4.80 
Retired 5.10 14.3 
Others 2.60 0.00 
Income level (%) 
< NMWa 25.80 10.00 
1-2 NMW 38.70 60.00 
2-4 NMW 35.50 30.00 
Note. aNational Minimum Wage. ITAU+IPPA, Improved Treatment as 
Usual with Intervention focused on the Promotion of Positive Affect; 
only-ITAU, only-Improved Treatment as Usual. 
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Table 5 shows participants´ clinical data for each condition. There were also no 
statistically significant differences between groups on the clinical outcomes (depression 
severity, affect, health-related quality of life, well-being, and mindfulness) (p >.05). 
Table 5. Clinical data and significant differences between conditions. 
ITAU+IPPA 
n = 40 
M(SD) 
only-ITAU 




 PHQ-9 15.83 (5.94) 14.32 (4.85) t(63) = 1.06, p = .291 
Affect 
PANAS 
Positive affect 18.13 (6.35) 18.64 (6.09) t(63) = -0.32, p = .748 
Negative affect 27.65 (8.22) 29.80 (8.66) t(63) = -1.01, p = .319 
Health-related quality of life 
Physical Health SF-12 
General health  31.88 (21.92) 39.00 (19.20) t(63) = -1.33, p = .186 
Bodily pain 47.50 (32.91) 56.00 (30.00) t(63) = -1.04, p = .299 
Role-physical  23.75 (37.53) 32.00 (43.01) t(63) = -0.81, p = .418 
Physical functioning 60.00 (32.91) 65.00 (29.76) t(63) = -0.61, p = .539 
Mental Health SF-12 
Mental Health  35.75 (17.38) 42.80 (18.62) t(63) = -1.54, p = .126 
Role-emotional  18.75 (33.37) 22.00 (35.59) t(63) = -0.37, p = .711 
Social-functioning 38.13 (25.31) 43.00 (21.06) t(63) = -0.80, p = .424 
Vitality 19.50 (17.82) 24.00 (21.61) t(63) = -0.91, p = .365 
Well-being 
PHI 
Total well-being 4.37 (1.79) 4.70 (1.93) t(62) = -0.67, p = .501 
Remembered well-being 4.37 (1.82) 4.80 (2.03) t(62) = -0.67, p = .500 
Experienced well-being 4.38 (2.49) 4.58 (2.45) t(62) = -0.32, p = .745 
Facets of mindfulness 
FFMQ 
Observing 19.88 (5.32) 21.54 (7.16) t(62) = -1.06, p = .292 
Describing 22.78 (7.20) 26.00 (7.77) t(62) = -1.68, p = .097 
Acting with awareness 22.93 (5.62) 22.79 (6.94) t(62) = 0.08, p = .933 
Not judging inner experience 22.30 (6.34) 21.17 (9.46) t(62) = 0.57, p = .568 
Not reacting to inner experience 17.28 (4.56) 17.63 (5.06) t(62) = -0.28, p = .776 
Note. ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of Positive 
Affect; only-ITAU, only-Improved Treatment as Usual; PHQ-9, Patient Health Questionnaire-9; PANAS, 
Positive and Negative Affect; SF-12, Short Form 12 Health Survey; PHI, Pemberton Happiness Index; 
FFMQ, Five Facet Mindfulness Questionnaire. 
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3.3.   Differential efficacy of two treatments conditions 
3.3.1. Change in primary outcome 
Depression severity (PHQ-9 scores) 
There was a significant main effect of time on depression severity, F(3, 130.68) = 
20.90, p < .001, indicating that both conditions were efficacious in decreasing depression 
across time. Moreover, there was no significant condition x time interaction effect on 
depression severity, F(3, 130.68) = 1.64, p = .182. 
Effect sizes for within-group comparisons for each condition (pre vs. post; pre vs. 
follow-up-1; pre vs. follow-up-2) confirmed significant reductions in depression severity 
because medium and large effect sizes were found for both conditions (see Table 6 for 
details). Moreover, effect sizes for between-group comparisons at each point in time were 
small at post-treatment and follow-ups (6 and 12 months) (see Table 7 for details). 
Figure 5 shows the changes in depression severity in both conditions (ITAU+IPPA 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5. Changes in depression severity (PHQ-9 scores) in both conditions (ITAU+IPPA and 
only-ITAU) at pre-treatment, post-treatment and follow-up (6 and 12 months) assessments. 
Note. Pre, Pre-treatment; Post, Post-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 
months); ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of 
Positive Affect; only-ITAU, only-Improved Treatment as Usual. 
3.3.2. Change in secondary outcomes 
Affect (PANAS scores) 
There was a significant main effect of time on PA, F(3, 133.48) = 12.16, p < .001, 
and NA, F(3,130.30) = 9.14, p < .001, indicating that both treatments were efficacious in 
increasing PA and decreasing NA across time. In addition, there was no significant 
condition x time interaction effect on PA, F(3, 133.48) = 0.57, p = .636, and NA, F(3, 
130.30) = 0.20, p = .896. 
Effect sizes for within-group comparisons for each condition (pre vs. post; pre vs. 
follow-up-1; pre vs. follow-up-2) confirmed significant increases in PA with medium and 
large effect sizes, and decreases in NA with medium effect sizes  for both conditions (see 
Table 8 for details). Furthermore, effect sizes for between-group comparisons at each 
point in time were small at post-treatment and follow-ups (6 and 12 months) (see Table 9 
for details). 
Figure 6 (a, b) shows the changes in affect in both conditions (ITAU+IPPA and only-

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6 (a, b). Changes in affect (PANAS scores) in both conditions (ITAU+IPPA and only-ITAU) 
at pre-treatment, post-treatment, and follow-up (6 and 12 months) assessments. 
Note. Pre, Pre-treatment; Post, Post-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 
months); ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of 
Positive Affect; only-ITAU, only-Improved Treatment as Usual.
Fig 6a. Positive affect 
Fig 6b. Negative affect 
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Health-related quality of life (SF-12 scores) 
There was a significant main effect of time on general health, F(3, 125.79) = 3.53, p 
< .05; bodily pain, F(3, 129.39) = 6.64, p < .001; role-physical, F(3, 133.41) = 5.54, p < 
.001; mental health, F(3, 137.27) = 10.09, p < .001; role-emotional SF-12, F(3, 135.76) 
= 15.18, p < .001; social-functioning, F(3, 128.25) = 12.71, p < .001; and vitality, F(3, 
135.75) = 7.85, p < .001, except on the variable of physical functioning, F(3, 125.25) = 
1.84, p = .143. These results indicated that the two conditions were efficacious in 
improving physical and mental health across time. Moreover, there was no significant 
condition x time interaction effect on general health, F(3, 125.79) = 2.07, p = .108; bodily 
pain, F(3, 129.39) = 1.39, p = .247; role-physical, F(3, 133.41) = 0.62, p = .602; physical 
functioning, F(3, 125.25) = 0.37, p = .777; mental health, F(3, 137.27) = 0.85, p = .47; 
role-emotional, F(3, 135.76) = 2.30, p = .080; social-functioning, F(3, 128.25) = 1.55, p 
= .204; or vitality, F(3, 135.75) = 1.48, p = .224. 
Effect sizes for within-group comparisons for each condition (pre vs. follow-up-1; pre 
vs. follow-up-2) confirmed significant increases in all variables of the SF-12, with 
medium and large effect sizes found for both conditions (see Table 10 for details). 
Moreover, effect sizes for between-group comparisons at each point in time were small 
at follow-ups (6 and 12 months) on all variables of the SF-12 survey, except physical 
functioning (Cohen’s d = -0.73), role-emotional (Cohen’s d = -0.52), and vitality 
(Cohen’s d = -0.59) with medium effect sizes, and social-functioning (Cohen’s d = -0.93) 
with a large effect size at the 12-month follow-up (see Table 11 for details). 
Figure 7 (a-h) shows the changes in health-related quality of life in both conditions 
(ITAU+IPPA and only-ITAU) at pre-treatment and follow-up assessments. 
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Well-being (PHI scores) 
There was a significant main effect of time on total well-being, F(2, 75.75) = 17.84, 
p < .001; remembered well-being, F(2, 75.74) = 16.63, p < .001; and experienced well-
being, F(2, 95.74) = 3.29, p < .05, indicating that both conditions were efficacious in 
increasing well-being across time. In addition, there was no significant condition x time 
interaction effect on total well-being, F(2, 75.75) = 1.57, p = .215; remembered well-
being, F(2, 75.74) = 1.51, p = .228; or experienced well-being, F(2, 95.74) = 0.42, p = 
.661. 
Effect sizes for within-group comparisons for each condition (pre vs. follow-up-1; 
pre vs. follow-up-2) confirmed significant increases in all the variables of the PHI, with 
medium and large effect sizes found for both conditions (see Table 10 for details). 
Furthermore, effect sizes for between-group comparisons at each point in time were small 
at follow-ups (6 and 12 months) (see Table 11 for details). 
Figure 8 (a-c) shows the changes in well-being in both conditions (ITAU+IPPA and 
only-ITAU) at pre-treatment and follow-up assessments. 
Facets of mindfulness (FFMQ scores) 
There was a significant main effect of time on observing, F(2, 77.14) = 9.49, p < .001; 
acting with awareness, F(2, 78.35) = 5.05, p < .01; not judging inner experience, F(2, 
79.92) = 5.28, p < .01; and not reacting to inner experience, F(2, 80.99) = 6.10, p < .01, 
but not describing, F(2, 78.88) = 1.81, p = .170. These results showed that the two 
treatment conditions were efficacious in improving the facets of mindfulness across time. 
Moreover, there was no significant condition x time interaction effect on observing, F(2, 
77.14) = 0.36, p = .697; describing, F(2, 78.88) = 1.25, p = .293; acting with awareness, 
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F(2, 78.35) = 0.55, p = .581; not judging inner experience, F(2, 79.92) = 0.59, p = .553; 
and not reacting to inner experience, F(2, 80.99) = 0.57, p = .568. 
Effect sizes for within-group comparisons for each condition (pre vs. follow-up-1; pre 
vs. follow-up-2) confirmed significant increases in all variables of the FFMQ, with small 
and medium effect sizes found for both conditions (see Table 10 for details). Moreover, 
effect sizes for between-group comparisons at each point in time were small at follow-
ups (6 and 12 months) in all facets of the FFMQ, except the observing facet (Cohen’s d 
= -0.53) with a medium effect size at 6-month follow-up (see Table 11 for details). 
Figure 9 (a-e) shows the changes in the facets of mindfulness in both conditions 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7 (a-h). Changes in health-related quality of life (SF-12 scores) in both conditions 
(ITAU+IPPA and only-ITAU) at pre-treatment and follow-up (6 and 12 months) assessments. 
Note. Pre-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 months); ITAU+IPPA, 
Improved Treatment as Usual with Intervention focused on the Promotion of Positive Affect; only-ITAU, 
only-Improved Treatment as Usual. 
Fig 7a. General health Fig 7b. Bodily pain 
Fig 7c. Role-physical Fig 7d. Physical functioning 
Fig 7e. Mental health Fig 7f. Role-emotional 





Figure 8 (a-c). Changes in well-being (PHI scores) in both conditions (ITAU+IPPA and only-ITAU) 
at pre-treatment and follow-up (6 and 12 months) assessments. 
Note. Pre-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 months); ITAU+IPPA, 
Improved Treatment as Usual with Intervention focused on the Promotion of Positive Affect; only-ITAU, 
only-Improved Treatment as Usual. 
Fig 8a. Total well-being 
Fig 8b. Remembered well-being 
Fig 8c. Experienced well-being 
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Figure 9 (a-e). Changes in the facets of mindfulness (FFMQ scores) in both conditions (ITAU+IPPA 
and only-ITAU) at pre-treatment and follow-up (6 and 12 months) assessments. 
 
 
Note. Pre-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 months); ITAU+IPPA, 
Improved Treatment as Usual with Intervention focused on the Promotion of Positive Affect; only-
ITAU, only-Improved Treatment as Usual. 
 Fig 9a. Observing 
Fig 9b. Describing 
Fig 9c. Acting with awareness Fig 9d. Not judging inner experience 
Fig 9e. Not reacting to inner experience 
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3.3.3. Clinically significant change in depression severity (PHQ-9) 
Figure 10 presents the proportion of completers in each condition who were classified 
as “recovered", “improved”, “unchanged”, or “deteriorated” at post-treatment (Fig 7a) 
and follow-ups (6 and 12 months) (Fig 7b and 7c) on depression severity. 
There were no statistically significant differences between groups (ITAU+IPPA and 
only-ITAU) in the clinically meaningful improvement in depression at post-treatment, 
χ²(3, N = 66) = 1.94, p = .672, Cramer’s V = 0.19; follow-up-1 (6 months), χ²(2, N = 41) 
= 0.12, p = .941, Cramer’s V = 0.06, and follow-up-2 (12 months), χ²(2, N = 36) = 1.88, 
p = .459, Cramer’s V = 0.23. 
Overall, both treatment conditions showed high percentages of “unchanged” 
participants during post-treatment, “improved” participants during follow-up-1, and 
“unchanged” participants during follow-up-2. 
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Figure 10. Clinical significance of changes in depression severity (PHQ-9 scores) in both conditions 
(ITAU+IPPA and only-ITAU) at post-treatment (Fig 7a) and follow-up (6 and 12 months) assessments 




Note. Percentage of the completer sample in each condition corresponding to recovered, improved, 
unchanged, or deteriorated.  ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the 
Promotion of Positive Affect; only-ITAU, only-Improved Treatment as Usual. 
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3.4.   Differential cost-effectiveness of two treatment conditions 
There were no statistically significant differences between groups on the cost-
effectiveness outcomes at baseline: number of visits to the GP in the past three months, 
t(55) = 0.80, p = .428; number of visits to the emergency room in the past three months, 
t(37) = 0.97, p = .330; number of days off work in the past year, t(35) = 1.59, p = .121; 
number of days that usual tasks have been left unfinished due to health problems in the 
past month, t(23) = 0.21, p = .833; and number of days when the quality of usual tasks 
has been reduced due to health problems in the past month, t(22) = -1.89, p = .072. 
There was no significant main effect of time on the number of visits to the GP in the 
past three months, F(2, 53.19) = 2.96, p = .061; number of visits to the emergency room 
in the past three months, F(2, 16.51) = 1.33, p = .292; number of days off work in the past 
year, F(2, 25.17) = 0.18, p = .839; and number of days that usual tasks have been left 
unfinished due to health problems in the past month, F(2, 47) = 1.48, p = .239, but there 
was on the number of days when the quality of usual tasks was reduced due to health 
problems in the past month, F(2, 47.55) = 9.48, p < .001, indicating that both conditions 
were only cost-effective in terms of the quality of the usual tasks across time. Moreover, 
there was no significant condition x time interaction effect on the number of visits to the 
GP in the past three months, F(2, 53.19) = 0.11, p = .897; number of visits to the 
emergency room in the past three months, F(2, 16.51) = 0.54, p = .591; number of days 
off work in the past year, F(2, 25.17) = 2.29,  p = .122; number of days that usual tasks 
have been left unfinished due to health problems in the past month, F(2, 47) = 0.81, p = 
.451; and number of days when the quality of usual tasks was reduced due to health 
problems in the past month, F(2, 47.55) = 1.38, p = .262. 
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Effect sizes for within-group comparisons for each condition (pre vs. follow-up-1; 
pre vs. follow-up-2) confirmed a reduction in health and social services use, as small and 
medium effect sizes were found for both conditions, except on the last variable (number 
of days when the quality of usual tasks was reduced due to health problems in the past 
month) with large effect size in follow-up 2 (12 months) (see Table 12 for details). In 
addition, effect sizes for between-group comparisons at each point in time were large at 
follow-up-1 (6 months) for the variable of the number of days that usual tasks have been 
left unfinished due to health problems in the past month (Cohen’s d = -0.80), and at 
follow-up-2 (12 months) for the variable of the number of days off work in the last year 
(Cohen’s d = 1.20) (see Table 13 for details). 
Figure 11 (a-e) shows the changes in cost-effectiveness in both conditions 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 11 (a-e). Changes in cost-effectiveness outcomes in both conditions (ITAU+IPPA and only-




Note. Pre-treatment; FW-1, Follow-up-1 (6 months); FW-2, Follow-up-2 (12 months); ITAU+IPPA, Improved 
Treatment as Usual with Intervention focused on the Promotion of Positive Affect; only-ITAU, only-Improved 
Treatment as Usual. 
Fig 11a. Number of visits to the GP in the past 
three months
Fig 11b. Number of visits to the emergency 
room in the past three months
Fig 11c. Number of days off work in the past year Fig 11d. Number of days that usual tasks have been left 
unfinished due to health problems in the past month 
Fig 11e. Number of days when the quality of usual tasks has been 
reduced due to health problems in the past month 
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3.5.   Post-module analyses in ITAU+IPPA condition: Changes in depression 
severity and affect 
Depression severity (PHQ-9 scores) 
There was a significant main effect of time on depression severity, F(5, 44.56) = 
834.01, p < .01, indicating that ITAU+IPPA was efficacious in decreasing depression 
severity across the modules of the treatment. Within-group comparisons showed a 
medium effect size from post-module 1 to post-module 2, and small effect sizes from 
post-module 2 to post-module 3, as well as from post-module 3 to post-module 4 (see 
Table 14 for details). 
Affect (PANAS scores) 
There was a significant main effect of time on PA, F(5, 55.49) = 2.61, p < .05, and 
NA, F(5, 45.52) = 3.95, p < .01, indicating that ITAU+IPPA was efficacious in increasing 
PA and decreasing NA across the modules of the treatment. Within-group comparisons 
showed medium effect sizes from post-module 1 to post-module 2, and small effect sizes 
from post-module 2 to post-module 3, as well as from post-module 3 to post-module 4, 
for both positive and negative affect outcomes (see Table 14 for details). 
Figure 12 (a-c) shows the changes in depression severity and PA and NA during 
treatment (pre-treatment, post-modules, and post-treatment). 
It is worth to mention that some participants accessed the web platform after finishing 
the treatment period. Specifically, 13 participants accessed to the web platform 
approximately 4 times from post-treatment to 6-month follow-up (M = 3.85, SD = 2.70), 
and 9 participants accessed nearly 2 times from 6-month follow-up to the 12-month 






























































































































































































































































































































































































































































































































































































































































































































Figure 12. Changes in depression severity (PHQ-9 scores) (Fig 9a) and positive and negative affect 
(PANAS scores) (Fig 9b and 9c) during treatment (pre-treatment, post-modules, and post-treatment). 
Note. Pre, Pre-treatment; Post-m1, Post-module 1; Post-m2, Post-module 2; Post-m3, Post-
module 3; Post-m4, Post-module 4; Post, Post-treatment. 
Fig 12a. Depression severity 
Fig 12b. Positive affect 
Fig 12c. Negative affect 
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3.6.   Opinion about the treatment received 
There was a significant main effect of time on rationale behind the treatment, F(1, 
54.99) = 4.35, p < .05; satisfaction with the treatment, F(1, 54.46) = 8.18, p < .01; and 
usefulness of the treatment in the person’s own case, F(1, 54.49) = 10.97, p < .01, but not 
on recommendation of treatment to others, F(1, 56.41) = 3.67, p = .06, and usefulness of 
the treatment for other psychological problems, F(1, 53.78) = 0.59, p = .445, indicating 
that both conditions (ITAU+IPPA and only-ITAU) were efficacious in decreasing the 
participants’ opinion (in terms of rationale, satisfaction, and usefulness for the problem 
itself) about the treatment received from pre-treatment (once the treatment has already 
been explained to the participant) to post-treatment. 
There was a significant main effect of condition 2  on the rationale behind the 
treatment, F(1, 60.24) = 12.67, p ≤ .001; satisfaction with the treatment, F(1, 61.61) = 
12.91, p ≤ .001; recommendation of treatment to others, F(1, 62.54) = 15.97, p ≤ .001; 
usefulness of the treatment in the person’s own case, F(1, 60.77) = 10.97, p ≤ .001; and 
usefulness of the treatment for other psychological problems, F(1, 62.24) = 8.54, p < .01, 
indicating that participants in the ITAU+IPPA condition showed a better opinion about 
the treatment received overall across all points in time than the participants in only-ITAU. 
There was no significant condition x time interaction effect on rationale behind the 
treatment, F(1, 54.99) = 2.69, p = .107; satisfaction with the treatment, F(1, 54.46) = 2.45, 
p = .123, and usefulness of the treatment for other psychological problems, F(1, 53.78) = 
1.24, p = .27, but there was significant differences on recommendation of treatment to 
2 A significant effect of condition was expected because we expected differences from pre-treatment, as 
both treatments had already been explained before filling out these measures at pre-treatment. 
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others, F(1, 56.41) = 5.66, p < .05; and usefulness of the treatment in the person’s own 
case, F(1, 54.49) = 5.83, p < .05. 
Within-group comparisons for each condition (pre vs. post) revealed changes in the 
participants’ opinions with small effect sizes in the ITAU+IPPA condition, and medium 
effect sizes in the only-ITAU condition (see Table 15 for details). Moreover, effect sizes 
for between-group comparisons were large at post-treatment (see Table 16 for details). 











































































































































































































































































































































































































































































































































































































































































































































































































Table 16. Between-group (ITAU+IPPA versus only-ITAU) comparison effect sizes at each point 
in time on opinion outcomes at post-treatment. 
Note. Mean dif, Mean differences; *Statistically Significant; d, Cohen’s d; CI, Confidence 
Interval. 
Note. Mean dif, Mean differences; *Statistically Significant; d, Cohen’s d; CI, Confidence 
Interval.
Measure Post-treatment 
Opinion about the treatment Mean dif. Between-group effect size, 
d [95% CI] 
Rationale behind the treatment 2.43* 0.83 [0.24, 1.41] 
Satisfaction with the treatment 2.58* 0.82 [0.23, 1.41] 
Recommendation of treatment to others 3.36* 0.99 [0.40, 1.59] 
Usefulness of the treatment in the person’s 
own case 
2.95* 0.99 [0.39, 1.59] 
Usefulness of the treatment for other 
psychological problems 




































































































































































































































































































































3.7.   Positive affect as mediator: Is the effect of the condition on the post, follow-up-
1, and follow-up-2-PHQ-9 scores mediated by changes in positive affect PANAS 
scores (post, follow-up-1 and follow-up2-PANAS scores)? 
Unstandardized regression coefficients, standard errors in parenthesis, and 
confidence intervals of the direct, total, and indirect effects are shown in Figure 14 (a-c). 
The indirect effects for all the models were not significant, indicating that the change in 
positive affect (post, follow-up-1, and follow-up-2-PANAS scores) did not mediate the 
relationship between the condition and depression severity (post, follow-up-1, and 
follow-up-2-PHQ-9 scores). Neither the direct effects nor the total effects were significant 










































































































































































































































































































































































































































































































































































































3.8.   Do the sociodemographic (sex, age, marital status, educational level, 
occupation, and income level) and baseline clinical variables (depression 
severity, health-related quality of life SF-12, well-being PHI, and mindfulness 
FFMQ) moderate the effect of the condition on the post, follow-up-1, and follow-
up-2-PHQ-9 scores? 
3.8.1. Post-treatment moderation models 
a) Sociodemographic variables
Moderation analyses showed that the sociodemographic variables did not moderate 
the effect of condition on the post-PHQ-9 scores: sex, F(1, 45) = 0.24, p = .627; age, F(1, 
45) = 2.67, p = .109; marital status, F(1, 45) = 3.31, p = .076; educational level, F(1, 45)
= 1.38, p = .249; occupation, F(1, 45) = 3.38, p = .073; and income level, F(1, 45) = 1.95, 
p = .174. 
b) Clinical variables
Depression severity (baseline PHQ-9 scores) 
No variables of the baseline PHQ-9 measure moderated the effect of condition on the 
post-PHQ-9 scores: F(1, 45) = 0.24, p = .626. 
Health-related quality of life (baseline SF-12 scores) 
The following variables did not moderate the effect of condition on the post-PHQ-9 
scores: general health, F(1, 45) = 0.66, p = .420; bodily pain, F(1, 45) = 0.01, p = .958; 
role-physical, F(1, 45) = 1.83, p = .183; mental health, F(1, 45) = 0.25, p = .622; social 
functioning, F(1, 45) = 0.01, p = .963; and vitality, F(1, 45) = 0.02, p = .876. 
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By contrast, the physical functioning variable moderated the effect of condition on 
the post-PHQ-9 score. The overall model explained 48.44% of the variance, F(4, 45) = 
10.09, p < .001. The interaction between condition and physical functioning did not 
include the zero value in the CI, F(1, 45) = 7.93, p < .01, 95% CI [0.04, 0.22], accounting 
for 9.58% of the variance. Analyses of simple slopes showed that there was a significant 
positive relationship between the condition and the physical functioning variable when 
the physical functioning was “high”, b = 6.11, 95% CI [2.41, 9.80], t = 3.32, p = .002. 
Participants in the ITAU+IPPA condition with higher baseline physical functioning SF-
12 scores achieved lower scores on the post-PHQ-9 (see Figure 15). 
Moreover, the role-emotional variable moderated the effect of condition on the post-
PHQ-9 scores. The overall model explained 36.44% of the variance, F(4, 45) = 9.67, p < 
.001. The interaction between condition and role-emotional did not include the zero value 
in the CI, F(1, 45) = 5.61, p < .05, 95% CI [-0.12, -0.01], accounting for 3.64% of the 
variance. Analyses of simple slopes showed that there was a significant positive 
relationship between condition and the role-emotional variable when the role-emotional 
was “low”, b = 3.46, 95% CI [0.11, 6.81], t = 2.08, p = .043. Participants in the 
ITAU+IPPA condition with lower baseline role-emotional SF-12 scores achieved lower 
scores on the post-PHQ-9 (see Figure 16). 
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Figure 15. Simple slopes graph of the regression of condition on the post-PHQ-9 scores at three 
levels of baseline physical functioning SF-12 (low, medium, high). 
Note. Post, post-treatment; PHQ-9, Patient Health Questionnaire-9; SF-12, Short Form 12 Health 
Survey; ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of 
Positive Affect; only-ITAU, only-Improved Treatment as Usual. “Low”, “medium” and “high” levels 
of the moderators represent the mean and ± 1 standard deviation (SD) (physical functioning SF-12: 
61.92 ± 31.59). Significant p-values (* p < .05, ** p < .01) represent the level of the moderator in 
which the conditional effect of condition on post-PHQ-9 scores is significant. Baseline score is entered 
as a covariate. 
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Figure 16. Simple slopes graph of the regression of condition on the post-PHQ-9 score at three 
levels of the baseline role-emotional SF-12 (low, medium, high). 
Note. Post, post-treatment; PHQ-9, Patient Health Questionnaire-9; SF-12, Short Form 12 Health 
Survey; ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of 
Positive Affect; only-ITAU, only-Improved Treatment as Usual. “Low”, “medium” and “high” levels 
of the moderators represent the mean and ± 1 standard deviation (SD) (role-emotional SF-12: 20.00 ± 
34.00). Significant p-values (* p < .05, ** p < .01) represent the level of the moderator in which the 




Well-being (baseline PHI scores) 
No variables of the baseline PHI measure moderated the effect of condition on the 
post-PHQ-9 scores: total well-being, F(1, 45) = 1.64, p = .207; remembered well-being, 
F(1, 45) = 1.97, p = .168; and experienced well-being, F(1, 45) = 0.06, p = .809. 
Facets of mindfulness (baseline FFMQ scores) 
The following variables did not moderate the effect of condition on the post-PHQ-9 
scores: acting with awareness, F(1, 45) = 0.13, p = .715; not judging inner experience, 
F(1, 45) = 0.21, p = .649; and not reacting to inner experience, F(1, 45) = 0.60, p = .443. 
However, the observing variable moderated the effect of condition on the post-PHQ-
9 score, but the moderation was only marginally significant. The overall model explained 
38.75% of the variance, F(4, 45) = 8.88, p < .001. The interaction between the condition 
and observing did not include the zero value in the CI, F(1, 45) = 3.88, p = .054, 95% CI 
[-0.81, 0.01], accounting for 4.26% of the variance. Analyses of simple slopes showed 
that there was a significant positive relationship between condition and the observing 
variable when the observing was “low”, b = 3.93, 95% CI [0.59, 7.26], t = 2.37, p = .022. 
Participants in the ITAU+IPPA condition with lower baseline observing FFMQ scores 
achieved lower scores on the post-PHQ-9 (see Figure 17). 
In addition, the describing variable moderated the effect of condition on the post-
PHQ-9 score. The overall model explained 44.08% of the variance, F(4, 45) = 10.01, p < 
.001. The interaction between condition and describing did not include the zero value in 
the CI, F(1, 45) = 6.58, p < .05, 95% CI [-1.06, -0.13], accounting for 13.69% of the 
variance. Analyses of simple slopes showed that there was a significant positive 
relationship between the condition and the describing variable when the describing was 
“low”, b = 6.87, 95% CI [2.71, 11.04], t = 3.32, p = .002. Participants in the ITAU+IPPA 
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condition with lower baseline describing FFMQ scores achieved lower scores on the post-
PHQ-9 (see Figure 18). 
Figure 17. Simple slopes graph of the regression of condition on the post-PHQ-9 scores at three 
levels of the baseline observing FFMQ (low, medium, high). 
Note. Post, post-treatment; PHQ-9, Patient Health Questionnaire-9; FFMQ, Five Facet Mindfulness 
Questionnaire; ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the 
Promotion of Positive Affect; only-ITAU, only-Improved Treatment as Usual. “Low”, “medium” and 
“high” levels of the moderators represent the mean and ± 1 standard deviation (SD) (observing FFMQ: 
20.50 ± 6.07). Significant p-values (* p < .05, ** p < .01) represent the level of the moderator at which 
the conditional effect of the condition on the post-PHQ-9 score is significant. Baseline score is entered 
as a covariate. 
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Figure 18. Simple slopes graph of the regression of condition on the post-PHQ-9 score at three 
levels of the baseline describing FFMQ (low, medium, high). 
Note. Post, post-treatment; PHQ-9, Patient Health Questionnaire-9; FFMQ, Five Facet Mindfulness 
Questionnaire; ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the 
Promotion of Positive Affect; only-ITAU, only-Improved Treatment as Usual. “Low”, “medium” and 
“high” levels of the moderators represent the mean and ± 1 standard deviation (SD) (describing FFMQ: 
23.98 ± 7.53). Significant p-values (* p < .05, ** p < .01) represent the level of the moderator at which 
the conditional effect of the condition on the post-PHQ-9 score is significant. Baseline score is entered 
as a covariate. 
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3.8.2. Follow-up-1 (6 months) moderation models 
a) Sociodemographic variables
Moderation analyses showed that the sociodemographic variables did not moderate 
the effect of the condition on the follow-up-1-PHQ-9 score: sex, F(1, 35) = 0.03, p = .863; 
age, F(1, 35) = 1.44, p = .238; marital status, F(1, 35) = 0.03, p = .855; educational level, 
F(1, 35) = 2.92, p = .098; occupation, F(1, 35) = 0.73, p = .396; and income level, F(1, 
35) = 0.08, p = .787.
b) Clinical variables
Depression severity (baseline PHQ-9 scores) 
No variables of the baseline PHQ-9 measure moderated the effect of condition on the 
follow-up-1-PHQ-9 scores: F(1, 35) = 0.55, p = .462. 
Health-related quality of life (baseline SF-12 scores) 
The following variables did not moderate the effect of the condition on the follow-
up-1-PHQ-9 scores: general health, F(1, 35) = 0.18, p = .678; bodily pain, F(1, 35) = 0.25, 
p = .618; role-physical, F(1, 35) = 1.18, p = .284; physical functioning, F(1, 35) = 0.13, 
p = .719; mental health, F(1, 35) = 3.33, p = .077; role-emotional, F(1, 35) = 0.68, p = 
.416; and vitality, F(1, 35) = 1.55, p = .221. 
Nevertheless, the social functioning variable marginally significantly moderated the 
effect of the condition on the follow-up-1-PHQ-9 score. The overall model explained 
41.91% of the variance, F(4, 35) = 5.61, p = .052. The interaction between condition and 
social functioning did not include the zero value in the CI, F(1, 35) = 4.03, p = .052, 95% 
CI [-0.33, 0.01], accounting for 7.81% of the variance. Analyses of simple slopes showed 
that there was a significant positive relationship between the condition and the social 
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functioning variable when social functioning was “low”, b = 6.04, 95% CI [0.42, 11.66], 
t = 2.19, p = .036. Participants in the ITAU+IPPA condition with lower baseline social 
functioning SF-12 scores achieved lower scores on the follow-up-1-PHQ-9 (see Figure 
19). 
Figure 19. Simple slopes graph of the regression of condition on the follow-up-1-PHQ-9 scores 
at three levels of baseline social functioning SF-12(low, medium, high). 
Note. Post, post-treatment; PHQ-9, Patient Health Questionnaire-9; SF-12, Short Form 12 Health 
Survey; ITAU+IPPA, Improved Treatment as Usual with Intervention focused on the Promotion of 
Positive Affect; only-ITAU, only-Improved Treatment as Usual. “Low”, “medium” and “high” levels 
of the moderators represent the mean and ± 1 standard deviation (SD) (social functioning SF-12: 40.00 
± 23.72). Significant p-values (* p < .05, ** p < .01) represent the level of the moderator at which the 
conditional effect of the condition on the follow-up-1-PHQ-9 score is significant. Baseline score is 
entered as a covariate. 
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Well-being (baseline PHI scores) 
No variables of the baseline PHI measure moderated the effect of condition on the 
follow-up-1-PHQ-9 scores: total well-being, F(1, 35) = 0.22, p = .639; remembered well-
being, F(1, 35) = 0.14, p = .712; and experienced well-being, F(1, 35) = 1.62, p = .211. 
Facets of mindfulness (baseline FFMQ scores) 
No variables of the baseline FFMQ moderated the effect of the condition on the 
follow-up-1-PHQ-9 scores: observing, F(1, 35) = 0.15, p = .704; describing, F(1, 35) = 
2.79, p = .104; acting with awareness, F(1, 35) = 0.34, p = .562; not judging inner 
experience, F(1, 35) = 0.32, p = .576; and not reacting to inner experience, F(1, 35) = 
0.11, p = .742. 
3.8.3. Follow-up-2 (12 months) moderation models 
a) Sociodemographic variables
Moderation analyses showed that the sociodemographic variables did not moderate 
the effect of the condition on the follow-up-2-PHQ-9 scores: sex, F(1, 30) = 0.01, p = 
.907; age, F(1, 30) = 2.57, p = .119; marital status, F(1, 35) = 0.17, p = .680; educational 
level, F(1, 35) = 2.92, p = .098; occupation, F(1, 35) = 0.73, p = .396; and income level, 
F(1, 35) = 3.40, p = .078. 
b) Clinical variables
Depression severity (baseline PHQ-9 scores) 
No variables of the baseline PHQ-9 measure moderated the effect of condition on the 
follow-up-2-PHQ-9 scores: F(1, 30) = 0.18, p = .674. 
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Health-related quality of life (baseline SF-12 scores) 
No variables of the baseline SF-12 measure moderated the effect of the condition on 
the follow-up-2-PHQ-9 scores: general health, F(1, 30) = 0.38, p = .541; bodily pain, F(1, 
30) = 0.48, p = .828; role-physical, F(1, 30) = 0.46, p = .501; physical functioning, F(1,
30) = 0.74, p = .395; mental health, F(1, 30) = 0.02, p = .901; role-emotional, F(1, 30) =
0.13, p = .721; social functioning, F(1, 30) = 0.01, p = .910; and vitality, F(1, 30) = 0.15, 
p = .700. 
Well-being (baseline PHI scores) 
No variables of the baseline PHI measure moderated the effect of the condition on the 
follow-up-2-PHQ-9 scores: total well-being, F(1, 30) = 0.85, p = .365; remembered well-
being, F(1, 30) = 0.88, p = .356; and experienced well-being, F(1, 30) = 0.03, p = .862. 
Facets of mindfulness (baseline FFMQ scores) 
No variables of the baseline FFMQ moderated the effect of the condition on the 
follow-up-2-PHQ-9 scores: observing, F(1, 30) = 0.17, p = .682; describing, F(1, 30) = 
0.75, p = .395; acting with awareness, F(1, 30) = 0.11, p = .743; not judging inner 
experience, F(1, 30) = 0.01, p = .928; and not reacting to inner experience, F(1, 30) = 
0.13, p = .725. 
In next chapter, the main findings will be summarized and the main results will be 
discussed in relation to previous literature. Moreover, the limitations and future directions 
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The general objective of this study was to investigate the efficacy and cost-
effectiveness of an improved treatment as usual (ITAU) with a low-intensity Internet-
based computerized intervention focused on the promotion of positive affect 
(ITAU+IPPA) for the treatment of depression, compared to only the ITAU (only-ITAU) 
in Spanish primary care (PC) settings. 
The specific objectives of this dissertation were: 
1. To examine the efficacy of both interventions (ITAU+IPPA and only-ITAU) in
decreasing depression severity and increasing other secondary variables (affect, 
health-related quality of life, well-being and mindfulness) after treatment and 
follow-ups (6 and 12 months). 
2. To analyze whether both interventions (ITAU+IPPA and only-ITAU) are cost-
effective psychological treatments for depression in PC settings. 
3. To analyze the participants' opinions of the treatment received.
4. To explore the possible mediator and moderator roles of several relevant variables
in the effect of the condition on the depression severity. 
In the following subsections, a general discussion will be presented. 
1. Efficacy of treatments for depression in primary care settings
The first hypothesis proposed that the condition of ITAU+IPPA would be more 
efficacious compared to the only-ITAU condition in improving depression severity and 
other secondary variables (affect, health-related quality of life, well-being and 
mindfulness) after treatment and follow-ups (6 and 12 months). This hypothesis was not 
confirmed, and the results showed that both treatments (ITAU+IPPA and only-ITAU) 
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were equally efficacious in producing changes in all the variables after treatment and 
follow-ups. 
Although there were no statistically significant differences between treatments, 
information regarding treatment effect sizes will be discussed for each condition in all 
measurement variables. 
1.1.   Depression severity 
Both treatments were efficacious in reducing depression severity across time. 
Participants in the ITAU+IPPA condition presented a moderate-severe baseline 
depression, which changed to moderate after the treatment, and to mild at follow-up 1, 
returning to moderate at follow-up 2. Participants in the only-ITAU condition presented 
a moderate baseline depression, remained the same after treatment and follow-up 1, and 
changed to mild at follow-up 2. 
Although depression severity decreased in all participants, it is observed that the 
change in the severity was faster in the ITAU+IPPA condition, with larger effect sizes 
compared to only-ITAU at post-treatment. Moreover, the percentage of participants 
classified as recovered and improved was higher (but not significantly) in the 
ITAU+IPPA condition (40%) compared to the only-ITAU condition (30%) after the, 
treatment. This result suggests that the Internet-based psychological intervention (IPPA) 
as an adjunct to the ITAU, could impact depression outcomes in a faster way than the 
only-ITAU. 
In addition, these findings are consistent with the results of the meta-analysis by 
Bower et al. (2013), which showed the influence of initial depression severity on the 
effectiveness of low-intensity psychological interventions (in traditional and online 
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format). Specifically, the outcomes of this study revealed that patients with more severe 
baseline depression had larger treatment effects than those who were less severely 
depressed, but not significantly. Thus, our results on the use of low-intensity Internet-
based interventions are encouraging, even in more severe disorders in the short term. 
Regarding follow-ups, the results showed that depression severity continued to 
decrease and with greater effect sizes for the ITAU+IPPA condition compared to the 
ITAU+IPPA at follow-up 1, but the difference was not significant. However, the 
outcomes showed slightly greater effect sizes for the only-ITAU condition compared to 
ITAU+IPPA at follow-up 2. There were also better percentages of recovered, improved, 
and unchanged participants in the only-ITAU condition during follow-ups. This result 
suggests that both treatment conditions have different time evolutions. More studies are 
needed to investigate the appropriate dose of psychological treatments to make them more 
efficacious in the long term (National Institute for Health and Care Excellence, 2017). 
Overall, the efficacy results are consistent with other studies that have examined the role 
of Internet-based interventions as an adjunct to the treatment provided in PC for adults 
with depression. For example, Gilbody et al. (2015) found that supported Internet-
delivered cognitive behavioral therapy (ICBT) (Beating the Blues or MoodGYM) was 
not more efficacious in reducing depressive symptomatology than usual medical care 
alone. Montero-Marín et al. (2016) also found no differences between a guided or self-
guided ICBT compared to ITAU at 3-month follow-up. Norlund et al. (2018) also found 
that computerized guided ICBT was not better than TAU in reducing depression 
symptoms in a sample of patients who had suffered a myocardial infarction. Finally, in a 
systematic review and meta-analysis on the effectiveness of Internet-based interventions 
in a sample of young adults, they were also not found to be more efficacious in reducing 
depression severity, compared to usual care (Ye et al., 2014). 
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1.2.   Affect, health-related quality of life, well-being, and facets of mindfulness 
Affect 
Both treatments were efficacious in increasing positive affect (PA) and decreasing 
negative affect (NA) across time, and there were no statistical differences between the 
two conditions. However, regarding NA, the effect size was slightly greater for the 
ITAU+IPPA condition, especially at post-treatment and follow-up 1, whereas effect sizes 
for PA were greater in the only-ITAU condition compared to the ITAU+IPPA condition 
at post-treatment and follow-up 2. 
These results may be controversial because the opposite pattern was expected, 
considering that the Internet-based intervention was specifically designed to regulate PA. 
However, our results support the idea that the positive psychological interventions (PPIs) 
could also have a relevant impact on the regulation of NA, coinciding with other studies 
(e.g., Pietrowsky, & Mikutta, 2012; Seligman, Rashid, & Parks, 2006; Sin & 
Lyubomirsky 2009; Taylor, Lyubomirsky, & Stein, 2017; Walsh, Cassidy, & Priebe, 
2016). Therefore, positive psychology techniques may lead to transdiagnostic treatment 
strategies for depression. 
Health-related quality of life 
Both treatments were also efficacious in increasing health-related quality of life in 
all variables (general health, bodily pain, role-physical, mental health, role-emotional, 
social-functioning, and vitality), except physical functioning (all participants had high 
baseline scores). The treatment effect size was greater for the ITAU+IPPA condition 
compared to the only-ITAU condition in the general health, bodily pain, mental health, 
role-emotional, and vitality variables at follow-up 1. However, and in the same line of 
depression severity, the treatment effect increased for the only-ITAU condition at follow-
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up 2 in the following variables: general health, role-physical, role-emotional, social-
functioning, and vitality. Here, we again find some different time trajectories of both 
treatment conditions. 
Well-being 
Both treatments were efficacious in increasing well-being (total well-being, 
remembered well-being, and experienced well-being) across time. The treatment effect 
was greater for ITAU+IPPA compared to the only-ITAU condition at follow-up 1. 
However, the treatment effect decreased for ITAU+IPPA and increased for the only-
ITAU condition at follow-up 2. Once again, it seems that ITAU+IPPA was more 
efficacious in producing well-being changes in the short term compared to only-ITAU, 
which was more efficacious in the long term, but not significantly. 
Facets of mindfulness 
Both treatments were efficacious in increasing the facets of mindfulness (observing, 
describing, acting with awareness, not judging inner experience, and not reacting to inner 
experience) across time. The treatment effect was greater for the ITAU+IPPA condition 
in the describing, acting with awareness, and not judging inner experience variables at 
follow-up 1, and for only-ITAU, the observing and not reacting to inner experience 
variables. Moreover, these effects were maintained at follow-up 2, except for the 
observing and not reacting to inner experience variable (which increased for 
ITAU+IPPA), and the acting with awareness (which decreased for ITAU+IPPA). 
Therefore, the ITAU+IPPA condition seems to be more efficacious in producing 
changes in some facets of mindfulness in both the short and long term. This finding is 
relevant because the psychological intervention also addressed aspects related to the 
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ability of mindfulness (e.g., the importance of living and enjoying the present moment, 
savoring) to regulate PA. 
Cebolla, Enrique, Alvear, Soler, and García-Campayo (2017) argue that mindfulness 
is congruent with many principles proposed by PP, such as the development of kindness, 
compassion, and positive emotions. In fact, many PPIs include mindfulness to promote 
well-being and mental health and reduce depression, obtaining good results (Baskin & 
Enrigh, 2004; Fredrickson, Cohn, Coffey, Pek, & Finkel, 2008; Kuyken et al., 2008). 
Therefore, although no differences between treatments were found, it appears that the 
ITAU+IPPA condition plays an influential role in attentional self-regulation for the 
treatment of depression in the short and long term. 
1.3.   Attrition rates 
The percentage of dropouts after treatment was higher for the ITAU+IPPA condition 
(25%) than for the only-ITAU condition (19%), and also at follow-ups. These results 
agree with the literature on Internet-based interventions and similar studies, which usually 
reported between 20-30% of treatment dropouts (e.g., Gilbody et al., 2015; Spek et al., 
2007; van Ballegooijen et al., 2014). 
1.4.   Summary of findings 
Both interventions were equally efficacious in reducing depression severity and NA, 
and increasing the other variables related to positive functioning (PA, health-related 
quality of life, well-being, and facets of mindfulness) until the 12-month follow-up. The 
adherence rate was higher for the only-ITAU condition. 
Although there are no statistically significant differences between treatments, we 
would like to highlight two aspects: first, it seems that the ITAU+IPPA condition 
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produced faster improvements with larger treatment effect sizes in the majority of the 
variables in the short term. And second, it seems that the only-ITAU condition was more 
efficacious in generating and maintaining changes in the long term (except for the 
mindfulness variables). 
Regarding the higher rate of dropouts in the ITAU+IPPA condition, we would like 
to emphasize that this treatment condition was more efficacious in the short term, and this 
result leads us to wonder if this greater efficacy in the short term could not be responsible 
for dropouts of treatment in a context with so little adherence as PC. 
To explain the results on efficacy and dropouts, we would like to take into 
consideration other possible factors (e.g., duration and number of treatment modules, 
therapist support) (Sin, Della Porta, & Lyubomirsky. 2011). These factors will be 
described below. 
Duration and number of treatment modules: Some evidence shows that PPIs with 
longer duration (more weeks) are more efficacious in the long term, both in reducing 
depressive symptomatology and in increasing well-being, than shorter interventions (Sin 
& Lyubomirsky, 2009). In this way, longer interventions can allow patients to have more 
time to practice activities, thus helping them to form habits. Moreover, the majority of 
the Internet-based interventions that were efficacious for the treatment of depression (e.g., 
CBT, transdiagnostic) included a larger number of modules such as Deprexis (Meyer et 
al., 2009), the Well-being program (Titov et al., 2011), or the Unified Protocol (Barlow, 
Allen, & Choate, 2004). However, most studies on online PPIs use short one-week 
exercises, compared to standard treatments, which use a series of modules and exercises 
(Görges, Oehler, von Hirschhausen, Hegerl, & Rummel-Kluge, 2018). Therefore, more 
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research is needed to better determine the appropriate duration (longer or shorter) for PP 
treatment programs to be efficacious in the long term. 
Inclusion of therapist support in the Internet-based intervention: It has been observed 
that Internet-based interventions are more efficacious when more support is offered by 
the therapist (Baumeister, Reichler, Munzinger, & Lin, 2014; Berger, Hämmerli, Gubser, 
Andersson, & Caspar, 2011; Richards & Richardson, 2012). In a similar line, it has been 
found that PPIs without therapist support are not as efficacious as individual therapy or 
group therapy (Sin & Lyubomirsky, 2009). 
Self-selection and motivation towards the assigned treatment: Previous data show 
that the interventions tend to be more successful when people freely choose to participate 
in them than interventions to which people are assigned (Sin & Lyubomirsky, 2009). 
Possibly, these people are more motivated and thus more responsible and enthusiastic in 
following the intervention guidelines. 
Involvement by GPs in the treatment:  The control group in this study consisted of an 
ITAU, which means that the GPs had to apply the medical treatment (e.g., medication) 
and follow the recommended guidelines for the treatment of depression in PC. It is 
possible that this indication and knowing that they were participating in a controlled trial 
encouraged them to effectively follow the guidelines, and, thus, the ITAU was very 
efficacious. 
Finally, considering the involvement by the participants in the treatment, the 
performance of the ITAU+IPPA implied that the participants had a more active role in 
their response to the treatment. In addition to receiving an ITAU (medication, sessions 
with their GP), they had to perform the Internet-based intervention. This could result in a 
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greater degree of involvement by the participants (in terms of time, activity, occupation) 
compared to the participants in only-ITAU. 
2. Cost-effectiveness of two treatment conditions
The second hypothesis proposed that the ITAU+IPPA condition would be more cost-
effective than the only-ITAU condition in terms of health and social services use (visits 
to the GP for any reason, visits to the emergency room, absence from work, leaving the 
usual tasks unfinished, and reduction in the quality of usual tasks due to health problems). 
This hypothesis was not confirmed, and the results only showed that both treatments 
(ITAU+IPPA and only-ITAU) were equally efficacious in producing changes in terms of 
the quality of usual tasks (number of days when the quality of usual tasks had been 
reduced due to health problems in the last month) across time. 
Although there was no significant change in hardly any of the variables related to 
health and social services (except on the item related to quality of usual tasks) from pre-
treatment to the follow-ups, it was observed that the number of visits to the GP (for any 
reason, not specifically psychological problems) and the emergency room, and the 
number of usual tasks left unfinished due to health problems, decreased in both conditions 
during the follow-ups, with small and medium treatment effects. However, the number of 
days off work decreased for the only-ITAU at follow-ups, and increased for the 
ITAU+IPPA condition at follow-up 2, with small and medium treatment effects. Finally, 
the number of days when the quality of usual tasks had been reduced due to health 
problems in the last month decreased in both conditions, but with a greater treatment 
effect in the only-ITAU condition at follow-ups. 
These results are consistent with similar studies, such as Duarte et al. (2017), who 
showed that technically supported interventions did not appear to be more cost-effective 
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than usual GP care from a healthcare perspective and outcomes measured using quality-
adjusted life years (QALYs) over 2 years. In addition, Kenter et al. (2015) showed that 
blended care (Internet-based interventions in combination with face-to-face sessions) was 
more expensive compared to established face-to-face treatments and did not lead to better 
outcomes in terms of general functioning. 
So far, systematic reviews of the cost-effectiveness of Internet-based interventions 
for the treatment of depression show a lack of consistency in the data, and most studies 
differ in the method used to estimate costs (Donker et al., 2015; Hedman, Ljotsson, & 
Lindefors, 2012; Tate, Finkelstein, Khavjou, & Gustafson, 2009). To overcome these 
limitations, Kolovos et al. (2018) evaluated the cost-effectiveness of guided Internet-
based interventions compared to control conditions in a sample of adults with depression 
through an individual–participant data meta‐analysis. Their results indicated that guided 
Internet-based interventions were not considered more cost-effective compared to 
controls (care as usual, waiting list). However, these authors included a minority of 
randomized control trials (RCTs) that had evaluated cost-effectiveness. Therefore, it is 
important to collect more data on cost-effectiveness in order to draw more robust 
conclusions. 
3. Post- module analyses in ITAU+IPPA condition: Changes in depression
severity and affect 
Overall, ITAU+IPPA was efficacious in decreasing depression severity and NA, and 
increasing PA, across the modules of the treatment. However, the effect of the modules 
was greater between modules 1 and 2. Therefore, it seems that the Internet-based 
interventions have an important initial impact on all variables, supporting the idea of a 
faster trajectory of symptomatology improvement. 
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Regarding the percentage of participants who completed each module in the ITAU+IPPA 
condition, only 45% of participants completed all the treatment modules, 65% completed 
three modules, 72.5% two modules, and 77.5% one module. As mentioned above, the 
decrease in the number of participants per module could be explained by the degree of 
involvement that this treatment required, compared to only-ITAU. Moreover, 
participants' depression severity and symptomatology improvement may also influence 
their response to treatment modules. 
It is worth mentioning that some participants accessed the web platform after 
finishing the treatment period. 
4. Participants’ opinion of the treatment received
The third hypothesis proposed that the users’ opinions about the treatment would be 
better in the ITAU+IPPA condition. This hypothesis was confirmed, as participants in the 
ITAU+IPPA  showed a better opinion about the treatment received (in terms of rationale, 
satisfaction, recommendation to others, usefulness for the problem itself, and usefulness 
for other psychological problems) overall, across all points in time (from pre-treatment to 
post-treatment), than the participants in the only-ITAU condition. Although opinions of 
both treatments decreased over time from pre-treatment (once the treatment has already 
been explained to the participant) to post-treatment, the ITAU+IPPA participants showed 
better outcomes on recommending the treatment to others and the usefulness of the 
treatment for the problem itself, compared to the only-ITAU. 




It appears that participants expressed a better opinion of the Internet-based 
intervention. This finding is encouraging because few studies have analyzed patients' 
opinions about different types of treatment (e.g., medical treatment, Internet 
psychological intervention) for depression in a PC setting. One exception is the work by 
Dorow, Löbner, Pabst, Stein, and Riedel-Heller (2018), who examined preferences for 
depression treatments (medication, psychotherapy, combined treatment, talking to friends 
and family, exercise, self-help literature, and Internet-based interventions) in a sample of 
PC patients. Their results showed that the patients had strong preferences for 
psychotherapy, talking to friends and family, and exercise. In addition, they found that 
1/5 patients considered Internet-based interventions to be a good treatment for depression 
(especially younger patients). Recently, Walsh, Szymczynska, Taylor, and Priebe (2018) 
analyzed the acceptability of an online intervention based on positive psychology for the 
treatment of depression, finding greater acceptance of this treatment among participants 
who considered it relevant to their depression (own problem), consistent with our results. 
Future studies should continue to investigate aspects related to opinions or treatment 
preferences for depression, taking into account different types of intervention (in 
traditional or online format) in a PC setting. Specifically, 13 participants accessed the 
web platform approximately 4 times from post-treatment to 6-month follow-up, and 9 
participants accessed nearly 2 times from 6-month follow-up to the 12-month follow-up. 
This may indicate a positive aspect of the Internet-based interventions, given that 
information is always available when the patient needs it, even if s/he has dropped out of 




5. Positive affect as mediator variable 
The fourth hypothesis proposed that participants in the ITAU+IPPA condition 
(compared to control) would have a greater change in PA (both after treatment and 
follow-ups), leading to a greater reduction in the depression severity (both after treatment 
and follow-ups). This hypothesis was not confirmed because the effect of condition on 
depression severity scores at post-treatment and follow-ups was not mediated by the 
change in PA at any assessment time. This result suggests that the IPPA was not as 
effective in producing changes in the PA. As explained above, no statistically significant 
differences were found between treatments, and the inclusion of IPPA did not result in 
larger effect sizes, compared to the control condition, in reducing depression symptoms 
in the long term. 
Although PPIs have often been used to promote well-being and up-regulate PA in 
the individual, their implications in the clinical setting seem questionable according to 
the literature (e.g., Mongrain & Anselmo-Matthews, 2012). For example, in some studies 
no differences have been found between online PPIs and placebo groups in increasing 
happiness and reducing depression (Woodworth, O’Brien-Malone, Diamond, & Schütz, 
2016a). Therefore, it is necessary to investigate these interventions in a theoretical 
framework that identifies possible mediating factors of their effects on depression 
severity (Woodworth, O’Brien-Malone, Diamond, & Schütz, 2016b). 
6. Sociodemographic and baseline clinical variables as moderators
No specific hypotheses were generated about which moderator variables 
(sociodemographic and baseline clinical variables) could be significant in the effect of 
the condition (ITAU+IPPA vs. only-ITAU) on depression severity after treatment and 
follow-ups, due to the exploratory nature of the analyses. 
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The results showed that the sociodemographic variables (sex, marital status, 
educational level, occupation, and income level) and some baseline clinical variables of 
depression severity, health-related quality of life (general health, bodily pain, role-
physical, mental health, and vitality), well-being (total well-being, remembered well-
being, and experienced well-being), and facets of mindfulness (acting with awareness, 
not judging inner experience, and not reacting to inner experience) did not moderate the 
effect of the condition on the depression severity scores at post-treatment and follow-ups. 
By contrast, the physical functioning and the role-emotional (health-related quality 
of life variables) moderated the effect of the condition on the depression severity scores 
at post-treatment. Specifically, the participants in the ITAU+IPPA condition with higher 
baseline physical functioning and lower baseline role-emotional scores achieved lower 
depression severity scores at post-treatment. Moreover, social functioning (another 
health-related quality of life variable) moderated the effect of the condition on the 
depression severity scores at 6-month follow-up, but in a marginally significant way. The 
participants in the ITAU+IPPA condition with lower baseline social functioning scores 
achieved lower depression severity scores at 6-month follow-up. It seems that participants 
with better physical functioning but worse role-emotional and social functioning 
benefited more from ITAU+IPPA in decreasing their depression severity. 
Good physical functioning (as a protective factor of depression) of participants in 
pre-treatment could have contributed to greater adherence to the IPPA guidelines (one of 
which focused on the role of activity in well-being) (Warburton, Nicol, & Bredin, 2006). 
Moreover, other therapeutic strategies of the IPPA (e.g., emotional regulation or social 
support) could have helped them to improve their role-emotional (emotional intelligence) 
and social functioning (social skills), resulting in an improvement in their depression 
severity across time. These findings support the idea that emotional regulation (Extremera 
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& Rey, 2015) and social support (Chou & Chi, 2001) may moderate the effect of 
depression. 
Taking into account the baseline facets of mindfulness, the observing and describing 
variables moderated the effect of the condition on the depression severity scores at post-
treatment. Specifically, the participants in the ITAU+IPPA condition with lower baseline 
observing and describing scores achieved lower depression severity scores at post-
treatment. It appears that participants with more difficulties in observing and describing 
benefited more from ITAU+IPPA in decreasing their depression severity. Therefore, the 
inclusion of the IPPA as adjunct treatment (focused also on aspects related to 
mindfulness) allowed the participants to attend to their internal and external experiences 
(e.g., sensations, thoughts or emotions) and label them with words, thus contributing to 
the improvement of their depression severity. These findings indicate that it is important 
to consider the mindfulness abilities within PPIs to reduce depressive symptomatology 
(Cebolla et al., 2017; Sin et al., 2011). 
More studies are needed to identify potential moderators of the response to online 
PPIs in depression, and also in PC settings. 
7. Limitations
Some limitations of the current study should be pointed out: 
First, the dropout rate in both conditions, and especially in the ITAU+IPPA 
condition, could have affected the statistical power, and therefore in the rest of the 




Second, we do not have information about the reasons for participant dropout. It is 
relevant to explore the reasons to find ways to address this problem. The qualitative 
perspective could help to analyze these experiences of treatment dropout in a clearer and 
deeper way (Fernández-Álvarez et al., 2017). 
Third, we do not have any record of the number of sessions directed to depression 
problems with the GP and the medication dose related to ITAU adherence. It would be 
necessary to consider these variables in the future, and analyze whether participants in 
Internet-based interventions receive less medical attention, which could be a cost-
effectiveness variable of this treatment. 
Fourth, we do not have information about the diagnosis of possible co-morbid 
disorders of depression. It would have been interesting to know if the treatments were 
also efficacious in producing changes in other symptomatologies such as anxiety. In this 
way, we could have obtained more information about the role played by the IPPA, which 
was based on the transdiagnostic perspective. 
Fifth, information about the participants' previous history of depression has not been 
taken into account in this study. These data are important because the possible chronicity 
or familiarity with treatments (medical or psychological) could have influenced the 
results (e.g., Görges et al., 2018). 
Finally, this study did not use a validated measurement instrument to analyze the 
cost-effectiveness of the treatments evaluated. It is important that all RCTs include the 
same or similar instruments in order to analyze their evidence in a more systematic way 




In this study, we include some elements related to therapeutic support to increase 
adherence to the Internet-based intervention. Specifically, there was a face-to-face group 
session with a therapist to explain the intervention. Moreover, we included weekly text 
messages and emails to encourage the participants to continue with the program and 
perform tasks. Future research could explore other types of therapeutic support (e.g., 
weekly telephone support, use of online therapists) to analyze whether there is greater 
participation and greater adherence to computerized treatment. Thus far, it has been 
shown that therapist support is positively associated with greater efficacy and a lower 
dropout rate from Internet-based interventions (e.g., Johansson & Andersson, 2012; 
Richards & Richardson, 2012). 
Another aspect that would be interesting to analyze in the future is the inclusion of 
other psychotherapeutic components aimed at NA regulation (e.g., CBT) along with the 
IPPA, as in other studies (e.g., Díaz et al., 2017). This would allow us to know whether 
IPPA would be more efficacious for depressive symptomatology and other variables 
related to positive functioning. 
Further studies could include tailored interventions targeted at the characteristics, 
needs, and preferences of patients with depression and possible comorbid disorders 
(Batterham, Calear, Farrer, McCallum, & Cheng, 2018). In this way, health professionals 
(both GPs and psychologists) would more efficaciously treat depression (Johansson et al., 
2012). 
In addition, hybrid designs are needed to progress in clinical efficacy (to provide 
evidence-based treatments) and knowledge about implementation (taking into account 
processes such as planning, educating, financing, restructuring, managing quality, and 
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policy context) to improve their translation into routing healthcare for the treatment of 
depression (Powell et al., 2012). 
So far, most Internet evidence-based treatments for depression have been delivered 
through computers. Future studies would also have to take into account other innovative 
technologies (e.g., smartphone, serious games, avatars and virtual reality) to improve 
access to these treatments and even their effects (Cuijpers, Kleiboer, Karyotaki & Riper, 
2017). A recent meta-analysis shows that smartphone devices are a promising self-
management tool for depression (Firth et al., 2017). More studies are needed on the 
application of these technologies in a PC setting. 
9. Conclusions 
This is the first study in Spain to analyze the efficacy and cost-effectiveness of a low-
intensity Internet-based intervention focused on the transdiagnostic perspective and 
positive psychology combined with ITAU, and compared to the only-ITAU for the 
treatment of depression in a PC setting.  Moreover, this work provides data on the effect 
of both interventions over time in relation to the changes achieved after the treatment (6 
and 12-month follow-up). 
The main findings regarding the objectives of this dissertation are presented in the 
following points: 
 The inclusion of an Internet-based intervention did not substantially improve
depression outcomes compared to the only-ITAU. However, our results support the 
use of low-intensity Internet based-interventions to promote faster improvements in 
depression along with the ITAU. Its implementation in PC centers would help both 
the patient (who often does not receive adequate treatment or is on a waiting list) and 
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the GP (who does not have enough time in consultation to offer adequate treatment) 
in reducing the gap between the treatment demand and supply. 
 Our study did not support the idea that a low-intensity Internet-based intervention
along with ITAU was more cost-effective than only-ITAU. Both treatments were 
equally cost-effective in terms of the quality of the performance of usual or daily life 
tasks. 
 Regarding participants’ opinions of the treatment received, the ITAU+IPPA was
better valued than the only-ITAU from pre-treatment to post-treatment. This suggests 
that technologies could be an attractive tool for the treatment of depression in health 
care. 
 The PA was not a mediator variable for the relationship between the condition and
the depression severity. 
 Some variables of health-related quality of life (physical functioning, role-emotional,
social functioning) and mindfulness (observing and describing) were moderator 
variables associated with a better prognosis in depression severity after the 
ITAU+IPPA treatment. 
It is important to continue to research the role of guided low-intensity Internet-based 
interventions for the treatment of depression and in the context of PC, taking into account 
the transdiagnostic perspective, tailored programs, implementation strategies, and other 
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